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ABSTRACT 
Block copolymers of polylactide and poly( ethylene glycol) (PLA-PEG) were 
investigated as biodegradable drug d e l i \ ' ( ~ r y y systems. They are defined by the 
differing molecular weight ratios of polylactide to poly( ethylene glycol). Copolymers 
containing more hydrophilic PEG than hydrophobic PLA per molecule self-dispersed 
in water giving spherical non ionic micelles. Purification by gel permeation 
chromatography gave two peaks. The first peak only formed micelles (the second 
was PLA-depleted). Analysis by dynamic light scattering (DLS) and transmission 
electron microscopy (TEM) gave diameters of IS.6nm and 18.9nm for I.S:2 and 2:S 
PLA-PEG micelles respectively. 
PLA-PEG copolymers with more PLA than PEG per molecule (4:2 and 6:2 PLA-
PEG) formed "solid particles" by the solvent-precipitation method. GPC purification 
again gave two peaks, but smaller second peaks. DLS analysis gave diameters of 
IS.1 nm and 20.8nm for 4:2 and 6:2 PLA-PEG particles respectively (confirmed by 
TEM and atomic force microscopy (AFM)). 
Static secondary ion mass spectrometry and X-ray photoelectron spectroscopy 
showed PEG at the surface of 4:2 and 6:2 PLA-PEG in watcr and acctone. Stability 
testing to salt suggested sterically stability. Rheological measurements determined 
PEG chain layer thicknesses, with the thickest chain for 2:S PLA-PEG (where PEG 
chain length is SOOOgmor l compared with 2000gmor l ). 
Testosterone and sudan black B (SBB), were used as "model" drugs with different 
hydrophobicities. Ultracentrifugation sedimentation velocity studies confirmed drug 
incorporation. Aromatic SBB loaded readily (2:S9.0%w/w) compared with steroidal 
testosterone «2%w/w). Loading of testosterone esters of varying hydrophobicity 
into PLA-PEG particles showed little difference compared to between testosterone 
and SBB, suggesting that aromaticity is more significant. In vitro release studies (4:2 
PLA-PEG particles/SBB) showed a small burst release, then linear release to twenty-
eight days. 
In vivo studies in the rat, using a radioactive marker, demonstrated extended blood 
circulation times for PLA-PEG micelles during the three-hour study, with increased 
blood levels and lower liver uptake for I.S:2 over 2:S PLA-PEG micelles. PLA-PEG 
particles were directed to the liver. 
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CHAPTER ONE 
INTRODUCTION 
1.1 THE CONCEPT OF DRUG TARGETING 
Despite the many advances in drug delivery In recent years, the achievement of 
improved selective action of drugs in the body remains a major goal. A great deal of 
current research is therefore being performed on the development of systems for the 
"targeting" of drugs to specific sites within the body. This approach was initiated by 
Ehrlich (1906), who hoped for a "magic bullet" which would be both potent and 
selective for a particular receptor. . Continuing this theme, the idea of a "magic gun" was 
formed (Tomlinson, 1983), which would act as a carrier, taking drug molecules to the 
site of action and then releasing them. This would be particularly advantageous with 
anticancer therapy, where compounds often have a low therapeutic index and are non-
specific, giving rise to unpleasant side effects. Frequently, only a fraction of the drug 
injected reaches its site of action, and the rest is distributed throughout the body 
depending on the drug characteristics. Also, drugs are commonly lipophilic and may be 
insoluble or unstable in aqueous media and therefore unsuitable for parenteral injection. 
Although more soluble derivatives can be synthesised, this has often led to a decrease 
in therapeutic effect (Leyland-Jones, 1993). Drugs have been formulated into organic 
surfactants, such as Tween 80 solutions, but this has been associated with anaphylactic 
reactions (O'Dwyer et ai, 1986), whereas changing the pH of the media to effect 
solubilisation can cause vasculitis or venous inflammation at the injection site (Leyland-
Jones, 1993). Therefore, there is still a continuing need for new drug delivery systems 
to attempt to solve the problems posed in the administration of both new and existing 
drugs. 
Several methods of targeting drug to a specific site via a carrier system have been 
explored. One such is the modification of the drug substance to give a prod rug (Bodor 
et al. 1975). Another is the use of either monoclonal antibodies, their immunologically 
active fragments (F(ab)) or target-recognising proteins, which can be conjugated with 
colloidal particles or drugs and act as "homing" devices for specitic antigens or target 
sites within the body (IlIum el ai, 1984; Blume el ai, 1993). However, no practical 
applications for drug therapy have yet been obtained. Several problems have heen 
identified in the use of mono clonal antibodies for drug targeting. These include uptake 
of the antibodies by the reticuloendothelial system (RES), otherwise known as the 
mononuclear phagocytic system (MPS), which clears most of the antibodies from the 
circulation, leaving only a few to carry out the selective action on tumours. Antibodies 
with anticancer drugs can also be taken up by normal cells, causing toxic side etTects. 
Monoclonal antibodies may also have low permeability from blood vessels into 
cancerous tissues (Yokoyama, 1992). This may be a consequence of the decreased 
blood flow in cancerous tissues, added to the low convectional transport across the 
vascular walls of such tissues due to their higher interstitial pressure over normal cells. 
A further approach is to alter the properties of the drug delivery system used to carry the 
drug to its site of action. Various colloidal drug delivery systems have been considered, 
including emulsions, liposomes, natural carriers (such as cells) and both synthetic and 
natural polymeric microparticles and nanoparticles. The use of polymeric particles in 
drug delivery will now be considered further. 
1.2 THE IDEAL PARENTERAL DRUG DELIVERY SYSTEM 
1.2.1 Requirements for a Drug Delivery System (DDS) 
When injecting a drug delivery system into the body, the effect of this system on the host 
must be considered and vice versa. The necessary attributes for the ideal parenteral DDS 
with a view to drug targeting are as listed below (Tomlinson, 1983; Davis and IlIum, 
1986). The preparation should: 
- Show selectivity for the target site. 
- Be able to load and protect drug. 
- Have controllable release of the drug at the site of action. 
- Be stable in vitro and in vivo until site of action is reached (i.e. minimal drug leakage). 
- Show no toxic or immunogenic effect on the host. 
- Be biodegradable and biocompatible. 
- Be inexpensive and able to be sterilised. 
- Be easily prepared on an industrial scale. 
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The above list can be quite fonnidable to achieve and much research is still needed. 
Various research groups have explored the use of colloidal systems in drug delivery over 
several years. A drug could be incorporated into the hydrophobic core of such a system 
and thereby be protected from inactivation by contact with the blood, proteins and 
enzymes. The hydrophobic core can also affect the release rate of the drug into the 
surrounding media, usually decreasing the release (Yokoyama et ai, 1 994a). Drug 
delivery systems may also increase the drug circulation and enhance the bioavailability 
of water-insoluble drugs. 
1.2.2 The Reticuloendothelial System (RES) 
The major challenge for an intravenously injected colloidal drug delivery system is to 
avoid the response to foreign particles mediated by the reticuloendothelial system (RES). 
This is the collective name for a group of highly phagocytic mononuclear cells that are 
distributed throughout the body, either at fixed sites or free in the circulation. Highest 
concentrations of these cells are found in the liver (as fixed macrophages known as 
Kupffer cells), the spleen and the bone marrow (Douglas et ai, 1987). Thus, when 
colloidal particles are injected into the bloodstream, the liver may take them up very 
efficiently. This uptake can lead to over 90% of particles being phagocytosed by the 
liver, with a half-time of less than one minute (Illum et ai, 1982). Uptake is facilitated 
by the substantial blood flow through the liver, with 25% of the cardiac output passing 
through, and also by the structure of the liver. The capillaries found in other tissues have 
been replaced in the liver by large blood vessels known as sinusoids, which have a more 
open structure and act as a filter. The macrophages are located in these sinusoids and 
are therefore able to ingest any passing colloidal particles. These particles are then 
exposed to oxidising agents and degradation by the enzymes of the lysosomes. 
Similarly, the structure of the spleen also consists of open sinusoids, which are designed 
to remove larger colloidal particles. 
The ability of the reticuloendothelial system to react to a colloidal particle is detennined 
by which blood components interact with the particle on injection into the blood. These 
blood components are known as opsonins and dysopsonins. Opsonins are plasma 
components that promote particle uptake by the RES, and dysopsonins are plasma 
components that reduce or inhibit the uptake of particles. The interplay between 
3 
opsonins and dysopsonins may determine whether the mononuclear cells of the RES 
take up a particle, and the rate of particle uptake. 
1.2.3 Colloidal Systems used in DruR Delivery 
Colloidal drug delivery systems discussed here are particulate systems, known as 
microparticles and nanoparticles. Nanoparticles is the collective name for nanospheres 
and nanocapsules in the diameter size range of about I to 1000 nm. Nanospheres have 
a matrix type structure, whereas nanocapsules have a polymeric shell and inner core. 
Drug is either adsorbed at the surface or more usually, entrapped/dissolved in the 
particle core. Similarly, microparticles are in the size range 1 to 1000 I-lm, and are split 
into microspheres and microcapsules. The systems discussed here will be nanospheres 
and microspheres, but the less specific terms, microparticles and nanoparticles, are often 
used. 
Other colloidal systems used in drug delivery are liposomes and micelles. Liposomes 
usually consist of one or more concentric phospholipid bilayers, separated by aqueous 
sections formed spontaneously when phospholipids come into contact with water. 
Within each bilayer, the hydrophobic acyl ends of the phospholipids are opposite each 
other, with the hydrophilic polar ends placed along the outer rim. Liposomes can be 
prepared in different sizes, namely small unilamellar (SUV), large unilamellar (LUV) 
and multi lamellar (ML V). Micelles will be discussed later in this chapter. 
1.2.3.1 Non-Biodegradable Nanoparticies 
In recent years, much work has been performed on non-biodegradable polystyrene latex 
particles. These have acted as a model system that can be easily characterised and 
reproduced with little variation in the characteristics of the particles. Polystyrene 
particles are available in many different sizes with narrow size distributions, allowing 
the effect of particle size on drug delivery to be studied. These nanoparticles of various 
sizes are all directed to the liver after intravenous injection into both rats and rabbits 
(lllum et ai, 1986b). 
Non-biodegradable polyacrylamide nanoparticies have also been synthesised and loaded 
with drug, but manufacture of these nanoparticles is ditlicult, involving large amounts 
of organic solvents and chemical initiators (Allemann el ai, 1993). Early work on 
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poly(alkyl methacrylate) nanoparticles was performed on poly(methyl methacrylate) 
(PMMA) nanoparticles. and drugs were added either by incorporation during the 
polymerisation process or by adsorbing the drug to previously polymerised 
nanoparticles. High incorporation efficiencies were achieved with both methods. but 
due to the lack of biodegradability and the need for a chemical or physical 
polymerisation initiator. these nanoparticles have not been used commercially. 
Similarly. acrylic acid and acrylamide have been studied as nanoparticle systems 
(Lukowski et al. 1992). but only as model polymeric systems and not for commercial 
use. These particles were also located in the RES after intravenous injection (Lukowski 
el ai, 1992). 
Although the use of these nanoparticles has allowed much information to be collected 
on the factors that affect the biodistribution of such particles (discussed below), no 
commercial applications are likely to result as no degradation of the particles would 
occur in vivo. 
1.2.3.2 Biodegradable Nanoparticles 
Research has now moved towards the use of biodegradable nanoparticIes, which have 
the potential to be exploited for therapeutic use in humans. Poly(alkyl cyanoacrylate} 
(PACA) nanoparticles have been studied extensively (Douglas et ai, 1987; Allemann el 
ai, 1993) and are prepared by the emulsion-polymerisation technique. This produces 
particles within the size range 30 nm to 200 run. Drug has been incorporated into these 
nanoparticles during polymerisation, but this can lead to a reduction in drug activity if 
the drug binds covalently to the polymer. Both hydrophilic and hydrophobic drugs have 
been loaded successfully (Allemann el ai, 1993), but further research is needed to assess 
the toxicity and biodegradability of these systems before they can be applied in drug 
delivery. After intravenous injection. these nanoparticles localise in the liver due to 
uptake by the Kupffer cells of the RES (Douglas et ai, 1987). This uptake can be 
minimised and methods of achieving this will be discussed later in this introduction. 
Nanoparticles prepared by polymerisation may, however. contain unreacted toxic 
monomers, and have a risk of reaction between any loaded drug and the monomer. 
Therefore. other means of nanoparticle preparation have been explored. One method 
that has been researched is the use of natural macromolecules such as human serum 
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albumin (HSA). Nanoparticlcs of this protein have been prepared by several methods. 
including heat denaturation (Chen el al. 1994) or cross-linking of a watcr-in-oil 
emulsion of albumin (Lin el af. 1994). Most drugs incorporated have been water soluble 
(Chen cl al. 1994) and high entrapment efticiencies have been achieved (Allemann el 
al. 1993). 
Other possibilities for material for nanoparticle preparation are synthetic polymers. The 
most research has been performed on the poly(a-esters). (that is. ester polymers prepared 
from a-hydroxy acids), particularly poly(lactic acid). otherwise known as polylactide 
(PLA). and poly(glycolic acid) (PGA) (Figure 1.1). These are usually prepared by ring-
opening polymerisation of the lactide or glycolide. Polylactide comes in two forms: 
poly(L-lactide) (LPLA) and poly(DL-lactide) (DLPLA). where LP LA is more crystalline. 
Poly(DL-lactide) is referred to as simply PLA in this thesis. Poly(glycolic acid) is the 
more hydrophilic of the two polymers and will therefore degrade faster than PLA, as the 
degradation is mostly hydrolytically controlled with the eventual degradation products 
being water and carbon dioxide (Langer, 1993). Copolymers of PLA and PGA have also 
been widely studied, with differing release rates and degradation achieved by varying 
the ratio and molecular weight of PLA:PGA. These copolymers are known as 
poly(lactide-co-glycolide) (PLG), or poly(lactic-co-glycolic acid) (PLGA). 
PLA and PGA have been widely researched for therapeutic applications due to their 
biodegradability in vivo and toxicological acceptability. PLA is degraded by hydrolytic 
deesterification in vivo to lactic acid, a normal metabolite in the glycolytic cycle of 
carbohydrate metabolism (Kulkarni et ai, 1971). Devices made from PLA for bone 
fracture internal fixation (Biofix and Phusilines) and from PLGA for anticancer drug 
delivery systems (Zoladex) are now commercially available (Vert el ai, 1995). PLGA 
microspheres have been explored for use as an implant in the brain and found to be 
biocompatible (Menei et al. 1993). The large range of properties of these polymers (they 
can be made into films, fibres, rods or nanoparticles) should allow their therapeutic uses 
to increase further. 
Nanoparticles of PLA and PLGA can be prepared by an emulsion-evaporation process. 
Here. the polymer is dissolved in a chlorinated solvent and emulsified in an aqueous 
phase containing a surfactant. The organic solvent is then evaporated. Another method 
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Figure 1.1 - Structures of Poly lactic Acid (PLA) and Polyglycolic Acid (PGA) 
CH 0 
1 3 11 
Q 
11 
[- CH-C-Q-] [-CI-I 2-C-1 
PLA PGA 
7 
of preparation is the "salting-out procedure", where an emulsion technique is used which 
eliminates the need tor the chlorinated solvents and surfactants used with the emulsion-
evaporation process (Allemann et ai, 1993). In this technique. a saturated electrolyte or 
nonelectrolyte solution is added to a solution containing poly(vinyl alcohol) and an 
acetonic solution of the polymer. An oil-in-water emulsion is produced and water added 
to allow complete ditlusion of the acetone into the aqueous phase, inducing nanoparticle 
formation. A further method of preparation is the solvent-precipitation method proposed 
by Fessi et al (1988). This involves dissolving the polymer in a water-miscible solvent, 
and adding this solution to a non-solvent for the polymer (usually water), which causes 
it to precipitate out as nanoparticies. The solvent is then evaporated. leaving a 
dispersion of nanoparticles. 
Various drugs have been incorporated into nanoparticles and microparticles prepared 
from PLA and PLGA polymers, and an overview of this drug loading is given in Chapter 
Five of this thesis. Proteins, peptides and hormones have also been successfully 
incorporated into PLGA copolymers (Couvreur and Puisieux, 1993; Heya et ai, 1994; 
Niwa et ai, 1994; Okada et ai, 1994; Lu and Park, 1995), and they have the potential for 
use in vaccine delivery (Alonso et aI, 1994; Coombes et ai, 1995; Van et ai, 1995). 
In vivo work with PLA and PLGA has shown that nanoparticles prepared from these 
polymers are predominantly localised in the liver. Krause et al (1985) showed that PLA 
nanoparticles « 1000 nm) injected intravenously into rats were mainly found in the liver 
(42.9% of injected dose), kidney (5.42%) and bone marrow (1.96%) at two hours after 
injection. Similarly, Allemann et al (1994) noted that PLA nanoparticles (736 nm) were 
mainly concentrated in the liver (55.22% of the injected dose) and spleen (8.41%), 
twenty-four hours after intravenous injection into rats. PLGA nanoparticles 
(approximately 100 nm diameter) were also predominantly taken up by the liver (89.8% 
of the injected dose) three hours after intravenous injection into rats (Dunn et ai, 1997), 
with the spleen accounting for a smaller percentage than the PLA nanoparticles (3.1 %). 
Less than 10% of the injected dose remained in the circulation, fifteen minutes after 
injection of the nanoparticles. 
Other candidates for use as biodegradable nanoparticles are derivatives of the 
poly(organo phosphazene) polymers. These polymers have an inorganic backbone 
consisting of alternating nitrogen and phosphorus atoms linked by alternating single and 
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double bonds. Particles have been produced, by the precipitation solvent evaporation 
method, from a poly(organo phosphazene) derivative cosubstituted with phenylalanine 
and glycine ethyl ester side groups (Vandorpe et ai, 1996). This method formed 
nanoparticles of about 200 nm diameter, with the formation and colloidal stability 
controlled by attractive hydrophobic forces between the phenylalanine ester groups and 
electrostatic repulsions between the carboxyl groups formed from partial hydrolysis of 
the ester bonds. 
1.3 FACTORS AFFECTING THE BIODISTRIBUTION OF COLLOIDAL CARRIERS 
1.3.1 Particle Size 
As described above, most colloidal particles are directed to the cells of the 
reticuloendothelial system, particularly the liver, on injection into the bloodstream. The 
physicochemical characteristics of the particles and their efTect on this RES uptake will 
now be considered in more detail. 
The size of particles is important in determining their in vivo biodistribution. This 
parameter can be manipulated to achieve "passive" targeting, where targeting is achieved 
by using a natural physiological process of the body. Particles of greater than 7 to 12 !lm 
in size are mechanically trapped in the capillary beds ofthe lungs, whereas smaller fibre-
shaped particles of less than 5 !lm can be trapped in the lungs in a "log-jam" effect 
(Illum et ai, 1982). Colloidal particles of 0.1 to 2 !lm are mostly taken up by the cells 
of the reticuloendothelial system of the liver and spleen, such as the liver Kupffer cells. 
This could also be exploited for passive targeting, for delivering anti-infectives in 
diseases such as candidiasis or leishmaniasis, or cytotoxics in some forms of leukaemia 
(Davis and IlIum, 1986). 
Particles of less than 100 nm offer the possibility of vascular escape through the 
fenestrations (i.e. openings) in the liver endothelium (Douglas et ai, 1987), if they can 
evade capture by the RES. The sinusoids of the liver, unlike the capillaries in other 
tissues, have no basement membrane and are discontinuous. As the capillaries are 
fenestrated, with fenestrae of around 100 nm, theoretically the nanoparticles could 
extravasate. Once through these gaps, they would reach the space of Disse and the 
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possibility of uptake by the liver parenchymal cells (hepatocytes) is presented (Davis and 
Ilium, 1986). This possibility is illustrated by viruses, which can he considered to be a 
naturally occurring model of a drug carrier, penetrating specific cells, and avoiding RES 
recognition. They may also penetrate through the sinusoidal and tCnestrated capillaries. 
which have pores of 100 nm in diameter (Yokoyama et aI, 1990). 
1.3.2 Sur/ace Hydrophohicityl li.vdrophilicitJ' 
When a colloidal particle is injected into the blood, it comes into contact with the 
various blood components, which can coat the particle surface. This process is known 
as opsonization if the blood components are opsonins, and leads to RES uptake. The 
likelihood of opsonization is related to the hydrophobicity of the particle surface. Van 
Oss (1987) studied the uptake of blood components onto the surface of bacteria and the 
effect of this on RES uptake, and concluded that surface hydrophobicity was an 
important factor. Thus, hydrophilic particles were made more hydrophobic bi the 
adsorption of immunoglobulin G (lgG) to their surface, which then allowed uptake of 
the particles by the RES. Conversely, hydrophobic particles are taken up by 
macrophages without the need for opsonization (Douglas et ai, 1987). This is explained 
by van der Waals (hydrophobic) interactions between the macrophages and the 
hydrophobic particles, such that the more hydrophobic the particle, the greater the van 
der Waals attractive forces between the particle and the macrophage, and the greater the 
chance of particle uptake. However, increasing hydrophilicity alone is not enough to 
prevent RES uptake. For example, Allemann et al (1994) compared the biodistribution 
in rats of uncoated poly(D,L-lactic acid) nanoparticles with similar nanoparticles coated 
with hydrophilic poly(vinyl alcohol) after intravenous injection. They found that the 
presence ofthe poly(vinyl alcohol) at the nanoparticle surface did not prevent the intense 
phagocytosis by the RES. They concluded that hydrophilicity alone could not prevent 
RES uptake if opsonin-activating groups were present at the nanoparticle surface (e.g. 
the hydroxyl groups). 
1.3.3 Sur/clce Charge 
Particles with different surface charges have been shown to have a similar surtace charge 
after incubation in serum. This is due to the adsorption of scrum components, which 
to 
shield the charge of the particle, creating a new charge. However. the initial surface 
charge contributes to the general surface characteristics of the particle and can detennine 
which serum components adsorb to the particle surface. The size and magnitude of this 
charge can either attract or repel serum components; i.e. serum components with the 
same sign of charge will be adsorbed less, and those with opposite charge will be 
adsorbed more. However, this parameter is not as int1uential as surface hydrophobicity. 
Research has shown that particle surface charge can afTect the biodistribution of 
colloidal particles. Increasing the negative surface potential of liposomes by altering 
phosphatide content showed a decrease in liposome uptake by mouse macrophages, 
when the liposomes were opsonized by complement (Roerdink et aI, 1983). Similarly, 
other authors have observed faster clearance from the circulation with negative 
liposomes compared with positive or neutralliposomes (Juliano et aI, 1975; Richardson 
et ai, 1978). Other studies on liposomes have shown that RES uptake can be reduced, 
and prolonged circulation times achieved with liposomes with a terminal negative 
charge, but that even better results are found with uncharged terminal groups (Allen, 
1994). Therefore, although particle charge affects the biodistribution and uptake by the 
RES of some colloidal systems, the effect is not as pronounced as for particle size or 
hydrophobicity. 
1.4 STERIC ST ABILISA TION 
Passive targeting of colloidal systems to the RES and lungs can be achieved as described 
above, by manipulating their natural path within the body. Active targeting to a desired 
site of action has proved more difficult, but it is recognised now that by altering the 
surface characteristics, the path of a colloidal drug delivery system in vivo can be altered. 
The particle surface characteristics determine whether a particle will attract opsonins 
or dysopsonins, and the most important factors in determining RES uptake are the 
coating of the particles with opsonins from the blood, and the adhesion of the coated 
particles to macrophages (usually the Kupffer cells of the liver). Therefore, a method 
of preventing opsonisation and/or promoting dysopsonisation should lead to decreased 
uptake by the RES and allow the potential for active targeting. 
One method of reducing RES uptake is to preblock the Kuptler cells by injecting a RES 
depressant such as dextran sulphate or latex particles. IlIum et al (1986a) showed that, 
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after such treatment. only 30% of subsequently injected polystyrene particles were found 
in the liver and spleen of rabbits, compared with 90% for untreated animals. However, 
this strategy for reducing RES uptake is far from ideal as impairment of the RES can 
have serious consequences. Another method of avoiding uptake is thus required. 
It is reasonable that a drug carrier that prolongs the circulation of a drug in the blood 
may also prolong its efficacy by allowing longer access to the site of action. Much 
research in the drug targeting field has therefore concentrated on prolonging the 
circulation time of potential drug delivery systems in the blood. Originally, it was noted 
that most cells in vivo have a surface glycocalyx of glycoproteins and glycolipids, 
making the cell surfaces hydrophilic and negatively charged (Alien, 1994a). 
Conclusions were drawn that these surface groups and the properties of the surface were 
therefore responsible for the non-recognition of circulating cells such as red blood cells. 
Research was then concentrated on emulating these surface properties, to see if similar 
results could be achieved with drug carriers. A certain degree of success has been 
achieved with the glycolipid, monosialoganglioside GM\, with a reduction in the uptake 
by the RES of the liver and concomitant increase in blood circulation ofliposomes noted 
(Allen, 1994a and b). However, potential problems with commercial acceptability of 
liposomes containing GM\ led to research for a substitute that would give comparable 
results in vivo. 
Research has now shown that the hydrophilic polymer, polyethylene glycol (PEG), also 
known as polyethylene oxide (PEO) or polyoxyethylene (POE), can be applied to the 
surfaces of colloidal particles (IlIum and Davis, 1983) and liposomes (by linking to 
phospholipids) (AlIen 1994a and b) and gives a similar effect to GM\. Generally, low 
molecular weight polymers (usually those ofless than ID,OOO gmor\) with hydroxyl end 
groups are referred to as polyethylene glycol, whereas higher molecular weight polymers 
are known as polyoxyethylene or polyethylene oxide. It is prepared by polymerisation 
using a catalyst which can be cationic, anionic or co-ordinated anionic. Polyethylene 
glycol contains ether oxygen groups as part of its structure (CHr CH2-O)n, and this 
allows the formation of hydrogen bonds with water, when PEG is in aqueous solution. 
PEG is therefore highly water soluble at ambient temperatures due to its ability to 
tetrahedrally co-ordinate water molecules about its ether group through hydrogen 
bonding, occupying the spaces in the water structure with minimum disruption to that 
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structure (Llanos and Sefton, 1993). The hydrophilic, hydrated PEG chains can form a 
"polymer brush" when applied to the surface of a hydrophobic colloidal entity (Alien. 
1994b), and have been shown to be effective in preventing protein adsorption. platelet 
adhesion and bacterial adhesion (Amiji and Park, 1994). These properties of PEG are 
thought to be due to its lack of reactivity towards proteins and cells. PEG is therefore 
biocompatible and has been shown to give no adverse physiological response after 
repeated intravenous dosing of PEG 4000 into beagles over a twelve month period 
(Carpenter et ai, 1971). PEG is therefore a suitable polymer for in vivo use and for 
incorporation into drug delivery systems. 
The amphipathic polymers poly(2-methyl-2-oxazoline) (PMOZ) and poly(2-ethyl-2-
oxazoline) (PEOZ), have also been shown to provide similar protection to GM 1 with 
liposomes, providing similar resistance to RES uptake to PEG-modified liposomes 
(Woodle et ai, 1994). This efTect of creating a hydrophilic barrier to reduce uptake by 
the RES of the body and allow the drug carrier system to remain in circulation has been 
termed "steric stabilisation". In this context, it has been defined as "repulsion between 
particles which is generated by oligomers or polymers attached to, or adsorbed to, the 
particle surface" (Harper et al. 1991). This has been accomplished by physically 
adsorbing or grafting hydrophilic polymer chains onto the surface of the particle. The 
dimensions of the stabilising chains need to be greater than the range of the attractive 
van der Waals forces (Illum, 1987; Illum et ai, 1987a; Napper, 1989) to provide a net 
repulsive force between the particles and the cells. This steric barrier is therefore able 
to prevent or alter the opsonisation and the close approach of macrophages necessary for 
the adhesion to the cell surface and hence, the engulfment. The best steric barriers have 
been produced with hydrophilic. uncharged surfaces. 
The theory behind this phenomena can be described in terms of the DLVO theory of 
colloid stability (Rutter and Vincent, 1980). If the particles are charged. both attractive 
(van der Waals) and repulsive (Coulombic) forces may exist and will vary with the 
distance between the particle and the cell. A net attractive force can be present when a 
negatively charged particle and a cell are a certain distance apart. which will become a 
repulsive force as the two approach each other and will appear as a potential energy 
barrier (Illum, 1987). This barrier may be overcome if it is small or the particle 
possesses additional kinetic energy. and adhesion can occur. However. in the case of 
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sterically stahilised particles, the potential energy harrier is high and therefore more 
difficult to overcome, so as to minimise the possihility of adhesion to the cell. 
1.5 SURFACE MODIFICATION BY PHYSICAL ADSORPTION 
1.5.1 Physical Adsorption with Block Copolymers 
Research has been aimed at positioning PEG at the surface of colloidal systems to 
provide a steric barrier. One method of achieving this is by physically adsorbing block 
copolymers to the surface of nanoparticles. Copolymers are defined as polymers 
consisting of several different monomer units. There are four main types of copolymer: 
random, alternate, graft and block copolymers. The two types that will be discussed here 
are graft and block copolymers. Graft copolymers have chemically linked pairs of 
homopolymers and may resemble a comb, with one homopolymer forming the backbone 
and the other covalentiy attached at various positions along this backbone. Conversely, 
block copolymers have terminally connected homopolymers, such that a mono mer 
consists of just one connection between the different homopolymers, as opposed to many 
for the graft copolymers. Block copolymers can be classified as diblock or triblock, 
according to the number of blocks present in each copolymer. The simplest type, is 
known as a diblock or AB block copolymer, and consists of two blocks, one of A units 
and one of B units. Triblock copolymers are known for example as ABA block 
copolymers, and consist of three blocks, where an A block is connected to both terminals 
of the B block. The other type of block copolymer, known as a multi block copolymer 
or (AB)n block copolymer alternately repeats A and B blocks in one polymer chain, and 
is not usually used in pharmaceutical work. 
In order to provide steric stabilisation for nanoparticles, block copolymers need to be 
composed of a hydrophobic block and a hydrophilic block (commonly PEG). The 
hydrophobic block is required to anchor the block copolymer to the particle surface, so 
it must have a high affinity for the particle surface and not be easily displaced by the 
plasma proteins. On the other hand, the hydrophilic block is needed to extend into the 
aqueous environment to prevent opsonization and therefore the uptake of particles by 
the RES. The length of the hydrophilic segment and its flexibility determines how 
successful the steric repulsion is at overcoming the van der Waals forces (Amiji and 
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Park, 1994). Thus, block copolymers are more effective at stabilising nanoparticks than 
homopolymers when physical adsorption is used, due to the di rtcrellt but complementary 
roles of the two segments. Most research to date has centred on the ABA block 
copolymers. poloxamers and poloxamines. 
Poloxamers and poloxamines (commercially known as Pluronics (HASI') or Synperonics 
(leI Surfactants) and Tetronics respectively) are ABA block copolymers. For 
poloxamers, the A blocks are composed of hydrophilic PEO and the B block is the 
lipophilic polypropylene oxide (PPO) block (PEO-PPO-PEO), whereas poloxamines are 
tetrafunctional with four PEO-PPO blocks joined by a central ethylenediamine bridge 
«PEO-PPOh-x-(PPO-PEO)2). The general structures are illustrated in Figure 1.2. The 
Pluronic/Synperonic copolymers each have a number that gives an indication of the 
molecular weight, such that the first one or two numbers indicates the molecular weight 
of the PPO block and the last number signifies the weight fraction of the PEO block. 
The notation also begins with L for liquid, P for paste or F for flakes. These polymers 
have been adsorbed onto hydrophobic particies to give a sterically stabilised coating 
layer, with the hydrophobic PPO part adsorbed to the particle surface and the hydrophilic 
PEO chains providing the steric stabilisation by forming an outer layer towards the 
aqueous medium. They are able to adsorb strongly to hydrophobic surfaces and are not 
displaced by dilution in aqueous buffer. The following sections will discuss the progress 
of these systems as coating layers on nanoparticies. 
1.5.2 Coated Model Polystyrene Particles 
Polystyrene particles have been used as a model system due to their ease of use, narrow 
size distribution and commercial availability in a wide range of particle sizes. They can 
be easily radiolabelled with iodine-l 31 to allow their path in vivo to be followed either 
by gamma scintigraphy or by sacrifice and organ removal. The in vivo and in vitro 
experiments discussed here all involve radio labelled polystyrene particles and detection 
ofthe biodistribution by one of those techniques. 
Early work by IlIum and Davis (1983) showed the effect on the in vi\'O distribution of 
radiolabelled polystyrene microspheres after coating with non ionic surfactant. This 
work illustrated the difference between uncoated polystyrene microspheres (1.27 flm 
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diameter) and microspheres coated with Poloxamer 338 when injected intravenously into 
rabbits. While the uncoated microspheres were cleared rapidly from the blood by the 
reticuloendothelial system. the coated microspheres showed a reduced RES uptake and 
a corresponding increase in the blood activity. When the Poloxamer 338 coating was 
compared with another surfactant (IlIum and Davis, 1984), Poloxamer 188. using 
smaller polystyrene microspheres of 50-60 nm, the Poloxamer 338 microspheres showed 
a much reduced RES uptake over both 188 coated microspheres and uncoated 
microspheres after intravenous injection into rabbits. The un coated microspheres were 
again cleared at a rate of about 90% of the injected dose to the RES, with a half time tor 
clearance of 50 seconds. This difference between the poloxamers was attributed to 
differences in their composition. especially of the PEO chain. Poloxamer 188 has an 
average ethylene oxide block of 75 (in mol) compared with 128 for Poloxamer 388, 
which corresponds to estimated adsorbed layer thicknesses of 14 nm and 26 nm 
respectively. The effect ofthe copolymer composition was studied further for a range 
of poloxamers and poloxamines, using mouse peritoneal macrophages as a model for 
RES uptake (Illum et ai, 1987a). The physicochemical characteristics of the coated 
particles were also studied, with regard to the adsorbed layer thickness, the surface 
charge (as measured by zeta potential) and the critical flocculation temperature. This 
paper showed that the adsorbed layer thickness of the coating on the polystyrene 
particles (60 nm) was directly dependent on the ethylene oxide content and independent 
of the propylene oxide content. From measurements of the adsorbed layer thickness 
compared with the estimated sizes for the poloxamers 188 and 338, it was concluded 
that the PEO chains are usually in the loop conformation on the surface of the particles 
(IlIum et ai, 1987a). Adsorption of the copolymers to the particle surface also led to a 
decrease in the negative surface charge (zeta potential), making the particles more 
neutral and less susceptible to RES uptake. The critical flocculation temperature gives 
a measure of the ability of a polymer to stabilise particles by steric stabilisation and 
became constant once the adsorbed layer thickness was over about 50 A. When these 
physicochemical data were correlated with the results of the mouse peritoneal 
macrophage uptake experiments. it was clear that the greater the adsorbed layer 
thickness. the lower the relative phagocytic uptake. Greater adsorbed layer thicknesses 
also corresponded to a greater decrease in surface charge. The molecular weight of the 
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PPO was found to be important in anchoring the copolymer to the particle surface, 
preventing desorption and displacement of the copolymer in vivo, with higher PPO 
molecular weights giving better anchoring (ilium et ai, 1986b). 
Thus, the magnitude of the adsorbed layer thickness and its ability to sterically stabilise 
the particle surface and suppress surface charge are important for decreasing the uptake 
of colloidal particles by the reticuloendothelial system. Hydrophilicity of the surface 
alone is not enough. This was illustrated in a paper by IlIum et al (l986b), where the 
efficiency of coating polystyrene particles with hydrophilic materials (secretory 
immunoglobulin A (SIgA), egg lecithin and the poloxamers 188 and 388) was compared 
with respect to reducing liver uptake in in vivo experiments in rabbits and mouse 
peritoneal macrophage uptake experiments. The in vivo experiments showed that the 
SlgA and lecithin only reduced 'the liver/spleen uptake by 2% and 14% respectively, 
compared with a reduction in liver/spleen uptake by 20% for poloxamer 188 and 44% 
for poloxamer 388. Mouse peritoneal macrophage experiments also confirmed this 
order of uptake. In the case of the poloxamer 388, the particles were redistributed to 
some extent to the bone marrow instead. Redirection to the bone marrow after 
intravenous injection into rabbits has also been noted with Poloxamer 407 (IlIum and 
Davis, 1987). Here, the liver/spleen uptake was reduced further than for Poloxamer 338, 
down to 17% of the activity, of which 10% could be attributed to the activity in the 
circulation (blood pool), i.e. not due to particle uptake. Targeting of the bone marrow 
would be useful both for treating diseases of the bone marrow, such as bone marrow 
cancer and for radiodiagnostics. 
The promising results seen with regard to bone marrow targeting for particles coated 
with poloxamer 407 were investigated further. Polystyrene particles (70 nm) coated 
with poloxamer 407 were compared with "solid" unilamellar liposomes 
(DSPC/ChoIIDCP), which had been incubated with poloxamer 407 (Moghimi et ai, 
1991a). However, no poloxamer coating could be found at the liposome surface in 
physicochemical analysis and no significant difference in biodistribution was observed 
after intravenous injection into rats. Research was therefore concentrated on colloidal 
particles, and further studies on coated polystyrene particles (less than ISO nm) showed 
that the particles were sequestered in the sinusoidal endothelial cells of the bone marrow 
utter intravenous injection into, rabbits, suggesting that the steric barrier was being 
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overcome and a specific interaction with the cell surface was occurring (Porter et ai, 
1992). This specificity of interaction was further implied by the lack of bone marrow 
uptake seen with other poloxamer and poloxamine coatings. The conclusions were 
complicated further by the discovery that only Poloxamer 407 from one supplier gave 
the pronounced bone marrow uptake (Porter et ai, 1992). This was attributed to 
differences in the molecular weight distribution of the polymer. 
Targeting of the vascular circulation has also been achieved by coating polystyrene 
particles (50-60 nm) with poloxarnine 908 (IlIum et ai, I 987b). These particles showed 
little uptake by the liver/spleen, but remained in the circulation, with 60% of particles 
detected in the circulation after one hour compared with 3% ofthe uncoated polystyrene 
particles. In this case, non-recognition by the reticuloendothelial system has been 
achieved, with a significantly prolonged circulation time. 
Spleen targeting has been achieved by using larger polystyrene microspheres (220-300 
nm) coated with poloxarnine 908. Following intravenous injection into rats, these 
microspheres were accumulated in the spleen by a filtration mechanism (Moghimi et ai, 
1991 b). These microspheres could then be phagocytosed by the macrophages of the red 
pulp 24 hours after administration (Moghimi et ai, 1993a). This was postulated as being 
due to either loss of the surface adsorbed poloxamine 908 or "neutralisation" of the anti-
phagocytic effect of the poloxamine 908 within the spleen. 
Lymphatic targeting has been attempted also using polystyrene micro spheres as model 
colIoidal particles. A wide range of poloxamers and poloxamines were used to coat the 
polystyrene particles (60 nm) and then the particles were injected sub-cutaneously into 
the rat footpads (Moghimi et ai, 1994). A correlation was found between the length of 
the stabilising PEO chains of the poloxamers and poloxamines, the drainage of 
nanoparticles from the injection site and their passage across the tissue lymph interface 
in the dermal lymphatic capillaries of the rat footpad. This correlation was that the 
longer the PEO chains, the faster the drainage. Therefore, whereas nanoparticles with 
PEO chains of 5-15 ethylene oxide units were effectively opsonized in the lymphatics, 
nanoparticles with longer PEO chains were rapidly drained and reached the systemic 
circulation. With the shorter chains, lymphatic targeting could be successfully achieved, 
with up to 40% of the administered dose sequestered by the macrophages of the regional 
lymph nodes. 
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1.5.3 Coated Biodegradable Particles 
While the above results were very promising and yielded much data on the principles 
involved in avoiding the reticuloendothelial system and targeting specific areas of the 
body, the systems involved can have no clinical application as they are non-
biodegradable. More recent research has therefore concentrated on producing similar 
systems to those described above, but replacing the non-degradable polystyrene particles 
with biodegradable particles. 
As mentioned above, the diameter of the nanoparticles is important, with some larger 
coated nanoparticles (over 200 nm) being directed to the spleen, and smaller coated 
nanoparticles (60-200 nm) able to remain in the vascular compartment or target the bone 
marrow or lymph nodes. Liu et al (1992) and Litzinger et al (1994) have carried out 
studies on the effect of liposome diameter on the circulation time and organ distribution 
after intravenous injection into mice. These groups studied liposomes stabilised with 
ganglioside GM, and PEG respectively. to provide the hydrophilic coating necessary for 
RES avoidance. Liu et al (1992) noted that with their system (liposomes of 
phosphatidylcholine. cholesterol and GM,). optimal circulation was achieved when the 
liposome size was in the diameter range 70 to 200 nm. Increasing the diameter further 
resulted in increased spleen uptake with a corresponding decrease in the circulating 
blood level. Spleen uptake became predominant when the liposome size was increased 
above 300 nm. Similarly, Litzinger et al (1994) noted that their liposomes (containing 
dioleoyl-N-(monomethoxypoly(ethylene glycol)succinyl)-phosphatidylethanolamine 
(PEG-PE)) also showed long circulation times for liposomes of 150-200 nrn, whereas 
liposomes over 300 nm were directed to the spleen. 
It was therefore important to produce PEG-coated particles of less than 200 nm diameter 
if long blood circulation times were to be achieved. Scholes et al (1993) succeeded in 
producing biodegradable PLGA nanoparticles in this size range by varying the 
parameters of the solvent evaporation technique. Small particle sizes (down to 90 nm) 
could be reproducibJy formed by the use of low PLGA concentration, increased 
surfactant concentration and a two stage emulsification process. Particles below 200 nm 
diameter were also produced from poly(beta-malic acid-co-benzyl malate) (PMLABeH) 
copolymers using the precipitation-solvent evaporation method (Stolnik et ai, 1994), 
which was subsequently also used to produce PLGA particles (Scholes, 1994). 
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These particles were coated with poloxamers and poloxamines as the polystyrene 
particles had been previously. PLGA nanoparticles \vere surface modified with 
poloxamers and poloxamines either by adsorption of the copolymers to previously 
prepared nanoparticles or by incorporation into the nanoparticles during production 
(Dunn et ai, 1997). Radiolabelling of the nanoparticles for in vitro and in vivo analysis 
was achieved by incorporating indium-lll-oxine into the nanopartides during 
production. Nanoparticles coated with Poloxamer 407 or Poloxamine 908 showed 
prolonged blood circulation times and a combined reduction in liver and spleen 
accumulation after intravenous injection into rats. Three hours after injection. 39% of 
the dose for Poloxamer 407 and 28% of the Poloxamine 908 dose remained in the blood 
circulation. On comparison with polystyrene-coated nanoparticles, the blood elimination 
profiles and biodistribution were similar. In vivo studies in the rabbit model also gave 
similar results, with long blood circulation times and reduced RES uptake again 
observed (Dunn et ai, 1997). 
Similarly, PLGA nanospheres have been coated with biodegradable polylactic acid-
polyethylene glycol (PLA-PEG) copolymers (Stolnik et ai, 1994). This coating was 
shown to decrease the negative surface charge, increase hydrophilicity and provide steric 
stabilisation when adsorbed to PLGA or polystyrene nanospheres, in comparison with 
uncoated nanospheres. When injected intravenously into rats, the biodistribution was 
greatly changed for the coated PLGA nanospheres in comparison with the uncoated 
PLGA nanospheres. Extended blood circulation levels were noted with the two PLA-
PEG copolymers used (3:4 and 2:5 PLA-PEG), with similar levels to Poloxamine 908 
coated systems being achieved. The blood clearance profiles and deposition of 
nanospheres in the liver and spleen were also similar to Poloxamine 908 coated systems. 
However, with the polystyrene coated systems, the PLA-PEG coated nanospheres 
showed an initial high blood circulation level similar to Poloxamine 908 coated 
nanospheres, which then fell dramatically between one and two hours post-
administration (Stolnik et al. 1994). Thus at three hours post-injection. the liver uptake 
of the coated nanospheres was similar to that of the uncoated polystyrene particles. The 
authors suggested that the reason for this might be a difference in the adsorption stability 
of the PLA-PEG coatings on the polystyrene and PLGA nanospheres. Adsorption of 
protein onto the surface of coated nanospheres is thought to occur gradually, in 
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comparison with polystyrene latex particles where the whole s l l r t ~ l c e e is thought to be 
coated instantaneously (Senior et ai, 1991). The PLA group of the PLA-PEG 
copolymers is the more hydrophobic group, which would be expected to anchor the 
PLA-PEG copolymers to the hydrophobic particle surface. This appears to anchor better 
to a surface of similar structure, i.e. PLGA nanospheres, compared with the polystyrene 
nanospheres, and therefore be more stable to the desorption and displacement that allows 
the gradual adsorption of plasma proteins. The mechanism for this difference is unclear. 
Lymph node targeting has also been explored with biodegradable nanospheres. I kre, 
the nanospheres were injected subcutaneously, which is considered to be the most 
appropriate route for reaching the regional lymph nodes (Hawley et ai, 1995). SlIb-J 00 
nm PLGA nanospheres were coated with poloxamers and poloxamines and radio labelled 
with indium-lll-oxine. The lymphatic distribution was then determined after 
subcutaneous injection into the rat. Coated nanospheres showed an increased lymphatic 
uptake by the regional lymph nodes over uncoated nanospheres, with a maximum lymph 
node uptake of 17% achieved, showing great promise for lymphatic targeting. 
More recent studies have investigated coating the surface of polystyrene and PLGA 
nanoparticles with PLA-PEG copolymers (1.5:0.75, 1.5:2 and 2:5 PLA-PEG) (Hawley 
et ai, 1997). Here, PLA-PEG copolymers were either physically adsorbed to the 
nanoparticle surface or used as a co-precipitate to form PLGA-PLA-PEG nanoparticles. 
In vivo studies in rats injected subcutaneously showed that, depending on the PLA-PEG 
copolymer used, lymph node localisation could be dramatically enhanced. Of the three 
PLA-PEG copolymers studied, the 1.5:2 and 2:5 PLA-PEG copolymers were too 
hydrophilic to be taken up by the lymph node macrophages when coated onto 
polystyrene particles, so that the lymph node localisation of nanoparticles coated with 
these copolymers was reduced in comparison with the uncoated control. However, with 
PLGA particles, all coated systems showed enhanced lymph node localisation over the 
uncoated control nanoparticles. The 1.5:0.75 PLA-PEG copolymer coating gave the best 
results, with 15% lymph node uptake after 24 hours for both polystyrene and PLGA 
coated nanoparticles. Coating of the nanoparticles with PLA-PEG copolymers also 
increased the drainage of the nanoparticles from the injection site, compared with 
uncoated nanoparticles, with the rate of drainage increasing with increasing PEG chain 
length. 
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For nanoparticles prepared hy co-precipitation of PLGA and 1.5:0.75 PLA-PU; 
copolymer. the lymph node uptake was highest with a 75% and 6YYo PLCiA content 
(16% and 17% of lymph node uptake respectively) (Hawley et al. 1997). The drainage 
of nanoparticies from the injection site also increased with increasing percentage of 
Pl.A-PEG in the nanoparticles. in line with the coated nanoparticle results. 
Other biodegradable nanospheres that are being considered for drug targeting are 
sterically stabilised human serum albumin (HSA) nanospheres. These have been 
prepared with a size of less than 200 nm using a modified coacervation method and 
crosslinking with methyl polyethylene glycol modified oxidised dextran (Dextranox-
MPEG) (HSA-mPEG), to give the sterically stabilised surface layer (Lin et al. 1994). 
When injected intravenously, both HSA and HSA-mPEG nanospheres gave a similar 
biodistribution profile, with 27.4% and 32.3% of the injected dose being associated with 
the carcass and 19.4% and 21.1 % of the dose associated with the gut tissue. for HSA and 
HSA-mPEG respectively (Dunn, 1995). The activity in the gut was unexpected, so a 
time course experiment was carried out. Again, HSA and HSAmPEG gave similar 
biodistribution patterns. For both HSA and HSA-PEG nanospheres. at five minutes 
post-injection, most of the injected dose was in the liver, but this activity decreased with 
time and relocated in the carcass, thyroid and gut. Over 20% of the injected dose was 
found in the gut at three hours post-injection for both systems. This was suggested as 
being due to degradation of the HSA in the lysosomal compartment of the liver. 
allowing iodinated metabolites to be selectively directed to the gut tissue. 
1.6 NANOPARTICLES WITH COVALENTLY BONDED PEG/PEO IN DRUG 
TARGETfNG 
Steric repUlsion with homopolymers is not usually effective when physically adsorbed. 
Only high molecular weight PEO homopolymers (MW > 100.000 gmor l ) are 
effectively adsorbed onto hydrophobic surfaces, and other molecules. such as proteins 
and cells. which have a higher affinity for the surface, can still easily remove these. 
Indeed, even the block copolymers described above carry the risk of being desorbed 
from a particle surface after injection into the body, as illustrated by the PLA-PEG 
copolymers when used as coatings for polystyrene nanospheres (Stolnik et al. 1994). 
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Homopolymers need to be covalently grafted to provide a stahle hydrophilic layer. This 
is only possible if the surface has functional groups that can react with PEO derivati\es, 
is pre-modified with reactive functional groups or if grafting is per/tmncd by using UV 
or gamma radiation. 
There are drawbacks to grafting, including the requirement for multiple steps due to the 
lack of functional groups available for modification on many polymers. but grafting of 
PEG to polystyrene nanospheres has produced further intt)rmation on the surface 
characteristics required for steric stabilisation with PEG. Dunn el al (1994) described 
an experiment where the effect of altering the PEG chain density of polystyrene-PEG 
particles was studied. Particles were prepared by varying the copolymerising reaction 
of styrene with a PEG macromonomer. The surface density of the particles was then 
determined by X-ray photoelectron spectroscopy (XPS). When injected intravenously 
into rats, the biodistribution was shown to be related to the density of PEG at the surface 
of the nanoparticles (after three hours). Liver uptake was related to the surface density, 
with the lowest surface density of PEG giving the highest uptake. As the PEG surface 
density increased, the liver uptake was reduced, with a corresponding increase in 
circulating blood levels. 
Another approach to covalentiy bonding the PEG groups is to produce "self-forming" 
systems. These can take the form of particles, micelles or liposomes (micelles are 
described further below). Self-forming nanospheres have been produced by Gref et af 
(1994) using diblock copolymers of PLGA, polycaprolactone (PCL) and their 
copolymers covalently bonded to PEG of different molecular weights. These 
nanospheres were prepared by dissolving the copolymer in an organic solvent and then 
forming an emulsion (oil in water) in an aqueous phase by vortexing and sonicating. 
The solvent was then evaporated to leave nanospheres. PEG was confirmed at the 
surface of these nanospheres using XPS and the nanospheres were radio labelled with 
indium-l1 I-DTPA-SA (diethylenetriamine pentaacetic acid stearyl amide). Intravenous 
injection into mice showed that blood circulation times increased with increasing PEG 
molecular weight. This was explained by an increased thickness of the PEG layer with 
the increased molecular weight, preventing opsonization of the nanospheres. Five 
minutes post-injection, 66% of uncoated PLGA nanospheres had been removed by the 
liver, compared with about 30% ofPEG-PLGA (PEG=20000 gmor l ) nanospheres in the 
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liver at five hours. These nanospheres appeared to possess the steric stability required 
for drug targeting and the physical stability offered hy covalently attached PEG as 
opposed to physically adsorhed PEG as part of a block copolymer. 
Further work by the same group has involyed the study of a wider range of dihlock 
copolymers of the type PEG-R (where R is polyester or polyanhydride). To increase the 
surface density of PEG on the nanoparticles. muItiblock (brush) (PEG}n-R copolymers 
were synthesised, where the R polymer block is covalently attached to more than one 
PEG block (Peracchia el ai, 1997). The increased PEG surface density was confirmed 
by ESCA studies, with even higher PEG surface densities being obtained with high 
molecular weight PEG polymers (PEG = 20000 Oa). The morphological structure and 
encapsulation properties of the nanoparticles were studied. These revealed that with 
PEG-PCL particles, the drug and polyester did not interact, but were segregated in 
separate domains. Conversely, with PEG-PLGA nanospheres there was interaction 
between the polymer and drug. It was also noted that, unlike the diblock copolymers, 
the PEG drastically increased the size of the particles made from the multi block 
copolymers (from 100-120 nm for uncoated particles to 180-240 nm for PEG-coated 
nanoparticles), with the size increasing with increasing PEG chain length. The 
encapsulation efficiency of the four-block copolymers also dropped to around 70%. 
compared with 75-95% for the corresponding diblock copolymers, and non-coated 
particles. In vitro release studies on diblock copolymers showed a biphasic release, with 
continuous release over several hours, and different kinetics for the different polymers. 
The presence of the PEG did not affect the overall amount of drug released. However, 
with the multiblock copolymers, the burst effect was reduced and the drug release 
slowed down. The authors concluded that although the drug is in the particle core, the 
characteristics of the PEG coat affected the time course of the drug release. 
1.7 PLA-PEG COPOLYMERS 
Biodegradable block copolymers produced from polylactic acid (PLA) and poly(ethylene 
glycol) (PEG) exhibit good potential for formulating drug delivery systems. The use of 
the individual polylactic acid and polyethylene glycol components in drug delivery have 
already been discussed, and the biocompatibility of these two polymers makes them 
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suitable candidates for further investigation. PLi\-PHi copolymers with varIOUS 
PLA:PEG ratios. molecular weights. structure and solubility can be synthesised. using 
either the racemic poly(D.L-lactic acid) or isomeric poly(L-lactic acid). Poly(D.L-lactic 
acid) is entirely non-crystalline. whereas poly(L-lactic acid) can form a crystalline phase 
(it is a semi-crystalline polymer). This crystallinity of the LPLA makes it less soluble 
in organic solvents than the DLPLA. and reduces the rate of water uptake of the polymer 
and hence the biodegradation rate compared with DLPLA. There has been considerable 
interest in the synthesis and characterisation of these copolymers. PLA-PEG copolymers 
are AB linear block copolymers. with the general structure shown in figure 1.3. These 
copolymers have been synthesised by ditlerent groups, using different catalysts, creating 
copolymers with differing molecular weight distributions. Zhu et al (1986) synthesised 
PLA-PEG copolymers containing poly(D,L-lactic acid), using aluminium and stannous-
based catalysts. Cohn and Younes (1988a) synthesised a range ofPLA-PEG copolymers 
using poly(L-lactic acid) and PEG, in the presence an antimony trioxide (Sb20 3) catalyst 
by a polyesterification reaction of the lactic acid in the presence of PEG. Another group 
working with poly(D,L-lactic acid) and PEG used ring-opening polymerisation in the 
presence of various catalysts to synthesis PLA-PEG copolymers (Deng et ai, 1990). 
They found that stannous octoate was the best catalyst for copolymerisation of D,L-
lactide with PEG, giving a high yield and molecular weight, whereas antimony trioxide 
was a poor one. The same group later used a complex aluminium catalyst, 
triisobutylaluminium with phosphoric acid and water (AI(i-Bu)3-H3P04-H20), as the 
initiator (Deng el ai, 1995). Hu and Liu (1994a and b) also synthesised PLA-PEG 
copolymers ofpoly(L-lactic acid) and PEG; using a stannous octoate catalyst. 
Research has not been confined to AB block copolymers. ABA block copolymers have 
also been synthesised where A is poly(L-lactic acid) and B is polyoxyethylene (Youxin 
and Kissel, 1993), using aluminium isopropoxide as catalyst. Similarly, ABA PLA-
PEO-PLA block copolymers have been synthesised and studied by Shah el al (1994) 
(using a stannous 2-ethylhexanoate catalyst). Rashkov et al (1996) (using a CaH2 
catalyst) and Li el af (1996) (using a CaH2 or zinc powder catalyst). Blends of PLA-
PEG copolymers with other biodegradable polymers have also been studied (Zhang el 
al. 1995) for potential biomedical applications. 
The research described above has centred on the chemical and physical characterisation 
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Figure 1.3 - Structure of PLA-PEG Copolymer 
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of the PLA-PEG copolymers. This has involved various chemical techniqucs including 
nuclear magnetic resonance (NMR), size exclusion chromatography (SEC) and 
differential scanning calorimetry (DSC). The hydrolytic degradation of the PLA-PEG 
copolymers has also been widely studied (Zhu el ai, 1986; Cohn and Youncs, 1988b: Hu 
and Liu, 1994a and b; Liu el ai, 1994; Shah el ai, 1994: Youxin el ai, 1994), with 
variation of the amount of PEG in the copolymer enabling the degradation rate of the 
copolymer to be controlled. 
The main focus of the interest in PLA-PEG copolymers is their potential for use in 
biomedical applications. PLA-PEG copolymers of low molecular weights have been 
successfully explored as a carrier for bone morphogenetic protein (BMP) as implants 
into bones (Miyamoto et aI, 1993). Zhu et al (1986; 1990) studied AB PLA-PEG 
copolymer matrixes as potential drug delivery systems, observing that drug release 
increased with increasing PEG content. Cohn and Y ounes (1988b) synthesised a family 
of poly(lactic acid)/poly( ethylene oxide) block copolymers in an attempt to provide 
biodegradable elastomers for cardiovascular implants. With these copolymers, the lactic 
acid sequences form degradable 'hard' blocks of the copolymer, whilst flexibility and 
elastic recovery properties were associated with the PEG 'soft' segments. Y ouxin el al 
(1994) studied the potential of LPLA-PEG-LPLA block copolymers as potential 
parenteral drug delivery systems, using bovine serum albumin as a model drug, and 
noted a pulsatile release of drug controlled by the structure and properties of the 
copolymer. 
The ability of PLA-PEG copolymers to form nanoparticles has also been studied. Zhu 
el af (1989) prepared 'super microcapsules' "Of 40-1 00 nm diameter for drug delivery. by 
phase separation of poly( ethylene oxide )-polylactide star-type copolymers. Similar 
higher molecular weight copolymers have been synthesised by Gref et af ( 1994) for drug 
targeting applications, using poly(lactide-co-glycolic acid) (PLGA) or polycaprolactone 
(PCL), attached to PEG. These copolymers formed nanoparticles of mean diameter of 
140 nm, that were able to incorporate drug and avoid uptake by the RES after 
intravenous injection into mice. Later work by the same group also looked at PLA 
attached to multiple blocks of PEG (see above section 1.6), to increase the surface 
density of PEG at the nanoparticle surface (Peracchia el al. 1997). PLA-PEG 
nanoparticles have been prepared by Bazile el af (1995) by the precipitation-solvent 
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diffusion method. In this case. nanoparticles were prepared either from the PLA-PEG 
copolymers as synthesised or with PLA blended into the preparation process. This gave 
nanoparticle sizes ranging from 56 nm to 112 nm for the PLA-PEG copolymers alone. 
or up to over 200 nm when PLA was blended with the PLA-PEG. After intravenous 
injection into rats of 14C-labelled nanoparticles. the circulating half-life of PLA-PEG 
nanoparticles (PEG Mw=5000, PLA theoretical Mw=30000) improved by a factor of 
180 over uncoated PLA nanoparticies. They also found that in ex-vivo experiments with 
cultured THP-l monocytes, the uptake by the monocytes was dependent on the PEG 
chain length, but once the surface density of PEG had plateaued, the chain length ceased 
to be important. 
Another group (AlIemann et ai, 1996) has studied the effect of coating PLA 
nanoparticles (988 nm) with PEG (Mw=20000) and using the nanoparticles as a carrier 
for hexadecafluoro zinc phthalocyanine (ZnPcF 16). This compound is a second-
generation sensitiser for the photodynamic therapy of cancer, and the tumour response 
of the nanoparticie formulation was compared with the response from a Cremophor EL 
emulsion. The authors demonstrated extended circulation of the PEG-coated 
nanoparticies after intravenous injection into mice thereby allowing prolonged tumour 
sensitivity towards the photodynamic therapy, and also an improved response of the 
tumour to the photodynamic therapy over the emulsion formulation. 
Micelles prepared from PLA-PEG copolymers have also been studied in recent research. 
Zareie et al (1996) studied micelles prepared from PLA-PEG copolymers produced by 
transesterification of poly(D,L-lactic acid) (Mn= 1866) with PEG (Mn=3300-4000). 
These micelles were studied using dynamic light scattering (DLS), scanning electron 
microscopy (SEM) and scanning tunnel microscopy (STM). Micelle sizes were found 
to be around 80 nm and 112 nm from DLS for micelles containing 35% (of their 
monomer molecular weight) of PEG and micelles containing 60% of PEG respectively. 
The microscopy techniques showed micelles oflarger sizes (up to 135 nm for 35% PEG 
micelles and 172 nm for 60% PEG micelles using STM). The authors attributed this 
increase in size to the interaction of the micelles with the substrate surface and 
dislocation of the micelles by the STM scanning tip. 
PLA-PEG micelles have been studied as potential carriers of the drug taxol (Zhang el 
al. 1996). The PLA-PEG copolymers were prepared by ring-opening polymerisation in 
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the presence of stannous octoate. producing copolymers with a PEG chain length of 
2000 and PLA to PEG ratios of40:60 and 50:50. Up to 25% w/w taxol was loaded into 
PLA-PEG copolymer matrices and on dissolution. this Vias completely solubilised 
within the micelles. The taxol was strongly bound or associated with the PLA-PEG 
copolymers even below the critical micelle concentration (cmc). 
The two different blocks of PLA-PEG copolymers can share the functions required by 
drug carriers: the outer shell is responsible for interactions with biocomponents (proteins 
and cells) which affect biodistribution and the core is responsible for carrying the drug. 
PLA-PEG copolymers form micelles or nanoparticles with the polylactic acid (PLA) 
providing a hydrophobic core and the polyethylene glycol (PEG) forming a hydrophilic 
shell around the core, with the PEG chains extending into the aqueous media. This 
hydrophobic core can potentially act as a microreservoir for hydrophobic drugs allowing 
PLA-PEG copolymer to be used as a drug delivery system. Incorporation of a drug into 
the core of a delivery system can also protect and stabilise the drug. Utilisation of PLA-
PEG copolymers as drug delivery systems would be advantageous due to the small sizes 
of the micelles and particles formed, which have the potential to circulate for extended 
periods in the bloodstream as discussed previously (section 1.3.1). PLA-PEG copolymer 
systems would be easy to administer and sterilise as parenteral drug delivery systems, 
as their small size would allow them to pass through filters with sub-micron pores, 
allowing sterilisation by filtration. Their biodegradability and biocompatibility also 
means that there would be no long-term accumulation after injection into the body. 
PLA-PEG copolymers therefore offer control of particle size, good structural stability, 
water solubility for micelle-forming systems, and potential for control of size through 
changing the chain length. Their stability should be higher than liposomes as the 
hydrophobic segments intertwine with each other through inter- and intramolecular 
interactions, whereas in liposomes hydrophobic interaction is limited to between 
adjacent lipids (Yokoyama et ai, 1990). The subject of this thesis is therefore to 
investigate further the potential of PLA-PEG copolymers for use as drug delivery 
systems. 
Amphipathic, linear AB block copolymers composed of hydrophobic polylactide (PLA) 
blocks and hydrophilic polyethylene glycol (PEG) blocks. with PEG content ranging 
from 25% to over 70% are the subject of the investigations in this thesis. The triblock 
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copolymer Po]oxamer 407 has been included in some of these studies for comparison 
with PLA-PEG dispersions. as an example of a copolymer that has produced 
encouraging results in drug delivery. Similarly. PLGA particles are also included for 
comparison in some studies as an example of biodegradable nanoparticles. with high 
molecular weight and a hydrophobic surface. The PLA-PEG copolymers discussed here 
are either directly dispersible in aqueous media, self-associating to form micellar 
complexes less than 50 nm in diameter or are formed by a precipitation-solvent 
evaporation method, producing a dispersion of more "solid" nanoparticles of less than 
50 nm in the aqueous media. Control over the chain length, ratio of the hydrophilic and 
hydrophobic components and the copolymer structure (branched or comb-type) is 
possible, and offers the potential for modifying the size and surface characteristics of the 
association complexes formed in water. PLA-PEG copolymers with PEG content in 
excess of 50% form micellar systems, whilst PLA-PEG copolymers with PEG content 
less than 50% (higher PLA content) are insoluble in water and form more solid 
nanoparticle structures. Micelles differ from nanoparticles in that they are dynamic 
systems; that is, they can break down and reform. Micelles also have a minimum 
concentration required for their formation, the critical micelle concentration (CMC). 
Nanoparticles do not have this restriction and are therefore less sensitive to dilution. 
The concept of micelles as a drug delivery system is discussed further below. 
1.8 PROTEIN ADSORPTION 
All colloidal systems will encounter plasma proteins on injection into the body. 
modifying the surface and therefore the properties of the system. These proteins can 
cause opsonization, whereby the adsorption of plasma proteins allows interaction with 
macrophages and subsequent uptake by these cells. There are several proteins in the 
blood that can interact with colloidal systems. Albumin is the most abundant blood 
protein, but does not act as an opsonin. Conversely, the immunoglobulins are likely to 
affect the fate of a colloidal system as the immunoglobulin IgG is a strong opsonin. 
Immunoglobulins can bind to particles either by simple adsorption or by a specific 
reaction with an antigen at the particle surface (Juliano, 1988). An example of the latter 
is the binding of IgG to liposomes composed of glycolipids, which can trigger specific 
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IgG binding, leading to direct opsonization or activation of complement. The 
complement system is composed of twenty different blood proteins that can interact in 
a complex cascade involving specific binding and proteolytic activation steps. The aim 
of this complement activation is to produce the "membrane attack complex", whieh 
causes lysis of cells and proteins. The binding of fragments to complement component 
C3 then opsonises these. Complement is activated by either the formation of an 
antibody/antigen complex or by accelerating the spontaneous conversion of C3 to its 
active form, C3b, a known opsonin. 
Another protein that plays a role in opsonization is fibronectin. This is a large complex 
glycoprotein, responsible for helping cell attachment to the extracellular matrix. 
However, mononuclear phagocytes have cell surface receptors for fibronectin, and it can 
be a strong opsonin, as illustrated by P i ~ k i n n et al (1994), who showed that preadsorbing 
polystyrene particles (2.5 ~ m ) ) with fibronectin significantly enhanced phagocytosis. 
The type of opsonization that occurs will influence the fate of particles. Opsonization 
by IgG leads to interaction with the Fc receptors on RES phagocytes, causing clearance 
by first-order kinetics by the spleen. Opsonization with complement-fixing IgM, which 
allows interaction with receptors for C3 fragments, leads to accumulation in the liver 
(Juliano, 1988). Determining which proteins adsorb to the particle surface can therefore 
aid the understanding of the processes that are involved in the biodistribution of 
colloidal systems. 
Protein adsorption to colloidal systems can be detected by polyacrylamide gel 
electrophoresis (PAGE). In this technique, the particles can be incubated with plasma. 
then washed and the bound proteins compared with protein standards. This technique. 
while providing valuable information. has the drawback in that loosely bound proteins 
will probably be removed by washing. SOS-PAGE (sodium dodecyl sulphate-PAGE) 
was used to study the adsorption of plasma and serum proteins to polystyrene 
microspheres coated with the block copolymers. poloxamers and poloxamines (Norman 
et al. 1993). These studies showed that the amount of protein adsorbed to the block 
copolymer coated system was less than that for the polystyrene system. Also, with 
increasing PEO chain length, the total amount of protein adsorbed was reduced. 
However, protein adsorption was not just dependent on hydrophilicity. but on other 
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factors such as surface confonnation, density and stcric stahilisation effects. The 
reduction in the adsorption of larger molecular weight proteins to coated systems over 
polystyrene was attrihuted to difficulties in penetrating the PEO layer to reach the 
polystyrene surface. Regarding the total amount of protein adsorhcd. the 
hydrophilic/hydrophobic balance between the PEO and PPO appears to be the critical 
parameter. This was illustrated with poloxamers, where those having the same PPO 
chain length adsorbed similar amounts of protein, whereas poloxamers with similar PEO 
chain lengths but longer PPO chain lengths reduced protein adsorption further. This is 
due to the anchoring effect of the PPO chains. Poloxamer 407 and Poloxamine 908 
showed the least protein adsorption, as would be expected from their biodistribution 
patterns, with no apparent differences between the proteins adsorbed to particles coated 
with these systems. Tan et al (1993) also found the poloxamers and poloxamines with 
higher HLB values more effective at reducing adsorption of plasma proteins to particles. 
They found that Pluronic FlO8 and Tetronic T908 were equally effective in preventing 
fibrinogen adsorption, while being more effective at preventing adsorption than similar 
copolymers with lower HLB values. Further, they again illustrated the importance of 
the anchoring PPO block by considering PEG homopolymer (Mw 22000). This was the 
least effective at preventing protein adsorption, when compared with FI08, T908 and 
sodium dodecyl sulphate, despite the greater molecular weight of the PEG compared 
with the PEO chains of the FlO8 and T908. 
Similarly, Blunk et al (1993) analysed polystyrene particles (60 nm) coated with 
poloxamers 184, 188 and 407 with two-dimensional PAGE, and found that the more 
hydrophobic the particles, the greater the ·total protein adsorbed. The authors found 
differences in both the qualitative and quantitative protein adsorption patterns, with the 
more hydrophobic poloxamer 184 adsorbing more protein than the other poloxamers 
studied, with IgG and transferrin being the major proteins detected. 
More recent research has shown that for polystyrene and PLGA particles coated with 
either Poloxamer 407, Poloxamine 904 or Poloxamine 908, increasing the length of the 
PEO chain decreased protein adsorption to the surface (Armstrong et al. 1997). 
Comparing the polystyrene and PLGA particles, the naked polystyrene particles bound 
25% more human serum albumin (HSA) than the naked PLGA particles. whereas 
polystyrene particles coated with Poloxamer 407 or Poloxamine 908 were equally 
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effective in reducing protein adsorption. but when coated onto PL(jA particles. 
Poloxamer 407 had a clear advantage. Coating of polystyrene particles \vith the PI.A-
PEG copolymers (1.5:2 and 2:5) gave a similar reduction in protein adsorption to that 
observed with Poloxamine 908. with no protein layer being detected by photon 
correlation spectroscopy (PCS) on the coated particles after incubation with HSA 
(Stolnik el al. 1994b). 
Polyethylene oxide (PEO) has been much studied as a means of preventing protein 
adsorption. Much work has centred on the block copolymers. poloxamers and 
poloxamines, as discussed above. Amiji and Park (1992) showed that poloxamers 
having 56 or more PO residues were better at preventing plasma protein adsorption and 
platelet adhesion than poloxamers with 30 PO residues. This research is not restricted 
to colloidal systems. Protein adsorption has been studied with regard to many biological 
surfaces, including fused-silica capillaries in capillary electrophoresis. where protein 
adsorption can also be reduced by coating with poloxamers (Ng et ai, 1994). 
With liposomes, PEG-DSPE has been shown to produce a non-specific reduction in 
protein binding to liposomes over conventionalliposomes (Allen. 1994b). Conventional 
liposomes have been shown to adsorb proteins at their surface within one minute of 
incubating in plasma, whereas it took several hours for PEG-containing liposomes to 
adsorb significant amounts. The proteins that were adsorbed could be removed by gel 
permeation chromatography (GPC), suggesting weak binding. Similarly, the uptake of 
poly(D,L-lactic acid) nanoparticles by lymphocytes and monocytes has been studied. 
with and without a PEG (Mw 20000) coating, in the presence and absence of plasma 
(Leroux et ai, 1994). The PEG coating significantly decreased the nanoparticle uptake 
by both the monocytes and lymphocytes, in both saline and plasma. giving evidence of 
the protein resistance of PEG. 
The mechanism whereby PEG/PEO induces protein resistance is thought to be due to 
a steric repulsion effect. As the protein approaches the PEO surface by diffusion, there 
is a van der Waals attraction between the protein and the PEO surface through the water. 
Closer approach of the protein results in compression of the PEO chains, causing a 
steric repulsion effect (Jeon et ai, 1991). There is a further van der Waals attraction 
between the substrate (i.e. the hydrophobic surface) and the protein. This attraction 
decreases with increasing PEO chain length and surface density. Therefore. a long PEO 
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chain length and high surface density should lead to the most protein resistance, with 
surface density being more important than chain length (Jeon et aI, 1991). One of the 
reasons for the success of PEO in protein resistance among the water soluble synthetic 
polymers is that it shows the weakest van der Waals attraction. The magnitude of the 
van der Waals attraction becomes negligible compared to the steric repulsion caused by 
compression of the PEO chains (Jeon et aI, 1991). Studies have also shown that linear 
PEO is more effective than branched PEO at preventing protein adsorption (Bergstrom 
et aI, 1994). This is believed to be due to a restriction in the confonnational freedom 
of the branched PEO chains compared with the linear chains. Other factors that are 
thought to be important in the ability of PEO to resist protein uptake are the 
hydrophilicity, the terminal group chemistry, the chain mobility and steric exclusion 
effects (Llanos and Sefion, 1993). The unique solution properties and molecular 
conformation of PEO in aqueous solution are also important. PEO is thought to fill the 
voids in the water structure while minimally disturbing the water structure, leading to 
a decreased tendency for hydrophobic interactions (Stolnik et ai, 1995). Water 
molecules are hydrogen bonded to the ether oxygens of PEO, fonning "structured" 
water. The dependence of protein resistance on PEO chain length has been suggested 
as due to low molecular weight PEO only being associated with tightly-bound water. 
Conversely, at higher PEO chain lengths, the chain begins to fold in on itself, trapping 
more loosely-bound water between the segments to fonn a repulsive hydrated layer. 
This folding is only possible at longer PEO chain lengths, with at least 1500 gmor l 
being required (Stolnik et ai, 1995). The high mobility of the chains also prevents 
protein adsorption by decreasing the contact time between the surface and the proteins. 
As well as opsonins, there are plasma proteins that can retard or inhibit uptake of 
particles by the RES, and these are known as dysopsonins. Moghimi and Patel (1989) 
found that saturated ammonium sulphate fractions in the ranges 0-35% (y-globulins) and 
50-65% (small molecular proteins) suppressed liposome uptake by Kupffer cells. Later 
research studied uncoated polystyrene and colloidal gold particles, both uncoated and 
coated with poloxamine 908 (Moghimi et aI, 1993b). The interaction of these particles 
with freshly isolated rat liver sinusoidal cells was examined by electron microscopy. 
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Both of the uncoatcd systems were found in the Kupffer cells. with the opsonization of 
the gold particles being identified as due to fibronectin. In contrast. there was little 
uptake of the Poloxamine 908 coated particles by the Kupffer cells. indicating that the 
Poloxamine 908 was preventing the adsorption of fibronectin to the surface of the gold 
particles. The Kupffer cells were unable to recognise the Poloxamine 908 particles 
before and after opsonization. whereas liver endothelial cells endocytosed the particles 
before opsonization but did not recognise the particles after the opsonization process. 
This was thought to be a result of dysopsonic activity in the plasma. Further studies 
using polystyrene particles (whose uptake by phagocytes is known to be independent of 
opsonization) showed that although coating of the particles with Poloxamine 908 
dramatically reduced their uptake by liver sinusoidal cells, the interaction was further 
reduced in the presence of plasma or serum. A heat stable serum component (Mw> I 00 
kDa) was found to regulate this effect. The authors therefore concluded that although 
Poloxamine 908 effectively blocked opsonization, it still allowed dysopsonisation to 
take place. Dysopsonic activity is also apparent with naked polystyrene particles, where 
a reduction in the uptake by Kupffer cells is noted after incubation in the presence of 
serum compared with particles incubated with no serum present (Dunn et ai, 1995). 
Recognition and uptake of colloidal systems by the reticuloendothelial system is 
therefore due to a combination of the hydrophobicity of the surface, the opsonization of 
the surface by plasma proteins of the blood, and dysopsonisation by plasma (or serum 
components). Biodistribution is controlled by a balance of opsonins and dysopsonins 
that adsorb to the particle surface depending on its characteristics. 
1.9 MICELLES 
When the concentration of aqueous solutions of many amphipathic substances is 
increased, a distinct deviation from solution ideality occurs as self-association results 
and micelles are formed. This change can be detected experimentally by measuring, for 
example, surface tension, the molar conductivity of the solution (for ionic micelles). or 
light scattering, and plotting these parameters as a function of concentration. The 
change in the slope indicates the onset of non-ideality where micelles are iomled and is 
referred to as the critical micelle concentration (cmc). The micelles are in dynamic 
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equilibrium with free molecules (knO\\"I1 as monomers or unimers) and are therefore 
continually breaking down and refom1ing. 
Micelle torn1ation is brought about by the amphiphiles reaching a state of minimum free 
energy. Water-hydrocarbon contacts are entropically unfavourable. whereas micelle 
iorn1ation leads to the more favourable hydrophobic interactions between the non-polar 
groups of the amphiphiles by removing the hydrophobes from the aqueous solution. The 
hydrophobic groups are therefore in the core of the micelles and the hydrophilic groups 
are in contact with the aqueous medium, forming a shell around the micelle core. 
otherwise known as the palisade layer or mantle. 
Micelles are considered to be in an association-dissociation equilibrium with their 
monomers. The cmc tends to be a range of concentrations, where the solution shows a 
gradual change in properties rather than a precise concentration, as micelle formation is 
not a distinct phase but remains in equilibrium with monomers. It is therefore diflicult 
to determine the crnc exactly, and there can be wide variability of values between 
methods (Kabanov et ai, 1992; Yu et ai, 1992). The mono mer concentration remains 
fairly constant above the erne, in equilibrium with the micelles. 
Block copolymers have potential in drug delivery systems as each block can have 
different characteristics, allowing it to perform a specific function. A block copolymer 
consisting of two blocks, of which one is soluble and one insoluble in the surrounding 
media can form intermolecular micelles. Thus, in aqueous media, a block copolymer 
with hydrophobic and hydrophilic blocks could form micelles with the hydrophobic 
block as the micelle core and the hydrophilic block surrounding the core and in contact 
with the aqueous media. AB block copolymers are most suitable for micelle fornlation 
due to their size, association number and micelle stability due to the simple architecture 
of their molecules (Yokoyama, 1992). The rate of dissociation of the block copolymer 
micelles into free polymer chains is likely to be slow, as the inner core is stabilised by 
hydrophobic interactions. These hydrophobic interactions may be strong, giving the 
cores a low mobility and solid-like character, as opposed to the liquid-like cores of lower 
molecular weight micelles (Kwon et al. 1993a). 
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J. 9. J Facturs Af[ectinR Micellar Properties 
Block copolymers form micelles with much lower cmc values than those for low 
molecular weight surfactants (Yokoyama et al. I 994a). This is because a block 
copolymer molecule has more interaction sites for other copolymer molecules than low 
molecular weight surfactants. A consequence of this lower cmc is that stable micelles 
will exist in an in vivo situation for longer periods of time than for a low molecular 
weight surfactant, and drug delivery can be controlled by the micelle properties rather 
than the properties of the single copolymer chains. 
The micellar behaviour of block copolymers mostly depends on their molecular 
characteristics, which are the type, molecular weight and block composition of the 
copolymer, and also, the selectivity and solubility parameters of the solvent (i.e. whether 
polar or non-polar), the temperature and the concentration ranges studied. 
An increase in molecular weight usually results in an increase in micellar diameter and 
aggregation number (Bahadur et ai, 1985). A similar trend is seen with an increase of 
the water insoluble block of the copolymer, in this case the hydrophobic chain length. 
Generally, cmc is also seen to decrease with increasing hydrophobe (Omnli et ai, 1985). 
Block copolymers with PEO (PEG) as their hydrophile show an increase in cmc and 
decrease in aggregation number with increasing PEO chain length, and therefore 
increasing hydrophilicity. 
For most non-ionic surfactants, an increase In micellar hydrodynamic radius and 
decrease in cmc are observed with increasing temperature (AI-Saden et ai, 1982). This 
increase is seen up to the cloud point, where the solution becomes turbid and there is 
separation into two phases (section 4.4). An increase in aggregation number may also 
be noted (Luo et ai, 1993). However, there are exceptions, such as with micelles formed 
using styrene-butadiene and styrene isoprene block copolymers in n-heptane, where an 
increase in temperature leads to a decrease in the hydrodynamic radius. This decrease 
is thought to be accounted for by a decrease in micellar weight or aggregation number 
(Bahadur et ai, 1985; Omnli et ai, 1985). For the poloxamers, it has been noted that not 
all of these copolymers form micelles, and in some cases micellisation only occurs when 
the temperature is increased to the critical micelle temperature (CMT). The CMT is 
mainly dependent on the length of the hydrophobic block, although the length of the 
hydrophilic block does have some influence (Almgren et ai, 1992). 
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Micelles are assumed to be dense spherical fonnulations and as such will undergo little 
defonnation in moderate concentrations as they approach each other. However, as the 
concentration is increased, the interaction becomes more important, detennining the 
properties of the solution. Here, the micelle experiences Van der Waals forces of 
attraction between the amphiphiles and the solvent, as well as the local interactions 
between micelles (Lobaskin and Pershin, 1993). An increase in temperature will also 
increase intennicellar interactions (Lobaskin and Pershin, 1993) and a decrease in 
micelle-solvent interactions will occur (AI-Saden et ai, 1982). Interaction of the 
micelles will cause contraction of the polymer chains, squeezing out the solvent, even 
if not much solvent is present. 
As the concentration is increased, starting from a dilute solution of the block copolymer, 
where the copolymer exists as monomers, the hydrodynamic radius increases (AI-Saden 
et ai, 1982; Lobaskin and Pershin, 1993). When the cmc is reached, the hydrodynamic 
radius of the micelles is constant (AI-Saden et ai, 1985; Lobaskin and Pershin, 1993). 
At concentrations far from the cmc, micelle properties such as aggregation number are 
only weakly dependent on concentration (Leibler et ai, 1983). The equilibrium between 
monomers and micelles will shift towards the micelles as the concentration is increased 
(Oranli et ai, 1985), and with further increases gelation may occur (Almgren et ai, 1992; 
Luo et ai, 1993). This may also occur with an increase in temperature, when the 
micelles pack close enough to prevent micelle translational motion. The amount of 
water associated with the PEO becomes much less as the temperature increases, 
allowing the micelles to pack closer together. Gelation results when the micellar 
solution reaches a concentration where the micelles can pack closely enough to undergo 
a transition from mobile fluid to immobile gel. 
J. 9.2 Drug Loading Into Micelles 
Solubilisation has been defined as the preparation of a thennodynamically stable 
isotropic solution of a substance nonnally insoluble or very slightly soluble in a given 
solvent by the introduction of an additional amphiphilic component or components 
(Attwood and Florence, 1983). Therefore, as surfactants are amphiphiles, which fonn 
micelles at concentrations above the cmc, solubilisation of drugs by micelles can occur. 
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Drug loading into micelles is usually referred to as solubilisation. but other terms may 
also be used. including incorporation. Similarly, the compound or drug that IS 
incorporated/solubilised by the micelles is often referred to as the soluhilisate. 
1.9.2.1 Sites ofSoluhilisation 
The site of solubilisation within the micelle is important for the successful retention of 
the solubilised agent and control of the release into the environment (Goldenberg et al. 
1993). Solubilisation deep within the micellar core would be expected to be the least 
easily displaced and require a more specific interaction of the micelle with the drug 
target to allow release of the drug at the appropriate site. Micelles from conventional 
surfactants and block copolymer micelles have solubilised a wide range of drug 
compounds, and block copolymer micelles can also solubilise homopolymer. In this 
case, true solubilisation can only occur when the molecular weight of the homopolymer 
is less than that of the miscible block of the copolymer (Quintana et ai, 1995). 
There are two possible sites of solubilisation in PEG-containing micelles. The chemical 
nature of the solubilisate determines in which of these sites solubilisation will occur. 
The first site, that of the non-polar core will solubilise hydrophobic compounds, 
whereas the second site, that of the polyethylene oxide shell surrounding the core (the 
palisade layer), will solubilise more polar compounds. As most drugs are hydrophobic, 
they can be incorporated into the micelle core either by covalently conjugating the drug 
to the monomer molecule or by noncovalent bonding, such as hydrophobic or ionic 
interactions (Yokoyama, 1992). However, there are examples in the literature of 
substances solubilised in the hydrophilic' shell of micelles. Elworthy and Lipscomb 
(1968) concluded that the most likely site of solubilisation of griseofulvin in surfactants 
based on hexadecanol and PEG was the polyoxyethylene part of the micelles. They 
based this conclusion on results that PEG solutions increased the solubility of 
griseofulvin, and that increasing the length of PEG chains in the micelles also increased 
solubility. Muketjee (1971) observed that polyoxyethylated nonionic micelles could. in 
theory, solubilise organic substances or electrolytes in their mantles, as these areas can 
behave as concentrated solutions of oxyethylene groups. The oxyethylene groups at the 
surface of a micelle are likely to be in closer proximity due to the geometry of micelles, 
than solutions of PEG, where the polymer exists as random coils. M u k e ~ j e e e also noted 
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that p-hydroxybenzoic and p-aminobenzoic acids were predominantly solubilised in the 
polyoxyethylene mantle of surfactants composed of alkyl chains and polyoxyethylene. 
This may be due to hydrogen bonding between the hydroxyl groups of the drugs and the 
polyoxyethylene chains. Indeed, when these drugs were esterified, more hydrophobic 
compounds were produced from the loss of their hydroxyl groups, decreasing the ability 
to hydrogen bond. The solubility of the drugs in the core increased, with a 
corresponding decrease in solubility in the polyoxyethylene mantle (Mukerjee, 1971). 
Differentiation between the two sites of solubilisation can be detennined by techniques 
such as NMR, UV Spectroscopy, X-ray diffraction, ESR and other indirect techniques 
including solubility in model solvent systems (Goldenberg et ai, 1993). It is however 
difficult to model micellar domains using model solvents that are not amphiphilic and 
form isotropic structures. Added discrepancies would occur if the solubilisation were 
at the hydrophobic/hydrophilic interface. The differences between solubility in the 
micelle core and that in bulk liquid are partly due to the Laplace pressure inside a 
micelle, which results from the curved interfacial region of the micelle, and opposes the 
entry of molecules into the micelle. This excess pressure inside spherical droplets, ~ P , ,
is defined by the Laplace equation: 
M=2y 
r 
where y is the interfacial tension and r is the radius. Micelle interiors may also be more 
solid-like than bulk hydrocarbons. Muketjee's theoretical model for the prediction of 
location of solubilisate could also be used (Muketjee, 1971). This is based on the 
assumption that the amount of the agent solubilised in the core and in the palisade layer 
is proportional to the number of equivalents of surfactant hydrophobe chain moiety and 
the number of equivalents of surfactant ethylene oxide groups, respectively. However, 
it has been shown that the predictions from this model do not match experimental 
results, which suggests that the model may be an over-simplification. This casts doubt 
on the usefulness of a theoretical model which does not account for factors such as 
micelle size, solubilising capacity and agent-agent-interaction (Goldenberg et ai, 1993). 
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There was also a lack of agreement between the experimental n.'sults from di ffcrcnt 
methods presented in the paper by Goldenherg et af (1993). which meant that no firm 
conclusions were possible from their results about the location or the soluhilisatc in thl.' 
micelle. 
1.9.2.2 Factors A.tleetinK Soluhilisation 
Solubilisation of agents in the micellar core increases the size of the micelles in two 
ways (Mukerjee, 1980; Al-Saden et ai, 1982). The core or palisade layer of the micelle 
is enlarged by the solubilisate, and the association number also increases due to a need 
for additional surfactant molecules to maintain the integrity of the micelle and increase 
its volume, although this generally only results when solubilisation is in the core 
(Attwood et al, 1971). This has been noted with both conventional surfactant micelles 
(Attwood et ai, 1971) and block copolymer micelles (Quintana el ai, 1995), and the 
larger the drug, the greater the effect on the association number. Generally, 
solubilisation capacity increases with an increase in hydrophobe chain length 
(hydrophobicity) when solubilisation takes place within the micellar core (Jacobs et ai, 
1972; Al-Saden et ai, 1982). This dependence may be linear or may increase faster than 
the hydrophobe content. There may also be a limit in the increased solubilisation 
capacity seen by increasing chain length. Arnarson and Elworthy (1981) noted that for 
a series of nonionic polyoxyethylene mono-ethers (CxEy, where x is the number of 
carbons in the hydrocarbon chain and y the number of polyoxyethylene groups), the 
solubilising ability of the micelles increased up to C 16, but further increases in 
hydrocarbon chain length led to a decrease in solubilisation. They speculated that this 
unexpected decrease was due to intrusion of part of the polyoxyethylene chain into the 
hydrocarbon core of the micelles. This effect may be due to an attempt to maintain the 
longer hydrocarbon chains of the core in a liquid state. 
When the solubilisation takes place in the palisade layer (the PEG shell). increasing the 
ethylene oxide chain length usually gives an overall increase in solubilisation capacity 
as although the aggregation number decreases, the number of micelles fomled increases 
thus giving an increased total amount solubilised (AI-Saden et ai, 1982; Goldenberg et 
ai, 1993). Conversely, decreasing the ethylene oxide chain length in a series of nonionic 
surfactants will give an increase in hydrophobicity and corresponding increase in 
42 
solubilisation efficiency as defined by the moles of drug solubilised per mole of ethylene 
oxide (Goodhart and Martin. 1962; Gouda et al. 1970). 
Hurter and Hatton (1992) have studied in some detail the solubilisation of polycyclic 
aromatic hydrocarbons into poly(ethylene oxide-propylene oxide) micelles. They found 
that the micelle-water partition coefficient. Km,," of the compounds increased with 
increasing polypropylene oxide content (i.e. increasing hydrophobe content) 1\)I" a given 
total polymer concentration. However, when Knm was normalised with PPO content, 
an increase in the partition coefficient was still observed; the nom1aliscd partition 
coefficient, K'm" , should be constant as the mass fraction of PPO increases if the 
solubilisation behaviour was solely dependent on the composition of the polymer in 
solution (Hurter et ai, 1993). As a small increase in K'mw was seen instead, this 
suggested structural changes within the micelle due to changes in polymer composition. 
These authors also studied the effect of concentration on solubilisation, and found that 
the partition coefficient, Kmw, remained constant over the concentration range studied. 
This indicated that the micelle structure was unchanged and the increase in 
solubilisation with concentration was due to an increase in the number of micelles rather 
than an increase in micelle size. It is usual for an increase in concentration and/or 
temperature to give an increase in the amount solubilised. The temperature effect is 
particularly noticeable in systems where the micelle size increases with temperature. An 
example of this was given by Saito et al (1994), who showed that the solubilisation of 
estriol in Pluronic L-64 micelles increased with increases in both temperature and 
concentration. They attributed this increase in solubilisation with temperature as due to 
an increase in micelle size and increased wetting of the drug. It is important to 
remember that the aqueous solubility of the agent may also increase, as the results may 
be misleading if this is not taken into account. Another example with Pluronic L-64 
micelles was provided by Pandya et al (1993), who showed an increase in solubilisation 
of diazepam with increasing temperature and concentration. The increased 
solubilisation with temperature was again attributed to an increase in association number 
and size of the micelles, and also to a decrease in cmc, which is affected by temperature. 
A decreased cmc leads to an increase in the micelle concentration, thus improving 
solubilisation. 
Hurter et al (1993) considered a theoretical model for solubilisation based on the mean-
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ticld lattice theory. This supported the conclusions of the previous experimental work 
of this group (Hurtcr and Hatton. 1992) regarding the increase in micelle-water partition 
coefficient with increased polypropylene oxide content of the copolymer. The model 
also showed that for naphthalene being solubilised by Pluronic micelles. the amount 
solubilised in the core fell off sharply as the radius of the core (i.e. the outer edge of the 
homogenous PPO core) was approached. and thus at the beginning of the polyethylene 
oxide corona region. They attributed this to a greater restriction on the possible 
orientations of the solute molecules in the interfacial region (between the PPO and PEO 
regions), as some conformations would result in unfavourable solute/EO segment and 
solute/water contacts. From this, it is apparent that smaller micelles will solubilise less 
if there is a significant energetic disadvantage to the solute in penetrating the corona of 
the micelle. This is because there will effectively be a "dead volume" in the core which 
will be less attractive to the solute molecule than the more hydrophobic inner core 
(Hurter and Hatton, 1992). Therefore, as this dead volume is of constant thickness, the 
fraction of the core volume affected will decrease as core size increases. 
Hurter and Hatton (1992) also compared solubilisation by micelles prepared from the 
branched Tetronic copolymers with the Pluronic micelles. They concluded that the 
structure of the polymer was important, with linear copolymers (Pluronics) solubilising 
more drug than branched copolymers (Tetronics). This was thought to be due to the 
ability of the linear copolymers to form tighter micelles, due to configurational restraints 
on the branched polymers, leading to a more hydrophobic environment in the micelle 
core of the linear copolymers. 
Although in general, micelles formed from block copolymers and conventional 
surfactants behave in a similar manner, there are important differences between them. 
Block copolymer micelles consist of blocks of several monomer units that can have 
many different configurations. The area occupied by each polymer at the interface 
between the core and the aqueous media is relatively large in order to gain greater 
entropic freedom, and is partly protected by the chains of the block copolymer that are 
compatible with the media (Nagarajan et aI, 1986). The entropy due to the numerous 
configurations of the polymer chains compensates for the increased interfacial free 
energy, but with conventional surfactants, fewer configurations are possible due to their 
shorter chains. Consequently. the area occupied by each surfactant molecule is smaller 
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to ensure that the free energy of the interface is small. There/lxe. micelles ltmned 11'0111 
conventional surfactants depend on interfacial interactions and give relatively rigid 
structures compared with block copolymer micelles. These interfacial interactions are 
expected to affect the solubilisation in surfactant micelles. whereas interactions between 
the solubilisate and polymer block will affect the solubilisation in block copolymer 
micelles (Nagarajan et ai, 1986). 
1. 9. 3 Micelles as a Drug Delivery System 
The structural properties of micelles, with their hydrophobic core and hydrophilic outer 
shell, make them potential candidates for drug delivery, particularly for drug targeting 
applications. As low water solubility of drug-polymer conjugates can lead to synthesis 
and injection problems, due to precipitation caused by high localised concentrations 
(Yokoyama et ai, 1994a), the water solubility of micelle systems is also an advantage. 
As micelles are fonned by intennolecular noncovalent interactions between polymer 
chains, and are in equilibrium, they can eventually break down into free polymer chains 
and complete excretion is possible via renal filtration (due to their low molecular 
weight). Therefore, long-tenn accumulation of micelles in the body is unlikely to be a 
problem. Several groups have studied the ability of micelles to carry drug in an in vivo 
situation. One of the most interesting and successful applications of micelles for drug 
delivery is the work by Y okoyama et al (1990, 1991, 1993, 1994a, 1994b. 1994c, 
1994d), and Kwon et al (1993a, 1993b, 1994a, 1994b, 1995), which has been described 
over the past few years. 
These groups have synthesised block copolymers composed of poly(aspartic acid) 
(P(Asp)) and PEG. Aspartic acid is a naturally occurring amino acid, and in polymeric 
form, may be biodegradable. The anticancer drug, adriamycin (ADR), was conjugated 
to the copolymer, so that the drug would remain with the carrier until released in a 
manner controlled by the carrier, and to allow very high quantities of adriamycin to be 
loaded (Kwon et ai, 1994b). Adriamycin is a very effective anticancer drug, but has 
many toxic side effects, including cardiotoxicity, that are dose-dependent (Yokoyama. 
1992). As P(Asp) is a polyamino acid, it is possible that ADR may be released from the 
copolymer by hydrolysis, after uptake by the target cells (Yokoyama, 1992). These 
block copolymer conjugates were water soluble and shown by gel permeation 
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chromatography (GPC) to foml micelles in aqueous solution (Yokoyama et ai, 1993). 
Micelle formation has also been confimled in vilro (Yokoyama el ai, 1990) and ;n \';m 
(Yokoyama el aI, 1991), using gel pem1eation chromatography. For the ;n \';VO 
experiments, plasma samples were taken at one hour post-injection and when analysed 
by GPC, the elution volume of the samples corresponded to that for micelles. The 
micelles were reported to be between 20 nm to 40 nm in size (Kwon et ai, 1994a). 
In vivo studies of the PEG-P(Asp(ADR)) micelles have been very promising. High 
anticancer activity was found against murine leukemia P388 and several solid tumours. 
When used against P388 leukemia (intraperitoneal injection in 0.9% NaCI solution), 
this system prolonged the survival time of mice (Yokoyama et ai, 1990). Free 
adriamycin will also prolong the survival time of mice innoculated with these tumour 
cells, but with serious side effects, including a pronounced decrease in body weight 
(15%). The PEG-P(Asp(ADR)) micelles were able to achieve comparable survival 
times with only a temporary weight loss, and possessed a wider therapeutic range than 
free adriarnycin. 
Similarly, increased or comparable anticancer activity was achieved with solid tumours 
after intravenous injection of PEG-P(Asp(ADR)) micelles (Yokoyama et aI, 1991). 
Significantly higher antitumour activity was observed for murine colon adenocarcinoma 
26 (C26) with the PEG-P(Asp(ADR)) micelles over adriamycin, which gave only 
moderate tumour inhibition at the maximum tolerated dose (10 mg/kg) (Y okoyama el 
aI, 1994a). The antitumour activity was highly dependent on the composition of the 
block-copolymer conjugate (Yokoyama et aI, 1994b). The compositions of the 
conjugates are described by three numbers, e.g. 120-81 (84), where the first number 
refers to the molecular weight of the PEG chain, which would be 12000 in this case, the 
second refers to the molecular weight of the P(Asp) chain (8100) and the number in 
brackets represents the adriamycin substitution percentage with respect to the Asp 
residue. Thus, the authors found that whereas a PEG-P(Asp(ADR» copolymer-
conjugate with a composition of 10-48(12) did not show any tumour inhibition against 
the control over 35 days, for the compositions 20-10(44),50-09(73), 120-21 (104), 120-
41(78) and 120-81(84), the tumour completely disappeared. Conversely, the in vitro 
cytotoxic activity of the conjugates against C26 tumour cells was independent of 
composition. The authors concluded that this difference between in vitro and in vivo 
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reflected the effective selective delivery orthe conjugates to the tumour. 
Poly(aspartic acid)-poly(ethylene glycol) micelles conjugated with adriamycin have 
shown selective delivery to tumours within mice (Yokoyama ('/ al. 1994a). The authors 
postulated that this was due to the hydrated outer PEG shell of the micelles. which 
allowed them to be preferentially taken up and retained hy the tumour. in a way similar 
to the enhanced penneation and retention of macromolecules descrihed hy Matsushima 
and Maeda (1986). 
These micelles have also shown long circulation times in blood. and a corresponding 
low uptake by the reticuloendothelial system (K won el ai, 1993a, 1994a. I 994b ). Free 
adriamycin binds rapidly to tissues after iv. injection, and the levels circulating in the 
blood drop quickly. The PEG-P(Asp(ADR» conjugates showed a greater accumulation 
in tumours after 24 hours (lO % dose per g tumour) over free adriamycin (0.90 % dose 
per g tumour), indicating that the previous conclusion of selective delivery to tumours 
was correct. 
More recent research has shown the presence of physically entrapped adriamycin in the 
micelles, in addition to the chemically conjugated adriamycin (Yokoyama el ai, 1994c. 
1994d, 1995). The effect of this physically entrapped adriamycin was subsequently 
investigated to study its contribution to the anti-tumour activity of the PEG-
P(Asp(ADR)) micelles, and it was concluded that this adriamycin was likely to 
contribute to the anti-tumour effects (Yokoyama et ai, 1994c). Physically entrapped 
adriamycin could be removed by dialysis in organic solvents. In vitro serum stability 
experiments indicated that the presence of physically entrapped adriamycin decreased 
the stability of the PEG-P(Asp(ADR)) micelles in rabbit serum (Yokoyama el al. 
1994d). The presence of this physically entrapped adriamycin in the PEG-P(Asp(ADR» 
micelles suggests that PEG-P(Asp(ADR)) micelles could be used to carry other 
hydrophobic anti-tumour drugs, to increase the tumoricidal activity of the conjugated 
adriamycin. 
The same research group has also studied the physical entrapment of adriamycin into AB 
block copolymer micelles consisting of poly(ethylene oxide-co-B-benzyl L-aspartate) 
(PEO-PBLA) (Kwon et aI, 1995). In vitro experiments using ope and serum albumin 
showed the adriamycin to be stably incorporated into the micelles. 
Another group has also explored micelles as a potential drug delivery system. Kabanov 
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et al (1989) considered the use ofPluronic P85 micelles for targeting neuroleptic drugs 
to the brain. They injected a micellar solution loaded with the drug haloperidol 
intraperitoneally into mice, and compared the biological action of the drug in micelles 
with that of free drug by considering the development of a specific neurolepsy and its 
lethal dose (LD95). The authors observed a five-fold increase in the toxicity of the 
haloperidol in micelles compared with free drug (shown by a decrease in LD95). Insulin 
was then conjugated to an "anchor" moiety. which was a Pluronic analog. BPEA 
(butylpoly( oxypropylene )-poly( oxyethylene) ether of 2-hydroxyacetaldehyde). to give 
Ins-BPEA. This allowed incorporation of the target-recognising molecule (i.e. insulin) 
into the Pluronic P85 micelles. When this was compared with free drug. the toxicity 
increased by twenty-five-fold. This was concluded to be a result of the insulin moiety 
on the surface of the micelles interacting with the insulin receptors on the surface of 
cells, leading to increased interactions between the micelles and membranes. A brain-
specific antibody, glia fibrillar acid antigen of brain glial cells (anti-GFA) was then 
conjugated to the BPEA molecules. This drastically increased the toxicity of 
haloperidol, giving an increase of nearly 500-fold over the free drug. Although there 
was an increased toxicity when the anti-GF A was incorporated into the Pluronic P85 
micelles without the BPEA, it was lower than with the BPEA bound antibodies and the 
BPEA method was successful in binding all the antibodies tested. However. these 
authors did not clarify whether the increase in in vivo activity was due to micelle 
formation or due to an increase in the permeability of biological membranes owing to 
the polymeric amphiphile (Yokoyama et ai, I 994a). There was also no evidence for 
micelle formation under physiological conditions. Micelle formation was assumed, but 
due to the high stated cmc value of Pluronic P85 micelles (4.5% w/v). this was not 
necessarily true. 
However, a later paper (Kabanov et ai, 1992) states that after measurement of the cmc 
of Pluronic P85 micelles using the dye solubilisation technique. the cmc was found to 
be 0.01 % w/v. No comment is given about the discrepancy in values between the two 
papers. If the latter value were correct, it would be more reasonable to expect micelles 
to be present in circulation. However, the concentrations of Pluronic P85 injected were 
high at 10% w/v, which could cause cell membrane damage. 
This later paper by Kabanov et al (1992) again studied PI uronic P85 as a means of drug 
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targeting from blood into the brain, and also to the lungs. The diameters of the micelles 
in this case were in the range of 11 - 17 nm. The model drug, fluorescein isothiocyanate 
(FITC) was incorporated into the micelles, which could then be studied using 
fluorescence. When injected intravenously into mice, a marked increase in the amount 
of FITC delivered to the lungs was noted when solubilised in Pluronic P85 when 
compared with free FITC. It has been suggested that this may be due to the 
membranetropic properties and small size of the micelles. The conjugation of Pluronic 
P85 molecules with either protein ligands to selectively interact with specific cell types, 
or antibodies against a target-specific antigen was again discussed. Firstly, conjugation 
with insulin "vector" which, as it is capable of specific binding with various cell types, 
showed an increase in the FITC fluorescence in all tissues including the brain. 
Secondly, conjugation of the pluronic with the antibodies to the antigen of brain glial 
cells (0.2 -glycoprotein) was described, where a considerable increase of fluorescence due 
to FITC was seen in the brain and a decrease seen in the lungs. It is possible that the 
micelles themselves penetrate the blood brain barrier (BBB) by, for example, 
transcytosis, but it must be considered that the antibody can also interact on the external 
side of the BBB. 
Control of drug release from micelles can also be initiated from an external source. 
Takeoka et af (1995) showed that electrochemical drug release was possible from 
micelles, by producing redox-active micelles of non-ionic surfactants with a ferrocenyl 
moiety (FPEG). This system forms micelles in the reduced fonn (FPEG), but exists as 
monomers in the oxidised fonn (FPEG+). This reversible change could be 
electrochemically controlled, to effect drug release. The hydrophobic model drug, 
perylene, was incorporated into the micelles, and could be released by using controlled 
potential bulk electrolysis. 
Another example of micelle use in drug delivery is given by Alkan-Onyuksel et af 
(1994). They prepared mixed micelles from bile salt and phospholipid, and loaded them 
with the poorly water soluble anticancer drug, taxol. On dilution, the micelles 
spontaneously fonned drug-loaded liposomes, but were stored as freeze-dried mixed 
micelles due to their greater stability. The mixed micelle fonnulation retained the 
anticancer activity when tested in cultured cell lines and seemed less toxic than the 
standard nonaqueous vehicle oftaxol containing Cremaphor EL in survival (LDso) tests 
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in mice. 
Micelle-containing products have reached the market place. One, known as 
"Amphocil", is composed of disk-like mixed micelles of cholesteryl sulphate and the 
drug. amphotericin. and this product shows an improved therapeutic index over both the 
free drug and another marketed micellar formulation. "Fungizone", which consists of 
amphotericin in deoxycholate micelles (Lasic, 1992). 
1.10 AIMS OF THE PROJECT 
This introduction has discussed using colloidal systems as a means of delivering drug 
within the body. Previous work involving coating of hydrophobic nanoparticles with 
block copolymers containing the hydrophilic polymer, polyethylene oxide (PEO), 
otherwise known as polyethylene glycol, has been discussed. The characteristics of 
these nanoparticles and their effect on the eventual fate of the nanoparticles within the 
body have been described, as have the successes achieved so far. This project aims to 
continue this work by studying a novel range of block copolymers, composed of the 
hydrophobic biodegradable polylactide (PLA) with the hydrophilic biocompatible 
polyethylene glycol (PEG). These copolymers have the necessary hydrophilic PEG to 
provide a hydrophilic shell. with the hydrophobic core to allow the uptake of 
hydrophobic drugs. 
The aim of this project is therefore to explore the PLA-PEG copolymers as potential 
drug delivery systems for use in drug targeting applications. Studying this will involve 
a wide range of experiments to investigate the different attributes of the nanoparticles, 
from the physicochemical properties to the drug loading and biodistribution. The 
surface chemistry, which is important in determining the extent and type of protein 
adsorption after intravenous injection into the blood, can be determined by the highly 
sensitive surface analytical techniques static secondary ion mass spectrometry (SSIMS) 
and X-ray photoelectron spectroscopy. Rheological analysis and determination of the 
cloud point temperatures can give further information on the surface PEG. This 
information can be used to predict and explain the in vivo behaviour of the systems. 
As potential drug delivery systems, the ability of the PLA-PEG systems to load drug is 
very important, and will be studied with the model hydrophobic drugs. sudan black B 
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(SBB) and testosterone. Release of drug is also crucial and can be investigated with 
sudan black B. 
Finally, to allow the complete picture, the systems must be able to incorporate a 
radiolabel. allowing the fate of the systems to be followed in an ill vi\'() situation. 
Radiolabelling of the PLA-PEG systems and biodistribution in the rat will therci()fc also 
be considered. 
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CHAPTER TWO 
MATERIALS AND METHODS 
2.1 INTRODUCTION 
This chapter introduces most of the methods used for preparing and characterising PLA-
PEG nanoparticles and micelles. From chapter one, it is apparent that the properties of 
the PLA-PEG systems will affect both their drug loading capacity and their 
biodistribution performance in vivo, which are crucial qualities for potential drug 
delivery systems. To be able to predict these attributes, the size, composition and 
surface characteristics of the dispersions are important, as well as the performance of the 
systems in vitro. 
2.2 PREPARATION AND CHARACTERISATION OF PLA-PEG COPOLYMERS 
2.2. I Materials 
The linear (AB) block copolymers described in this thesis were derived from poly(DL-
lactic acid) or poly(L-lactic acid) and methoxy polyethylene glycol [PEG 2000 gmor t 
and PEG 5000 gmort] and were supplied by Zeneca Pharmaceuticals (Alderley Park, 
MaccIesfield, U.K.). The copolymers were synthesised by ring opening polymerisation 
of lactide, using a stannous octoate catalyst, at 160°C. This involved stirring together 
under nitrogen, purified methoxy polyethylene glycol, (after rigorous drying for one hour 
at 0.1 mmHg (13.3 Pa» and freshly prepared rigorously dried D,L-Iactide or L-lactide. 
Stannous octoate (stannous 2-ethylhexanoate) was then added as a catalyst and the 
mixture refluxed for three hours. This produced straw-coloured, slightly viscous liquids 
that solidified on cooling (Churchill and Hutchinson, 1986). The lengths of the PLA and 
PEG blocks were controlled by the starting materials, with the length of the PLA block 
controlled by the initial input of lactide, and the PEG blocks being of a fixed length of 
either 2000 gmor t or 5000 gmort. The 1.5:2, 2:5, 4:2 and 6:2 PLA-PEG copolymers 
appeared clear after solidification whereas the 1.5:2 LPLA-PEG appeared white. The 
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copolymers were then used as received from Zeneca Pharmaceuticals. 
The copolymers have been designated 1.5:2 PLA-PEG, 2:5 PLA-PEG, 4:2 PLA-PEG, 
6:2 PLA-PEG and 1.5:2 LP LA-PEG respectively. The numeric values signify the 
molecular weights of the PLA and PEG blocks; for example, 4:2 PLA-PEG indicates 
approximate molecular weights of 4000 for the PLA block and 2000 for the PEG block, 
whereas 2:5 PLA-PEG indicates a PLA block of approximately 2000 and a PEG block 
of 5000. All the copolymers are produced using D,L-Iactide with the exception of 1.5:2 
LPLA-PEG, which was synthesised from the more crystalline L-Iactide, and thus carries 
the prefix "L-" before PLA-PEG, as opposed to 1.5:2 PLA-PEG, which was synthesised 
from D,L-Iactide and therefore carries no prefix. 
2.2.2 Size Exclusion Chromatography (SEC) 
Molecular weights of the copolymers and their polydispersities were determined by size 
exclusion chromatography (SEC) on three PL Gel 10E3 A columns (30 cm x 7.S mm). 
Dimethyl formamide was used as the mobile phase, at a flow rate of 1 ml/minute, and 
the columns (calibrated using polystyrene standards) were thermostatted at 70°C. The 
peaks were detected by refractive index, with the signal captured by HP Chem Station 
software and analysed using Polymer Laboratories GPC/SEC software. This work was 
performed by Zeneca Pharmaceuticals (Alderley Park, Macclesfield, UK) and the 
resulting molecular weights and polydispersities (Mw/Mn) are shown in Table 2.1. 
2.2.3 Determination of PEGILactide Ratio by NMR 
The PLA-PEG copolymers were examined by NMR in CDCh solution, using a Broker 
AC250 250 MHz Fourier Transform NMR Spectrometer. The areas at the resonance 
peaks were integrated and the integrals from the multiplets at 1.55 ppm 8 shift (PLA 
methyl group) and 3.65 ppm 8 shift (PEG methylene groups) were converted to a weight 
ratio assuming the MeOPEGs have weight average molecular weights of 2000 Da and 
5000 Da. This work was performed by Zeneca Pharmaceuticals (Alderley Park, 
Macclesfield, UK) on 1.5:2 and 2:5 PLA-PEG. 
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Tahle 2.1 
Characlerisalion (?fPLA-PEG ('ojJolymers hy Size E'(c/usiol1 Chromatography (,,,'f( ') 
Sample Lactide PEG Chain Mw Mn Polydispersit), 
(Mw) 
1.5:2 LPLA-PEG L 2000 3446 3193 1.08 
1.5:2 PLA-PEG D,L 2000 3518 3233 1.09 
4:2 PLA-PEG D,L 2000 6433 5179 1.24 
6:2 PLA-PEG D,L 2000 7798 6498 1.20 
2:5 PLA-PEG D,L 5000 6307 5803 1.09 
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2.3 PURIFICATION AND PREPARA TIO\: OF AQUEOUS J ) I S P I ~ R S I O N S S OF PLA-
PEG COPOLYMERS 
2.3./ Preparation of Un Fa cl iona led PLA-PEG Micelles (1.5:2 and 2:5 PIA-P/:'G) 
Aqueous dispersions of the 1.5:2 and 2:5 PLA-PEG copolymers were prepared b ~ ~
dissolving the copolymer in water purified by ion exchange and charcoal absorption 
(Elga Stat, Elga Ltd., High Wycombe, Bucks. U.K.) to give final concentrations in the 
range 0.1 - 10% w/v. The copolymer/water system was generally retained at room 
temperature for several hours with occasional shaking, until clear dispersions were 
obtained. 
2.3.2 Purification of PLA-PEG Aqueous Dispersions by Gel Permeation 
Chromatography (GPC) 
Purification of the PLA-PEG copolymer dispersions was achieved by aqueous gel 
permeation chromatography (GPC). Initially, a C26/40 column containing sepharose 
CL-4B (2.6 x 30 cm) was employed for preliminary work on the analysis of the 
copolymers. Samples (IOml) were loaded at concentrations ranging from 1 to 5% w/v, 
using a peristaltic pump (12000 Varioperpex, LKB Bromma, Sweden) and eluted at 80 
mllh with deionised water. Peaks were detected using a refractive index detector (Gilson 
model 131, Villiers, France) with deionised water as the reference and the signal was 
interpreted using a potentiometer chart recorder (Auto-graph S, Shandon Southern 
Instruments Ltd., Surrey, UK). 
2.3.3 Preparation ofFractionated PLA-PEG Micelles (/.5:2 PLA-PEG and 2:5 PLA-
PEG) 
PLA-PEG micelles were also produced after fractionation by gel permeation 
chromatography (GPC) (Sepharose CL-4B). Preparatory runs were performed using a 
larger XK50/30 column, packed with sepharose CL-4B (5 x 30 cm) with the aid of a 
RK50 reservoir. Samples (5% w/v, 20 ml) were eluted through this column at a tlow' 
rate of 180mllh. Peaks were detected and interpreted as before (section 2.3.2). The 
eluent from the GPC columns was collected using a fraction collector (2112 Redirac. 
LKB Bromma, Sweden) and the fractions corresponding to the peaks were freeze-dried 
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(Edwards. Sussex. England). and the copolymers redispersed as above (section 2.3.1). 
2.3.-1 Preparation ofPLA-PE0 Particles (../:2 and 6:2 PLA-PEG) 
Particulate dispersions of 4:2 and 6:2 PLA-PEG were prepared usmg the 
precipitation/solvent evaporation method described previously (Fessi et al. 1988). This 
involved dissolving the copolymer (O.025g to 2g) in 10 ml of acetone (HPLC grade. 
Fisons Chemicals, Loughborough, U.K.) and then adding this solution dropwise to 20 
ml of deionised water, whilst stirring using a magnetic stirrer. The stirred sol ution was 
left overnight to allow the acetone to evaporate, leaving a dispersion of PLA-PEG 
particles (0.25% to 10% w/v) in water. 
PLA-PEG particles were also produced after fractionation by gel permeation 
chromatography (GPC) (Sepharose CL-4B) as described above (section 2.3.3). After 
separation of a dispersion (5% w/v) by GPC, samples were freeze dried and the 
copolymers reprepared as above. 
2.3.5 Preparation of 1.5:2 LPLA-PEG Particles 
These particles were prepared as described above for 4:2 and 6:2 PLA-PEG. 
2.4 MICROSCOPY 
2.4.1 Transmission Electron Microscopy (FEM) Method 
Aqueous dispersions of the fractionated and unfractionated 1.5:2 LPLA-PEG, 1.5:2 
PLA-PEG and 2:5 PLA-PEG copolymers, fractionated 4:2 and 6:2 PLA-PEG, and 
Poloxamer 407 were examined at a concentration of 1 % w/v, in an air dried condition 
using transmission electron microscopy (TEM). Samples were negatively stained by 
mixing three drops of the copolymer system with three drops of phosphotungstic acid 
(adjusted to pH 4 using potassium hydroxide). Specimens were then prepared by 
applying one drop of the dispersion onto a carbon coated EM grid. The grid was held 
horizontal for 20 seconds to allow the molecular aggregates to settle. The excess fluid 
was then drained using absorbent paper and the grid air dried. Specimens were 
examined using a Jeol 1200 EX 12 transmission electron microscope (Jeo!, Tokyo, 
Japan). 
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2.,/.2 Atomic Force Microscopy (AFM) Method 
This analysis was performed on fractionated 4:2 and 6:2 PLA-PEG particles, at a 
concentration of approximately 0.001% w/v. The sample (5 J.!I) was applied by drop-
casting onto a freshly cleaved square of mica (1 cm2), which was then analysed. 
Atomic force images were obtained by using a Polaron SP300 (VG Microtech, Uckfield, 
UK). Silicon nitride probes were mounted on cantilevers with spring constants of 0.064 
and 0.032 N/m (Park Scientific, California, USA) and were used at imaging forces 
between 1.0 and 0.1 nN, with a scan frequency of 10Hz. 
2.5 PARTICLE SIZING 
2.5.1 Dynamic Light Scattering Method 
Dispersions of the fractionated 1.5:2 PLA-PEG and 2:5 PLA-PEG copolymers of 
concentration 1% w/v, were produced as described above. A comparison was also made 
with 1 % w/v aqueous dispersions prepared from freeze dried unfractionated material and 
with 1 % w/v Poloxamer 407. Also analysed were 1 % w/v dispersions of the 4:2 and 6:2 
PLA-PEG copolymers, and a 0.5% w/v dispersion of LPLA-PEG copolymer. The 
dispersions were prepared as described above in section 2.3.2. 
Samples were analysed by dynamic light scattering, using a Malvern System 4700 
dynamic light scattering photometer, with a Siemens HeliumJNeon laser light source 
operating at a wavelength of632.18 nm at 40 mW, with an assumed refractive index of 
1.60 and viscosity of 8.9x I 0-3 Pas. The sample cell was cleaned before each measuring 
run by flushing for at least 5 minutes with deionised water, using a filling apparatus 
similar to that described by Sanders and Cannell (1980), and dried with ultrafiltered air. 
Traces of deionised water were removed from the cell by vacuum prior to injection of 
samples. Polymer dispersions prepared as outlined above were injected into the sample 
cell from a 1 ml disposable syringe through a 0.2 ~ m m Millipore filter (type HA) and 
hypodermic needle. 
Ten measuring runs were performed on samples of each copolymer in triplicate to 
provide data for the effective hydrodynamic radius and polydispersity of each sample. 
The sample time for PLA-PEG micelles was 5 ~ s s and the experimental duration 90 
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seconds. whereas with PI,A-PEG and LPLA-PEG particles. the sample time was 
determined by the Malvern system and the experimental duration was 30 seconds. All 
measurements werc performed at 25 0(, at a measurement angle of 9()0. The 
polydispersity. which is an indication of the narrowness of the particle size distrihution. 
with increased values shov,ing a greater spread of particle sizes. was also measured. 
being calculated by the Malvern 4700 softwarc. This measures the variance of the 
distribution in decay times. and hence the particle size, and gives a log n0l111al intensity 
distribution for the measured data from which a polydispersity value is calculated. 
2.6 DETERMINATION OF THE CRITICAL MICELLE CONCENTRATION (CMC) 
OF PLA-PEG MICELLES 
2.6.1 Surface Tension Methodfor Determining CMC 
Surface tension measurements (y) of dilute aqueous solutions offractionated PLA-PEG 
copolymer were measured using the Wilhelmy plate method by a Dynamic Contact 
Angle (DCA) analyser (DCA-322, Cahn Instruments, CA, USA). All glassware was 
cleaned using chromic acid and a glass cover slip employed as the glass plate. The plate 
was suspended from a microbalance (calibrated with standard weights) and the surface 
tension of each copolymer solution measured at 20 DC ± 0.5 0c. The required 
concentrations were obtained by diluting a stock solution of copolymer with distilled 
water (HPLC grade, Fisons Chemicals, Loughborough, U.K.) and allowing to equilibrate 
overnight. Each concentration was performed in triplicate, with frequent distilled water 
readings performed as a control. A control experiment on Polysorbate 80 (Tween 80, 
Sigma Chemical Company, St. Louis, USA) was also performed at 25°C ± 0.5 °C. 
Measurement of the receding force was taken after 300 seconds and the surface tension 
measurements plotted against the logarithm of the concentration of the copolymer. The 
surface tension values were calculated using the equation, 
F = mg + yp cosS, 
where F is the total force recorded by the balance of the DCA analyser. 
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m is the mass of the plate, 
g is the acceleration due to gravity, 
y is the surface tension of the liquid. 
p is the perimeter of the plate, 
and e is the contact angle (Andrade et aI, 1985). 
The perimeter value was measured for each batch of glass slides used (n=30) and input 
into the DCA program before the experiment was commenced. 
The effect of ageing on the HPLC water was also examined. This experiment was 
performed in duplicate, by performing a surface tension measurement with the glass 
slide at zero immersion for a period of one hour. 
2.7 UL TRACENTRIFUGA TION ANALYSIS 
2.7.1 Sedimentation Velocity Method 
A Beckman Optima XL-A analytical ultracentrifuge equipped with scanning absorption 
optics and a monochromator was used in sedimentation velocity experiments, in order 
to assay the homogeneity and determine the sedimentation coefficients of the samples 
(Harding, 1984). 
Solutions were prepared of fractionated material from the first elution peak (250 fJ.I, 
0.2% w/v) and scanned against deionised water (250 fJ.I) loaded into a 10 mm pathlength 
cell. Sedimentation runs were then performed at 40,000 revs/minute and 20 QC, with 
UV scanning every ten minutes at 231 nm for 1.5:2 PLA-PEG and 225 nm for 2:5 PLA-
PEG. Absorption profiles were subsequently obtained and overlaid to determine an 
"apparent" sedimentation coefficient S20, (i.e. not extrapolated to zero concentration) 
(Harding, 1984). 
The same experiment was then performed on 4:2 and 6:2 PLA-PEG particles. 0.2% w/v 
PLA-PEG dispersions (350 fJ.I) were scanned against 400 fJ.1 of deionised water loaded 
into a 10 mm pathlength cell. The run was then performed at 25,000 revs/min and 20 
0c, with UV scanning every ten minutes at 226 nm. 
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2.7.2 5;edimenlalion Equilihriul1I Method 
A Bcckman Optima XLA a n a l ~ 1 i c a l l ultracentrifuge was used to determine the ,,,eight 
average molecular weight of solutions of the fractionated 1.5:2 and 2:5 PLA-PEG 
copolymers and Poloxamer 407 respectively. as described by Morgan cl 0/ (1990). under 
micelle fonning (aqueous) conditions. These data were subsequently used to provide 
an estimate of the association number of copolymer molecules per micelle. The 
ultracentrifuge employed Rayleigh interference optics. a 5 m W He-Ne laser light source 
(632.18 nm) and an RTIC temperature control system. A low speed was used (5000 
rpm) to avoid meniscus depletion conditions. The meniscus concentration therefore 
remained measurable and was obtained by mathematical manipulation of the fringe data 
(Creeth and Harding, 1982). The solution was loaded into a 30 mm pathlength double 
sector cell (200 ,....1, 0.2% w/v) and the temperature was maintained at 20°e. 
Thennodynamic non-ideality was assumed to be negligible at the copolymer 
concentration used. 
Whole cell apparent weight average molecular weights (MwO, app.) were obtained from 
the limiting value of the M* function at the cell base (Harding et ai, 1992). The 
aggregation number of copolymer molecules in a micelle/particle was then calculated 
by dividing by the copolymer molecular weight. The aggregation number is the average 
number of copolymer molecules per aggregate. 
2. 7. 3 Measurement of Partial Specific Volume 
When a solute is added to a solvent, the total volume of the solution is not the sum of 
the volumes, but is related to the nature of both. The change in volume caused by the 
addition ofa solute to a particular solvent is known as the partial specific volume, v, and 
is defined as the volume change upon addition of 1 g of solute to a large volume of 
solution whilst keeping all other parameters constant. 
The partial specific volume was measured using a densitometer with deionised water as 
reference. Ten density readings were taken at concentrations of 0.25% w/v. 0.5% w/v 
and 1.0% w/v for each PLA-PEG copolymer sample. The mean density was then plotted 
against the concentration of the copolymer giving a linear dependency and the partial 
specific volume was then estimated from the slope of this line. 
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2.8 DETERMINATION OF PEG LAYER T I I I C K N I ~ S S S BY R l l l ~ O L O G I C A L L
M EAS U REMENTS 
2.8.1 Preparation and Si::ing ( ~ ( P I A - P E C ; ; Aggregates/hr Rhe%gica/ Measurements 
Dispersions of PLA-PEG micelles and particles ( 10% w/v) were prepared using the 
precipitation/solvent evaporation method as described above in section 2.3. All samples 
were prepared with fractionated PLA-PEG copolymers with the exception of LPLA-PEG 
copolymer. where unfractionated copolymer was also used. More concentrated 
dispersions were produced by evaporation of the 10% w/v dispersion, using an oven 
adjusted at 50°C, and lower concentrations were prepared by diluting the 10 %w/v 
dispersion with deionised water. This gave dispersions with concentrations ranging 
from ~ ~ 6% w/w to ~ ~ 27% w/w. The hydrodynamic radius, Rh, of the particles was 
determined by dynamic light scattering (DLS), using a dilute dispersion of aggregates 
prepared and analysed as described in section 2.5.1. 
2.8.2 Rheological Measurements 
Dynamic (oscillatory) measurements were carried out using a Bohlin VOR (Bohlin 
Reologie, Lund, Sweden) interfaced with an IBM computer, as described previously 
(Prestidge and Tadros, 1988; Liang et ai, 1992). This instrument operates in the 
frequency range 10-3 - 20 Hz and it has interchangeable torsion bars covering a wide 
range of sensitivities. Measurements were carried out in the frequency range 10-2 - 5 Hz 
at 25 ± 0.1 QC. A coaxial cylinder (C25) with a moving cup of radius 27.5 mm and a 
fixed bob of radius 25.0 mm was used. Initially, the frequency was kept constant at 1 
Hz and the strain amplitude was gradually increased, up to approximately 0.2, whilst 
measuring the rheological parameters. This allows the linear viscoelastic region to be 
defined, where the rheological parameters are independent of strain amplitude. 
Measurements were then carried out in the linear viscoelastic region as a function of 
frequency. The experiments were performed at several different concentrations of the 
respective PLA-PEG aggregates. 
From the stress and strain amplitudes ('to and Yo respectively) and the phase angle shift. 
(5 it is possible to obtain the following rheological parameters, 
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G" I c*1 sin (i 
(I' !C*!cosb' 
where G* is the complex modulus, 
G' is the storage modulus (the elastic component) 
and G" is the loss modulus (the viscous component). 
Together with the particle diameter, these parameters can be employed to calculate the 
PEG layer thickness, as described in section 4.2.5, and also the radius of the core. 
2.9 ANALYSIS OF SURFACE CHEMISTRY AND STRUCTURE 
2.9.1 Static Secondary Ion Mass Spectrometry (SSIMS) Method 
Dispersions (1% w/v, 200 Ill) of 4:2 and 6:2 PLA-PEG copolymers, in both chloroform 
(Fisons Scientific Equipment, Loughborough, U.K.) and as nanoparticles in aqueous 
media, were dropped onto aluminium foil and allowed to dry by evaporation. The 
samples were then analysed by static SIMS using a VG Ionex SIMSLAB 3B instrument 
(VG Scientific Ltd., Sussex, U.K.), employing a differentially pumped EX05 ion gun 
and a 12-12M quadrupole mass spectrometer. Argon atoms at 2 ke V were used as the 
primary source with an equivalent current of 0.8 nA. The total dose per sample was 
approximately 5 x 1012 atoms/cm2, which is within the regime of the static SIMS 
experiment (Briggs and Hearn, 1986). Emitted secondary ions were analysed in terms 
of their mass/charge ratio (m/z), to give positive and negative spectra which were 
interpreted by conventional mass spectrometry rules (McLafferty, 1980). 
2.9.2 X-Ray Photoelectron Spectroscopy (XPS) Method 
1% w/v dispersions (25 Ill) of 4:2 and 6:2 PLA-PEG copolymer, both in chlorofonn and 
as nanoparticles in aqueous media, were dropped onto aluminium foil and allowed to 
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dry. Analysis of the samples was then perfomled using a vc; Scientific ESCALAB Mk 
11 electron spectrometer (VG Scientific Ltd., Sussex. U.K.) employing Mg Ko. X-rays 
(h' = 1253.6 eV) with electron take otf angle of 45°. The X-ray gun was operated at 10 
kV and 34 mA. and survey spectra (0 - 1000 eV binding energy) were run, followed by 
high resolution spectra of the C 1 sand 0 1 s regions. The data was collected and 
analysed using a VGS 5000S data system based on a DEC PDP 11173 computer. Peak 
fitting was carried out with a linearly subtracted background and Gaussian peaks with 
30% Lorentzian character. Spectra were corrected for sample charging by referencing 
photoelectron peaks to C-C/C-H at 285 eV. The atomic composition for each sample 
was calculated from the CIs and 01s envelope intensities using an OIs sensitivity factor 
of2.85 relative to CIs. 
2.10 THE STABILITY OF PLA-PEG AQUEOUS DISPERSIONS TO ADDED SALT 
2.10.1 Method 
The stability of dispersions to electrolyte addition was measured by determining the 
temperature of turbidity increase (the cloud point temperature (Tc», for 1 % w/v aqueous 
solutions ofpoly(ethylene glycol) molecular weight 8000 (PEG 8000), Poloxamer 407, 
l.5:2 PLA-PEG copolymer and 2:5 PLA-PEG copolymer, as a function of molar 
concentration of added Na2S04 (Sigma Chemical Company, St. Louis, USA), using a 
turbidimeter. Salt concentration was varied between 0 and 0.5 M. In addition, the 
unfractionated PLA·PEG was compared with the fractionated copolymer. Also, for 
Poloxamer 407, and 1.5:2 and 2:5 PLA-PEG (both fractionated and unfractionated), a 
solid phase separation temperature (Ts) was measured, which was taken as the point of 
decrease in turbidity after a plateau region was observed. 
The test method was similar to that described by Comet and Ballegooijen (1966) for 
measurement of theta temperatures of polymer solutions, in that the sample was 
illuminated using a light source and changes of turbidity with temperature were recorded 
by a change in light transmission detected by a photo cell (Figure 2.1). The glass cuvette 
containing the solution was inserted into a thermostatically controlled water jacket. The 
sample temperature was recorded using a temperature probe inserted into the sample cell 
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and changes in turbidity with increased temperature (10 ne/minute) were monitored lip 
to an upper limit of80 QC (the limit of the apparatus). Photocell and temperature prohe 
outputs were fed to a computer (Acorn. U.K.) for data storage. handling and display. 
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CHAPTER THREE 
PHYSICOCHEMICAL CHARACTERISATION AND SIZE ANALYSIS OF PLA-
PEG SYSTEMS 
3.1 INTRODUCTION 
The physicochemical properties of a potential drug delivery system will influence the 
ability of the system to carry drug, release the drug and the destination of both the drug 
and carrier in vivo. As discussed previously in chapter one, the diameter of the 
micelle/particle system used greatly influences the destination of the particles in vivo and 
it is therefore essential that this important parameter is known for a potential drug 
targeting system. It is also important that this diameter should be reproducible; that is 
that the micellar/particulate system should be relatively monodisperse and that the 
method of preparation should give similar micelles/particles with each preparation. This 
reproducibility will be important for the drug release and performance in vivo of the 
potential drug delivery system. This chapter therefore explores the purity, composition, 
size and shape of PLA-PEG systems and compares their properties with other 
copolymers that have been studied as potential drug delivery systems, mainly the 
poloxamers and poloxamines discussed in sections 1.5 and 1.9. In particular, Poloxamer 
407 has been compared, as the molecular weights of the two PEO chains of this 
copolymer are 4000 each, which is intermediate between the 2000 and 5000 PEG chain 
lengths on the PLA-PEG copolymers studi-ed in this thesis. Poloxamer 407 has also 
shown promising in vivo results in previous work (section 1.5.2). PLGA particles have 
also been compared in some studies, as an example of a "solid" biodegradable particle 
system. 
3.2 COMPOSITION OF PLA-PEG COPOLYMERS 
3.2.1 . ~ ' i z e e Exclusion Chromatography 
The PLA-PEG copolymers produced for this work consisted of a PEG block of defined 
molecular weight, linked to a PLA block, the size of which is determined by the input 
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of PLA to the reaction mixture. Characterisation of these copolymers by SEC in 
dimethyl f()mlamide gave polydispersity indices in the range 1.09 to 1.2 (calculated from 
Mw/Mn) showing a narrow distribution of PLA block sizes (Table 2.1). From Table 
2.1, it appears that the more PLA present in the sample. the more polydisperse the 
copolymer. This will be considered in more detail in section 3.3. The polydispersity 
values compare favourably with values for PLA-PEG copolymers and other copolymers 
achieved by other groups (Table 3.1). 
3.3 PURIFICATION OF AQUEOUS DISPERSIONS OF PLA-PEG COPOLYMERS 
3.3. J Gel Permeation Chromatography (GPC) 
Gel permeation chromatography (GPC) is usually used for aqueous systems, whereas 
size exclusion chromatography (SEC) is usually used for organic systems. Gel 
permeation chromatography (also known as gel filtration) is a separation method that 
works on the basis of molecular size. This means that soluble molecules of large 
molecular weight can be separated from molecules of small molecular weight by this 
method. The technique involves a porous gel, which is tightly packed into a column and 
completely filled with solvent. The sanlple is then passed down the column in the same 
solvent and the small molecules diffuse into the pores of the gel whereas the large 
molecules, which are too large to diffuse into the pores, remain in the interstitial fluid 
and pass straight through the gel column. Smaller molecules, which are diffusing in and 
out of the pores, are eluted later. Thus separation is achieved between the differently 
sized molecules, and a high molecular weight molecule, such as a micelle or a particle, 
can be separated from any smaller molecules that are not part of the aggregates. 
This technique has been widely used to purify block copolymers, including 
poly(oxyethylene-oxypropylene-oxyethylene) (PEO-PPO-PEO) copolymers (Luo et al. 
1983; Ding et al. 1991; Sun et al. 1991: Yu et ai, 1992) and poly( oxyethylene-
oxybutylene-oxyethylene) copolymers (Nicholas et aI, 1993). GPC can be used as a 
preparative technique to purifY the sample. or as an analytical technique to provide 
information on the molecular weight and volume of particles. This latter use of GPC is 
usually carried out by HPLC (high performance liquid chromatography) using two 
columns in series to provide a more accurate analysis (Lesieur et ai, 1993; Yokoyama 
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el aI, 1993). 
Sepharose CL-4B is a cross-linked agarose gel with good thcnnal and chemical stability, 
which can be used in aqueous media of pH range 3-14 (Pharmacia, 1982). It is also 
stable in a variety of solvents, including acetone and ethanol, and as the gel-forming 
fibres are relatively stitTbundles of polysaccharide chains, the solvents have little effect 
on pore size. Its molecular weight fractionation range is approximately 3 x 10-1 
g/molecular to 5 x 106 g/molecular and a similar gel, Sepharose CL-2B has been used 
previously with poly(lactic acid) nanoparticles in the 50-200 nm size range, and other 
Sepharose gels have been used with liposomes (Szoka and Papahadjopoulos, 1980; 
Allen, 1984). Sepharose CL-4B was chosen for all the GPC experiments on the PLA-
PEG copolymers as the expected molecular weights of the micelles/particles produced 
from PLA-PEG copolymers and the copolymer molecules themselves would be around 
the opposite limits of the fractionation range. 
3.3.2 The Gel Permeation Chromatography of PLA-PEG Copolymers 
Data for aqueous gel permeation chromatography (GPC) were derived from preparative 
runs on a column of sepharose CL-4B (2.6 x 30 cm) as described in section 2.4.2. 
Samples (1 Oml) were loaded at a concentration of 1 % w/v and eluted at 80 ml/h with 
distilled water to investigate the composition of the PLA-PEG copolymers in aqueous 
solution. 
Although the polydispersity data from SEC studies suggests a narrow distribution of the 
copolymer molecular weight, initial work with these block copolymers indicated that 
they were not homogenous (unpublished data). Subsequent gel permeation 
chromatography of the PLA-PEG copolymer dispersions on a sepharose CL-4B matrix 
in aqueous media, resulted in a clear separation into two peaks (Figures 3.1 and 3.2). 
A similar case has been reported for the Poloxamer 407, which also gave a bimodal 
distribution on GPC separation (Yu el ai, 1992; Nicholas et ai, 1993). To determine the 
relative proportions of each of these peaks, a 1 % w/v dispersion of each PLA-PEG was 
separated by GPC as described in section 2.4.2, using a known weight of copolymer. The 
fractions were collected. freeze-dried and weighed to allow calculation of the proportion 
of the starting material in each peak. The results are given in Table 3.2. 
The results highlight the decrease in the amount of peak two material in the starting 
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Figure 3.1a - Gel Permeation ('hromatograph of 1.5:2 PLA-PEG 
Figure 3.lb - Gel Permeation Chromatograph of2:5 PLA-PEG 
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Figure 3.2a - Gel Penneation Chromatograph of 4:2 PLA-PEG 
r-------------------- --- - - - - - - - - - - - - - - ~ ~
J 
Figure 3.2b - Gel Penneation Chromatograph of 6:2 PLA-PEG 
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Table 3.1 
Polydi.\persily o(PLA-PEG and Related ('opolymers A.tier S ~ v n l h e s i s s
Copolymer Sample Polydispersity Range Reference 
PLA-PEO 1.4-1.6 Zhu el ([I (1986) 
Star-PEO-PLA 1.3-1. 7 Zhu el ([I (1989) 
PLA-PEG 2.0-2.7 Zhu et af (1990) 
LPLA-PEG 1.5-2.5 Hu and Liu (1994) 
LPLA-PEO-LPLA 1.18-1.55 Y ouxin and Kissel 
(1993) 
LPLA-PEO-LPLA 1.48-1.80 
Youxin et al (1994) 
PLA-PTMG 2.58-3.00 
Xiong el al (1995) 
POE-POB 1.04-1.11 
BedeIls et at (1993) 
PEO-PPO-PEO <1.1 
Reddy el al (1990) 
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copolymer with the 4:2 and 6:2 PLA-PEG copolymers compared with the water soluble 
1.5:2 and 2:5 PLA-PEG copolymers. with the 1.5:2 LPLA-PEG copolymer result falling 
hetween the two groups. 
The peak one and peak two material resulting from aqueous GPC was subsequently 
analysed by SEC as detailed in section 2.2.2. Table 3.3 shows the weight average 
molecular weight of the block copolymer and the PEG component. relative to 
polystyrene standards. as estimated by SEC. before and after purification by aqueous 
GPC. 
The PLA-PEG copolymers produced for this work consisted of a PEG block of defined 
molecular weight, linked to a PLA block, the size of which is determined by the input 
of PLA to the reaction mixture. Therefore it is to be expected that some variation in the 
amount of PLA attached to the PEG block will occur, and that the actual molecular 
weight will vary from the theoretical molecular weight predicted from the input of 
starting materials. This has been noted for PLA-PEG particles previously (Bazile et ai, 
1995). 
In the majority of cases, the second peak has a lower molecular weight than the first 
peak from GPC, with the molecular weight for the unfractionated material having an 
"average" molecular weight between the two. This would be expected from the method 
of SEC where the molecular weight deduced is the peak of an approximately Gaussian 
distribution. The data shows that the molecular weight of material from the first GPC 
peak was close to that expected from the synthesis, whereas the molecular weight of 
material from the second GPC peak was significantly lower. This indicates that the 
second peak is low in PLA content ('PLA-depleted') as the PEG chain is completely 
defined by the starting materials. This data therefore shows that the material produced 
from the two different peaks differ in molecular weight and the two materials may 
therefore have different characteristics from each other in aqueous solution. Further 
information is therefore needed to identify the roles of each of these two materials. 
3.3.3 Nuclear MaRnefic Resonance (NMR) of PLA-PEG Copolymers 
NMR analysis of the freeze-dried material obtained from the two peaks produced by 
GPC for 1.5:2 PLA-PEG. 2:5 PLA-PEG and 1.5:2 LPLA-PEG (Table 3.4 and Appendix 
1) was carried out hy Zeneca Pharmaceuticals (Alderley Park, Macciesfield). Table 3.4 
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shows the expected lactic acid to ethylene glycol ratio as predicted from the input of the 
starting materials. assuming the PEG molecular weight to be 2000 gmor' for 1.5:2 PLA-
PEG and 1.5:2 LPLA-PEG. and 5000 gmor' for 2:5 PLA-PEG. Similarly. the values 
for the lactic acid to ethylene glycol ratio as calculated from the molecular weight values 
from the NMR studies are shown in Table 3.4. This analysis confirmed that the first 
peak had a similar ratio of lactic acid groups to ethylene oxide groups to that predicted 
from the relative proportion of starting materials for the synthesis. but again. the second 
peak appeared to be low in PLA content (,PLA-depleted'). There was good agreement 
between the values of molecular weight calculated from the NMR data and the values 
obtained experimentally by SEC, except for the 1.5:2 LPLA-PEG (Table 3.4). 
3.3.4 Calibration of the GPC Sepharose CL-4B Column 
A simple calibration was performed using lactic acid, poly(ethylene glycol) standards 
and PLGA (polylactide-co-glycolic acid) particles in order to determine where the 
components of the PLA-PEG dispersions should elute. Solutions ofPLGA particles (1 % 
w/v, 2 ml) were employed to simulate micelle/particle formation. Two polymer 
standards of PEG Mw 5600 and Mw 10300, of similar molecular weight to the 
monomers were chosen to simulate monomer elution, and free lactic acid used to detect 
where residual lactic acid from the synthetic process would be expected to elute. The 
method was as described in section 2.4.2 and the results, compared with the values for 
the PLA-PEG copolymers are shown in Table 3.5. 
It can be seen from Table 3.5 that the PLGA particles elute fairly quickly in the void 
volume of the column, as they are large enough to be excluded from the gel pores. 
Comparing the elution volume for PLGA particles with the first peak produced with the 
PLA-PEG copolymers, it can be seen that the values of V c for all the copolymers are 
very similar. As the molecular weight of the gel-exclusion volume is much higher than 
the molecular weights of the individual copolymer molecules (Table 3.5), this supports 
the idea that micelles are formed from the first peak. 
The second peaks produced from the PLA-PEG copolymers eluted with a similar Veto 
the standard PEG polymers. Any free monomer should be eluted in the second peak. 
The amount of free monomer present would depend on the concentration of the micellar 
solution. with dissociation decreasing with increase in concentration. but trace amounts 
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Table 3.2 
Relative Proportions olthe 1'11"0 Peaks Produced by Aqueous GPC 
Copolymer % Peak One % Peak Two % Recovery 
1.5:2 PLA-PEG 69.8 26.8 96.6 
2:5 PLA-PEG 53.8 41.1 94.9 
1.5:2 LPLA-PEG 58.2 20.2 78.4* 
4:2 PLA-PEG 86.5 8.3 97.2 
6:2 PLA-PEG 87.4 10.2 97.6 
* -Low recovery thought to be due to losses on the GPC column. 
Table 3.3 
Characterisation of PLA-PEG Copolymers by Size Exclusion Chromatography (SEC) 
Before and After Aqueous Gel Permeation Chromatography (GPC) 
Sample Elution PEG Experimental Theoretical Polydispersity 
Peak Chain Mw Mw 
(Mw) 
1.5:2 PLA-PEG - 2000 3518 3500 1.09 
1.5:2 PLA-PEG 1 2000 3947 3500 1.07 
1.5:2 PLA-PEG 2 2000 2519 3500 1.03 
2:5 PLA-PEG - 5000 6307 7000 1.09 
2:5 PLA-PEG 1 5000 6987 7000 1.10 
2:5 PLA-PEG 2 5000 5547 7000 1.09 
1.5:2 LPLA-PEG - 2000 3446 3500 1.08 
1.5:2 LPLA-PEG 1 2000 3840 3500 1.08 
1.5:2 LPLA-PEG 2 2000 - 3500 -
4:2 PLA-PEG - 2000 6433 6000 1.24 
4:2 PLA-PEG 1 2000 - 6000 -
4:2 PLA-PEG 2 2000 - 6000 -
6:2 PLA-PEG - 2000 7798 8000 1.20 
6:2 PLA-PEG 1 2000 7017 8000 1.18 
6:2 PLA-PEG 2 2000 7770 8000 1.13 
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Tahle 3 . .f 
Comparison olNMR Peak /11Iegralionj(Jr Fraclionaled PLA-Pf:'(J C ( ) p o ~ v m e r s s
Copolymer PEG Expected Elution Molecular Molecular Experimental 
Mw Lactic acid! peak weight weight Lactic acid! 
Ethylene (SEC) (NMR) Ethylene 
glycol ratio glycol ratio 
(NMR) 
r----. 
1.5:2 PLA-PEG 2000 1 :2.1 1 3947 3455 1:2.1 
1.5:2 PLA-PEG 2000 1 :2.1 2 2519 2386 1:8.3 
2:5 PLA-PEG 5000 1 :4.0 1 6987 6818 1 :4.4 
2:5 PLA-PEG 5000 1:4.0 2 5547 5500 1:16.0 
1.5:2 LPLA-PEG 2000 1 :2.2 1 3840 4909 1: 1.1 
1.5:2 LPLA-PEG 2000 1:2.2 2 - 2464 1 :6.9 
75 
would he expected as the separation process during GPC leads to dissociation of the 
micelles from their monomers (CoIL 1971: Wang er ai, \993). 
Free lactic acid was also eluted later indicating that ifany was present resulting from the 
synthesis it would he with or after the second peak. 
From GPC theory, the ratio of elution volume to void volume (the liquid phase) is 
linearly related to the logarithm of molecular weight (Squire, 1964; Detennann and 
MicheL 1966; Billmeyer Jr. and Altgelt. 1971). Thus, the samples with the higher 
molecular weight would be expected to have higher Ye. However, a linear relationship 
is only present in the fractionation range of the sepharose gel and the samples, apart 
from peak one of the PLA-PEG copolymers and the PLGA particles, are outside this 
range. Therefore, the standard PEG copolymers (and hence the PLA-PEG monomers) 
and the lactic acid all elute with similar Ve. These results show that the material in the 
first GPC peak is of a much higher molecular weight than the standard polymers (and 
hence the monomers) and the free lactic acid. 
3.3.5 Assessment of Stability using GPC 
It was considered possible that the second peak was a decomposition product of the 
copolymer. To test this hypothesis, experiments were carried out to investigate the 
effects of storage on the fractionated copolymer dispersions, in aqueous environment, 
and determining any degradation. This was achieved by passing 1 % w/v dispersions of 
the water soluble polymers (1.5:2 PLA-PEG and 2:5 PLA-PEG) down the Sepharose 
CL-4B column, to separate the polymers into two peaks. A dispersion of material 
isolated from the first peak was kept under different storage conditions (4°C and room 
temperature) in water for a period of two weeks, before analysis on the column as 
described in section 2.3.2. An accelerated study was also performed by incubating the 
dispersion in water, at 37°C, for one week then refractionating by GPC. Sodium azide 
was added at a concentration of 0.02% w/v to prevent microbial degradation. 
Only a single peak resulted for samples kept at 4°C, room temperature and 37°C. 
suggesting that the second peak shown in the initial GPC analysis was not due to 
degradation. For the 4°C and room temperature samples, a single peak was obtained at 
a similar elution volume to the micelles. For the accelerated sample kept at 37°C, the 
elution volume was greater than that noted with the other samples, suggesting a lower 
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molecular weight but still less than the elution volume for the second (ipe peak. This 
implies that some degradation has in fact occurred. but the initial GPC chromatograph 
of two peaks was not reproduced. 
A further experiment performed at Zencca Pharmaceuticals. where a PLA-PEG 
copolymer was dialysed in distilled water at room temperature for fifteen days. also 
showed no change in the molecular weight properties of the PLA-PEG copolymer when 
reanalysed by NMR and SEC. 
3.3.6 DisclIssion 
From the above results, it is clear that two species exist in aqueous media for all PLA-
PEG copolymers. The GPC chromatographs in Figures 3.1 and 3.2 show the two peaks, 
with the GPC calibration data showing that the first peak corresponds to aggregates 
similar in size to PLGA particles, which are therefore likely to be micelles or 
nanoparticles (depending on the copolymer batch). This first peak shows tailing with 
the micelle-forming copolymers, which is thought to be due to the continuous 
establishment of an association equilibrium on the column (Katime et ai, 1994). As the 
micelles and free copolymer chains are applied to the column they are separated, and 
some micelles disassociate to re-establish the equilibrium of free copolymer molecules 
in the micelle peak. This allows the free copolymer chains to move into the gel pores 
to be eluted later (Wang et ai, 1993; Yokoyama et ai, 1993; Katime et ai, 1994). 
The material in the second peak was shown by NMR and SEC studies to have less PLA 
attached to the PEG block (PLA-depleted) than the material in the first peak. As a lower 
amoW1t of PLA in a copolymer molecule makes association into a micelle or particle less 
likely (El Eini et ai, 1976), this provides an explanation as to the presence of this second 
peak, rather than all the material being converted into micelles/particles. The NMR data 
on the second peak indicated that the PLA chain length was about five to seven PLA 
residues. It can therefore be assumed that copolymer molecules with at least five PLA 
residues are necessary to allow association into micellar/particulate systems. This also 
leads to an explanation for the larger proportion of second peak material separated by 
GPC for the micelle-forming PLA-PEG copolymers (1.5:2 PLA-PEG and 2:5 PLA-
PEG) and LPLA-PEG, compared with the more hydrophobic PLA-PEG copolymers (4:2 
and 6:2 PLA-PEG) (Table 3.2). As smaller blocks ofPLA are grown onto the PEG 
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Tah/e 3.5 
Results oj'( 'alihralion oj'Sepharose CL-..JB ('olumn (2.6 x ..J() cm) 
Sample Elution Peak Elution Volume, Vc WI!2 
PLGA Particles - 43 4.5 
PEG 5600 - 115 12 
PEG 10300 - 115 13 
Free Lactic Acid - 133 7 
1.5:2 PLA-PEG 1 46,52 18 
1.5:2 PLA-PEG 2 124 12 
2:5 PLA-PEG 1 43 11 
2:5 PLA-PEG 2 114 18 
1.5:2 LPLA-PEG 1 49 8 
1.5:2 LPLA-PEG 2 122 13 
4:2 PLA-PEG 1 42 10 
4:2 PLA-PEG 2 112 20 
6:2 PLA-PEG 1 47 10 
6:2 PLA-PEG 2 131 16 
W 112 gives the width of the peak at 50 % of the peak height and is a measure of the 
molecular weight distribution within the peak. 
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blocks for 1.5:2 PLA-PEG. 1.5:2 LPLA-PEG and 2:5 PLA-PECi (constituting 
approximately 1500. 1500 and 2000 gmor' respectively). more of the PLA-depleted 
copolymer molecules \\'ill be formed than for the 4:2 and 6:2 PLA-PEG, where the 4000 
and 6000 gmor' PLA blocks aimed for contain significantly more than the five PLA 
blocks required for incorporation into a micelle/particle. 
Thus. there are more likely to be copolymer molecules produced with depleted PLA for 
the 1.5:2 PLA-PEG. 2:5 PLA-PEG and 1.5:2 LPLA-PEG than for 4:2 and 6:2 PLA-PEG. 
This is reflected in the increased amount of the second peak seen on (lpe of these 
copolymers. 
The question therefore remains of the origin of the material in the second peak. There 
are two likely theories: firstly that the second peak is a result of degradation of the 
copolymer, and secondly that the second peak is a by-product of the synthesis. The 
literature provides examples of both scenarios. Recent papers by other authors studying 
the PLA-PEG copolymers have shown that on studying the degradation ofthese systems, 
a bimodal distribution was produced with SEC studies. Hu and Liu (1993) note that the 
higher the PEG content ofPLA-PEG copolymers, the faster the rate of hydrolysis, which 
would correlate with the 1.5:2 and 2:5 PLA-PEG copolymers (which have a higher 
proportion of PEG) having a greater peak two content. They also observed a change 
from unimodal to bimodal distribution using SEC (with chloroform as eluent) in studies 
up to 510 hours of hydrolysis. During this period, the GPC peak area for the higher 
molecular weight species decreased and that for the lower molecular weight species 
increased in parallel. Similar results are discussed in a second paper by the same 
authors, where a bimodal distribution was also observed after hydrolysis (Hu and Liu, 
1994). However, the results described in section 3.3.5 make this explanation unlikely. 
Samples stored at 4°C and room temperature, clearly showed a single peak after 14 days 
when rechromatographed, indicating that no significant degradation had occurred. 
Samples kept at 37°C also gave a single peak on rechromatographing, although the 
elution volume was larger than for the first peak of the original sample. This is likely 
to be the result of some degradation, as would be expected with a biodegradable 
copolymer. However. the elution volume of this peak was also different from that of the 
second peak of the original sample, indicating that whilst some degradation had 
occurred, the molecular weight was still greater than the peak two material and 
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micelles/particles were still likely to be present. It is unlikely that degradation of the 
PLA-PEG copolymers is a significant factor in producing the second peak seen with 
aqueous GPc. 
The second theory. that the second G PC peak is a by-product of the synthesis. appears 
more likely. Kricheldorf and Meier-Haack (1993) noted that in their production of 1.5:2 
LPLA-PEG triblock copolymers. there was likely to be a few percent of diblock 
copolymers present. Similar reports have been reported with poloxamers. where with 
Synperonic F127 (a PEO-PPO-PEO copolymer). a bimodal distribution was observed 
with SEC (with N.N-dimethylacetamide as eluent). This was thought to be due to the 
presence of diblock copolymers originating from the introduction of moisture to the 
transfer reaction in the anionic polymerisation of propylene oxide and homo-
poly(oxyethylene) (Luo et ai, 1983; Yu et ai, 1992). Malmsten and Lindman (1992) also 
reported the existence of two peaks on GPC, of which the slowest peak decreased on 
increasing the temperature and so was attributed to polymer impurities. Linse (1994) 
also investigated the presence of polymer impurities with poloxamers, particularly the 
effects of diblock copolymer, PEO homopolymer and PPO homopolymer impurities 
produced from the synthetic process on the properties of the resultant micelles. Thus 
impurities resulting from the synthetic production of block copolymers are well 
documented and it seems likely that this is the cause of the PLA-PEG material with the 
depleted PLA block, which separates out by aqueous GPC in peak two. Block 
copolymers are not monodisperse and even though the PLA-PEG copolymers discussed 
here have very low polydispersity values (Table 2.1), the distributions are still broad in 
comparison with low molecular weight surfactants (Zhou and Chu, 1987; Linse, 1994). 
Therefore, even with the best polydispersity value of 1.08 there will still be a variation 
in the PLA chain lengths of the copolymer molecules. Hence. this explanation for the 
presence of peak two in the aqueous GPC is probable. The polydispersity values from 
the SEC analysis do not show a great difference for peak one material compared with 
the unfractionated material for most of the PLA-PEG copolymers (Table 3.3). This is 
likely to be due to a lack of sensitivity in the SEC technique. The increase in 
polydispersity with increased PLA content (i.e. for 4:2 and 6:2 PLA-PEG) indicates a 
wider variation in the molecular weight of the PLA-PEG copolymer molecules. This 
reflects a greater distribution of the PLA chain length (as the PEG Mw is fixed), with 
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the greater input of lactide into the starting materials leading to a greater range of PLA 
chain lengths. 
The presence of impurity that is not associating into micelles can affect the micellar 
properties. For the poloxamer series, the presence of diblock impurities resulting from 
the synthesis has led to widely differing estimates in the critical micelle concentration 
(CMC) of the micelles produced which will be discussed in section 3.6. Also, the 
diblock impurities and PPO homopolymer can affect the association number and the 
ability of the micelles to solubilise drugs (Linse, 1994). Given this problem, the 
remaining characterisation was carried out on the first micelle-fonning fraction of 
material purified by GPC, except where the role of the second fraction in micelle 
fonnation was being addressed. 
3.4 MICROSCOPY 
3.4.1 Analysis of Micelles/Particles by Microscopy 
Microscopy is a technique widely used to study the shape. size and characteristics of 
micelles/particles. The two types of microscopy discussed here are high resolution 
techniques that are used with samples in the nanometre size range. They can give an 
estimate of micelle/particle diameter, confinn the shape, and indicate the polydispersity 
of the distribution and, with atomic force microscopy (AFM), can also show the 
topography of the surface. As the diameter of the micelles/particles is important for the 
distribution in vivo, it is useful to be able to obtain an estimate of diameter by a variety 
of methods. Microscopy is able to give a visible estimate of diameter. which can then 
be compared with other methods. 
3.4.2.1 Transmission Electron Microscopy (fEM) 
Electron microscopes have superior resolution over light microscopes due to the very 
short wavelengths of the high-energy electrons (Thomas and Goringe, 1979). The 
transmission electron microscope has an electron beam, focused by highly concentrated 
magnetic fields fonned between soft-iron pole pieces and generated by currents flowing 
through annular coils (Cowley, 1988). This electron beam illuminates the specimen 
(usually with an illuminating system of lenses) and interacts with the thin metallised 
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sample and is scattered elastically. This scattered radiation is then focused by an 
objective lens onto a fluorescent screen, where further magnifYing (or projector) lenses 
fonn an image of the sample of a suitable size. This image can be photographed. 
3.4.2.2 Calibration o{TEM 
A platinum calibration grid was purchased (Agar Aids, UK) and examined using the Jeol 
1200 EX12 transmission electron microscope (leol, Tokyo, Japan). The grid was 
photographed at a magnification of 200,000 diameters, which allowed the accuracy of 
the scale bar for the TEM photographs to be detennined by comparing the actual 
measurements of the grid with the calculated measurements as given by the scale bar. 
This showed that using the measurement bar for the photographs gave an error of 
approximately 17 %, such that all measurements need to be scaled up by a factor of 17 
% to give the actual size. 
3.4.2.3 rEM ofPLA-PEG Micelles 
Figures 3.3 and 3.4 show transmission electron micrographs offractionated 1.5:2 and 
2:5 PLA-PEO copolymers respectively, with the scale bar corresponding to 58.5 nm. 
This scale bar value is corrected as described above (section 3.4.2.2), but there may be 
a minor discrepancy due to the difference in the magnification (the calibration was 
perfonned at 200,000 diameters, whereas the Figures shown were taken at 100,000 
diameters). These clearly indicate the presence of micelles in the material from the first 
peak for both copolymers, as shown by light spherical entities surrounded by the darker 
staining. With the material from the second peak, only the background of the coated 
grid is seen, with no micelles present for either copolymer (Figure 3.5). 
The micelle diameters were measured using a micrograph at 200 K magnification, using 
the scale bar as a reference with the above correction, and taking a sample size of 200 
micelles to give a statistically valid mean and standard deviation. This gave micelle 
diameters in the material from the first ope peak of7.2 nm for 1.5:2 PLA-PEO and 17.0 
nm for 2:5 PLA-PEG, which were smaller than micelles seen with the unfractionated 
copolymer (8.3 nm ± 1.5 nm and 20.4 nm ± 8.0 nm respectively). The electron 
micrograph obtained for a 0.5% w/v solution of Poloxamer 407 (unfractionated) 
exhibited similar features to those found in PLA-PEG specimens (data not shown) and 
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Figure 3.3 - Transmission Electron Micrograph of Fractionated 1.5:2 PLA-PEG 
Micelles (Magnification = lOOK) 
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Figure 3.4 - Transmission Electron Micrograph of Fractionated 2:5 PLA-PEG Micelles 
(Magnification = lOOK) 
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Figure 3.5 - Transmission Electron Micrograph of Peak Two Material from 1.5:2 PLA-
PEG Copolymer (Magnification = lOOK) 
• 6'" " ~ ~ . ' , .... ~ . . '. ' . I 
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\\ith micelles which \\ere 1 :2.() I1m il1 diameter. 
3 . ../.2 . ../ TFM o/I)I..·1-PUi Purtic/cs 
Figures 3.6 and 3.7 show thelTM photographs of fractionated 4:2 and 6:2 PLA-PEG 
particles respectively. These pictures clearly shO\v the presence of particles as the \vhite 
spherical entities surrounded by the grey staining. The particles have a narrow size 
distribution, giving measurements of 11.3 nm ± 1.9 nm for 4:2 PLA-PEG particles and 
15.1 nm ± 3.2 nm for 6:2 PLA-PEG particles. 
PLA-PEG particles have previously been viewed using TEM by Zhu et al (1989), where 
star-PLA-PEG copolymers were examined after preparation from solutions of the 
copolymers in chloroform. Spherical entities in the size range 40 to 100 nm were seen. 
These structures were prepared from a solution in chloroform, so it is expected that the 
PEG groups would form the core in this instance, with the PLA groups forming the outer 
shell. The increased molecular weight (Mn values between 20100 and 41500) probably 
accounts for the larger size of these star-PLA-PEG structures. 
3.4.2.5 rEM of 1.5:2 LPLA-PEG Particles 
TEM studies have been performed on the 1.5:2 LPLA-PEG particles after cleaning by 
GPC. Figure 3.8 shows a typical TEM photograph for fractionated 1.5:2 LPLA-PEG 
particles. This picture is much less conclusive, with fewer discrete particles being 
observed. Moreover, it can be seen that string-like entities are present along with a few 
particles. LPLA is more crystalline than DLPLA, which leads to 1.5:2 LP LA-PEG also 
being more crystalline than the other PLA--PEG copolymers. It was therefore possible 
that these string-like entities could have been crystals due to the LPLA, but after closer 
examination under the electron microscope, it was clear that they were strings of 
particles joined together. 
Experiments were performed to attempt to break down these strings of particles. 
Initially. a sonic bath (Decon FS 1 00. Decon Ultrasonics Ltd., Sussex. England) was 
employed. with the sample being sonicated for up to thirty minutes. However. TEM 
showed that this had little ciTect on breaking down the particle chains. Therefore. the 
1.5:2 LPLA-PEG samples were subjected to higher energies of sonication by using a 
sonic prohe (Type 7532-1 A. Dawes Instruments Ltd., England) and di1Terent energy 
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Figure 3.6 - Transmission Electron Micrograph of Fractionated 4:2 PLA-PEG Particles 
(Magnification = lOOK) 
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Figure 3.7 - Transmission Electron Micrograph ofFractionated 6:2 PLA-PEG 
Particles (Magnification = lOOK) 
88 
Figure 3.8 - Transmission Electron Micrograph of Fractionated 1.5:2 LP LA-PEG 
Particles Before Sonication (Magnification = 100K) 
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outputs of pulsed sonication. The samples were also sonicated for dilTcrent lengths of 
time (up to ten minutes). On analysis by TEM. the best results were seen with an energy 
output of level 8 on the sonic probe. A distinct improvement was seen with output 7 
compared with the lower energy outputs (1-6). and further improvement was seen with 
output 8. which showed a large number of discrete particles. Chains of particles were 
still seen. but these had decreased in number when compared with the TEM photographs 
taken following the use of the lower energy outputs from the sonic probe. At the higher 
outputs of 9 and 10, there was no significant improvement in the number of discrete. 
1.5:2 LPLA-PEG samples were therefore sonicated using the sonic probe at output 8 
for 4, 7 and 10 minutes. Examination by TEM of the samples showed an improvement 
with time, such that the sample sonicated for 10 minutes gave the best result, with the 
highest number of discrete particles and lowest number of chains present (Figure 3.9). 
However, the difficulty in obtaining single, discrete particles shows that the particles 
containing L-PLA, as opposed to DL-PLA appear to be much less sterically stable, and 
due to this and the polydispersity of the particle distribution, they are not likely to be 
useful as a drug delivery system. These particles were therefore only considered for 
comparison of the physicochemical properties, and not for drug loading or 
biodistribution. 
3.4.3.1 Atomic Force Microscopy (AFM) 
The atomic force microscope can be used to image the surface of materials and produce 
topographic images. A tiny, sharp probe is employed which is mounted on a flexible 
cantilever and when this probe is applied to the sample surface, the forces experienced 
between the probe and the surface allows topographs to be generated of the material 
(Shakesheff et ai, 1994). The AFM works by focusing laser light on a cantilever, which 
bounces otT toward a photodiode. This detects the deflection of the cantilever by sensing 
the location of the reflected beam. A feedback loop keeps the position of the reflected 
beam and thereby the force on the sample constant, by moving the sample up and down 
as the sample is scanned (Drake et ai, 1989). 
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Figure 3.9 - Transmission Electron Micrograph of Fractionated 1.5:2 LP LA-PEG 
After Sonication (Energy Level = 8; 10 minutes) (Magnification = 200K) 
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3.4.3.2 Atomic Force Microscopy (AFM) olPLA-PEG Particles 
This experiment was performed as described in section 2.5.2 on 4:2 PLA-PEG and 6:2 
PLA-PEG. High concentrations cause "sweeping" of the particles to occur, i.e. there 
was movement of the particles as the probe scanned across them (Figure 3.10). This 
prevented the acquisition of surface images (Roberts et ai, 1992) and to prevent this 
phenomenon, a low concentration of particles (0.001 %w/v) was employed. 
Figures 3 .11 and 3 .12 show the pictures produced for 4:2 and 6:2 PLA-PEG particles 
respectively, which show the particles in two and three dimensions, with a cross section 
of the particle shown below the image (line profile). The images are represented as 
grey-scale, so that the height of the image is shown by the shade of the pixels, with black 
pixels representing the lowest points on the topography and white pixels the highest 
points, with shades of grey indicating intennediate heights (Shakesheff et ai, 1994). The 
4:2 PLA-PEG particles showed an even distribution and spherical particles as seen in 
Figure 3.11. Figure 3.12 clearly shows a single particle of6:2 PLA-PEG, which is again 
spherical. The three-dimensional picture shows that some compression of the particle 
has occurred, making the height of the particle appear less than in reality, usually about 
half the actual value, as the tip of the AFM probe pushes down onto the particle. 
The line profiles show image "broadening" due to the interaction between the AFM 
probe and the sample. This occurs when the AFM generates an image of a rough surface 
of similar magnitude to the AFM tip itself, causing the side of the probe to become 
involved in the image generation (Shakesheff et ai, 1994). The image produced 
therefore begins with a self-image of the probe, as the AFM probe contacts with the 
curvature of the particle. The next stage in the image is then of the particle itself as the 
probe scans the upper part of the particle surface giving real surface data. Finally, 
another self-image of the probe completes the scan as the reverse side of the probe 
contacts with the particle. This gives an increase in the apparent particle diameter, 
giving an apparent particle diameter of about 40 nm, whereas the true diameter of the 
particle can be estimated by the equation:-
broadened particle diameter = 2w = 4(Rr)'/' 
where w is the distance between the centres of the particle and the tip, R is the radius of 
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Figure 3.10 - Sweeping of 4:2 PLA-PEG Particles Using an Atomic Force Microscope 
3888.8 "M 
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Figure 3.11 - 4:2 PLA-PEG Particles as Imaged Using Atomic Force Microscopy 
(AFM) 
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Figure 3.12 - 6:2 PLA-PEG Particles as Imaged Using Atomic Force Microscopy 
(AFM) 
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the tip and r is the radius of the particle. In this experiment the radius of the tip can he 
taken as 10 nrn and the broadened particle diameter is taken as 36 nm for 4:1 PLA-PH i 
and 40 nm for 6:2 PLA-PEG. After calculation, this gives an estimated actual particle 
size of 16.2 nm for 4:2 PLA-PEG and 20.0 nm tor 6:2 PLA-PEG. These results 
compare reasonably with TEM results. 
Atomic force microscopy (AFM) is therefore a suitable tool for providing an estimate 
of particle size and for viewing the topography of particles. It allows high resolution of 
a naked particle surface and it is possible to observe chemical and biological processes 
occurring in real time on the same area of surface, such as when Drake el al (1989) 
studied the polymerisation of fibrin, the basic component of blood clots, using AFM. 
Thus, there is the possibility for future work on PLA-PEG copolymers, where the 
degradation of the particles could be studied in real time using this technique. 
3.5 PARTICLE SIZING 
3.5.1 Dynamic Light Scattering (DLS) 
The use of dynamic light scattering (DLS) (also known as photon correlation 
spectroscopy (PCS» to determine the size of sub-micron particles has been widely 
described, including reviews by Douglas and Davis (1986), Washington (1992) and 
Harding (1993). It is considered to be the most appropriate method for sizing particles 
in the nanometre size range as it covers the range from a few nanometres to a few 
micrometres (Washington, 1992). 
In this technique, a laser beam is passed through the dilute particulate system and the 
random Brownian motion of the particles causes fluctuations in the intensity of the 
scattered light. Small particles will diffuse rapidly giving rapid fluctuations in the 
scattered light, whereas large particles will diffuse more slowly giving light scattering 
fluctuations over a longer timescale. A photomultiplier then measures the intensities of 
the scattered light and feeds the information to an autocorrelator. The correlator then 
calculates the normalised intensity correlation function g2(t) as a function of the delay 
time (t). A plot ofln (g2(t) -1) against t will then give the diffusion coefficient, 0, with 
the plot being fitted to a linear, quadratic or cubic plot to supply the best fit (Harding. 
1993). The hydrodynamic radius, rh, can then be calculated using the Stokes-Einstein 
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equation. 
rh = kT / 67t11D 
where k is the Boltzmann constant. T is the absolute temperature. 11 is the viscosity of 
the solvent and D is the diffusion coefficient. The diameter can thus be determined by 
multiplying the radius by a factor of two. 
Light scattering techniques are widely used for characterisation of colloidal particles. 
Static light scattering can be employed to give information on the shape. radius of 
gyration and molecular weight of a micelle/particle, whereas the technique of dynamic 
light scattering (DLS) discussed here can give the particle size and an indication of the 
particle size distribution to a reasonable degree of accuracy (Lodge, 1994). DLS has the 
advantages of being applicable over a wide size range (5-3000 nm), having a rapid 
analysis time (usually around a minute), and requiring no prior knowledge of the 
concentration (Douglas and Davis, 1986). This technique provides a hydrodynamic 
diameter, which is a hydrated diameter including both the core and the surrounding PEG 
shell. 
3.5.2 Determination of the Hydrodynamic Radius of P LA -PEG Micelles and Particles 
DLS measurements have been performed as described in section 2.6.1, on triplicate 
samples of fractions of both peaks produced from GPC, and also on the unfractionated 
copolymer dispersions and Poloxamer 407, for comparison (Table 3.6). The fractionated 
1.5:2 PLA-PEG and 2:5 PLA-PEG material from the first GPC peak resulted in micelles 
which were smaller than those formed from freeze-dried unfractionated material. 
Micelles were not detected by DLS measurement in material eluted in peak two, in 
agreement with the GPC and TEM results. The polydispersity of the samples is also 
shown in Table 3.6. The reproducibility between the triplicate samples of each system 
was reasonable for all of the micellar systems, giving low standard deviations. 
This shows that the micelles produced from the unfractionated material are about 4 nm 
larger for 1.5:2 PLA-PEG and over 6 nm larger for the 2:5 PLA-PEG than those 
produced with the fractionated material. The polydispersities are similar between the 
fractionated and unfractionated samples for the 1.5:2 PLA-PEG. but for the 2:5 PLA-
PEG, the unfractionated PLA-PEG sample polydispersity is noticeably larger than that 
for the fractionated sample. 
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Dynamic light scattering size analysis has also been perfonlled on triplicate samples of 
4:2 and 6:2 PLA-PEG particles. The particle size and polydispersity results are shown 
in Table 3.7. This shows that despite /(xming particle distributions \vith low 
polydispersity (contirmed by TEM), there is a wide size distribution between samples, 
even though the samples were prepared under the same conditions. 
3.5.3 Determination olthe Hydrodynamic Radius £?ll.5:2 LPLA-PEG Part ides 
Due to the difficulty in obtaining discrete particles of 1.5:2 LPLA-PEG copolymer, the 
samples had first to be treated with the sonic probe as described above in section 3.4.2.4. 
Dynamic light scattering (OLS) was then performed on the samples in triplicate as 
described in section 2.6.1. This gave a particle size value of 14.5 nm ± 0.8 nm for the 
fractionated 1.5:2 LPLA-PEG particles. 
3.5.4 Discussion 
Table 3.8 shows that there is a general agreement between the different methods of 
particle sizing. The agreement between the calculated AFM and the DLS results for the 
4:2 and 6:2 PLA-PEG particles is particularly good, with the TEM results being of a 
similar magnitude but lower. The smaller micelle/particle size measured from TEM can 
be explained by the sample preparation technique, which involves a drying process 
causing a collapsing of the hydrophilic PEG shell onto the surface of the particle 
(Bahadur et ai, 1985; Polverari and van de Yen, 1994). In contrast. the size obtained 
from DLS is a hydrated size and therefore includes the hydrated PEG shell and the 
solvent associated with it (Bedells et ai, 1993) and will thus reflect the length of the 
hydrated PEG chains as well as the particle core. 
The data in Table 3.6 showed a larger micelle size for the unfractionated micelles over 
the fractionated micelles. This increase in size is presumably due to the presence of the 
second peak material in the sample. It is possible that interaction between the micelles 
and the second peak material (which is PLA-depleted and therefore, predominantly 
PEG) causes a decrease in the difTusion coefficient 0, which is inYersely proportional 
to the particle size. Thus, the PEG chains of the micelles could undergo transient 
entanglements with the PEG chains of the peak two material (Nicholas et al. 1993). 
which would give a slower diffusion coefficient and hence an increased particle size. 
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Tahle 3.6 
Dynamic light scallering results/i)r /.5:1 and 2:5 PLA-PEG Micelles 
Copolymer Size (nm) Polydispcrsity 
1.5:2 PLA-PEG Unfractionated 19.8 ± 0.6 0.19 ± 0.02 
1.5:2 PLA-PEG Peak One 15.6 ± 0.9 0.22 ± 0.07 
1.5:2 PLA-PEG Peak Two - -
2:5 PLA-PEG Unfractionated 25.3 ± 0.6 0.68 ± 0.01 
2:5 PLA-PEG Peak One 18.9± 1.6 0.28 ± 0.01 
2:5 PLA-PEG Peak Two - -
Poloxamer 407 29.1 ± 0.5 0.12 ± 0.06 
Table 3. 7 
Dynamic light scattering resultsfrom 4:2 and 6:2 PLA-PEG Particles 
Sample Size (run) Pol)ldispersity 
4:2 PLA-PEG (l) 18.9±0.1 0.103±0.019 
4:2 PLA-PEG (2) 15.3±0.3 0.171 ± 0.062 
4:2 PLA-PEG (3) 10.5 ± 0.3 0.325 ± 0.054 
4:2 PLA-PEG (mean) 15.1 ± 3.5 0.200 ± 0.106 
6:2 PLA-PEG (I) 25.2 ± 0.2 0.102 ± 0.025 
6:2 PLA-PEG (2) 21.1 ± 0.1 0.148±0.0IS 
6:2 PLA-PEG (3) 16.1 ± 0.2 0.264 ± 0.038 
6:2 PLA-PEG (mean) 20.8 ± 3.8 0.171 ± 0.074 
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This is supported by the greater ditterence between unfractionated and fractionated 1.5:2 
LPLA-PEG particles at the higher concentration of 10% w/v. which is discussed in 
section 4.2.4. where there would be an increased amount of peak two material present 
and theret()re, a greater chance of interaction. 
The above theory suggests an "unreal" effect, where the particle size is not increased but 
the experimental technique makes it appear so. However. it is possible that the increase 
in particle size is a "real" effect. The second peak material, as already established, is 
predominantly PEG. These PEG chains from this species could become entangled with 
the palisade layer of the micelles. the "primary" layer of PEG. Polverari and van de Yen 
(1994) have illustrated this, by adding more PEO to a dispersion of latex particles 
previously coated with PEO. They showed that a "secondary" layer of PEO was able to 
adsorb onto the primary layer by entanglement of the polymer chains of the excess PEO 
into the loops of the primary layer. The polymer in the secondary layer would be in 
equilibrium with the free polymer chains in solution. 
Finally, it is also feasible that some of the peak two material separated out by GPC, can 
incorporate into micelles. This means that some of the material in the second peak from 
GPC would be able to incorporate in a transient manner into micelles in the 
unfractionated dispersions. The peak two material would be in equilibrium, with a more 
rapid exchange relative to the higher PLA-containing material of peak one. This could 
cause an increased association number, thus increasing micelle size by increasing the 
micelle core size and possible also increasing the PEG chain length as the tighter-packed 
PEG chains repulse each other and stretch out closer to a tail conformation (Polverari 
and van de Yen, 1994). This theory is supported by the TEM results, where a small 
increase in size is also observed, which due to the drying process discussed above, 
cannot be due to an increase in the hydrophilic PEG chain length alone. 
Comparing the different PLA-PEG copolymers, it can be seen that the particle size 
varies relatively little with the change in PLA to PEG ratio. Generally, increasing PEG 
chain length results in increased size of micelles and particles (El Eini el aI, 1975; 
Gtiveli et ai, 1981; Almgren el al. 1995). However, this is not retlected in the results for 
the fractionated PLA-PEG copolymers, as 2:5 PLA-PEG micelles (with a PEG chain 
length of 5000 as opposed to 2000 for the other PLA-PEG copolymers) are no larger 
than the other PLA-PEG micelles/particles. Considering the hydrophobic chain length. 
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Amarson ,md E1worthy (19X I) ohser;ed that i/.)r surfactants containing long hydrocarhon 
chains. there was an increase in micellar size with increasing hydrocarhon chain length. 
Bahadur el af ( 1985) also noticed that micelle size increased with an increase in the size 
of the insoluble component of a hlock copolymer and an increase of the total molecular 
weight of the copolymer. Again. the PLA-PEG copolymers do not appear to follow 
these generalities. Despite the differences in hydrophobic chain length between the 
PLA-PEG copolymers. with theoretical PLA contents of 1500. 4000 and 6000 for 1.5:2 
PLA-PEG. 4:2 PLA-PEG and 6:2 PLA-PEG respectively, 6:2 PLA-PEG, there is little 
difference between the sizes of the micelles and particles formed from these copolymers. 
Therefore, it appears that a greater increase in the molecular weight of the hydrophilic 
PEG block and/or hydrophobic PLA block would be necessary to give a significant 
increase in micelle or particle size. 
The PLA-PEG copolymer micelles and particles are of the expected size range 
considering their block lengths and results quoted for similar copolymers, such as the 
poloxamers (Pluronics), diblock copoly( oxybutylene/oxyethylene), BxEy, copolymers 
and triblock copoly(oxyethylene/oxybutylene/oxyethylene), BxEyBx, copolymers (Table 
3.9). 
In the only comparable DLS results from the literature, the PLA-PEG particles were 
prepared by different methods and had different ratios of PLA to PEG to the copolymers 
discussed here, and are therefore not directly comparable. However, the Me.PEG-PLA 
particles produced by Bazile et al (1995) were in the nanometre size range (56 - 112 
nm). 
3.6 DETERMINA nON OF CMC OF PLA-PEG SYSTEMS 
3.6. J Methods {or Determining Critical Micelle Concentration ((,MC ') 
The critical micelle concentration is defined as the concentration at which the 
experimental method used can just detect the presence of micelles in the system. If 
micelles are to be used as drug delivery systems, it is imperative that their stability on 
dilution in an in vivo situation can be established. The cmc is thus a useful 
thermodynamic parameter for characterising micelle stability on dilution (Kabanov el 
al. 1995). 
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Tahle 3 . ~ ~
5,'ummary o/Particle ,<"'i::e Analysis hy Dynamic Light ,<"'cattering and 1I,licroscop), 
Copolymer Diameter, DLS Diameter, TEM Diameter. ArM I 
(nm) (nm) (I1m) 
1.5:2 PLA-PEG J5.6±0.9 7.2 -
2:5 PLA-PEG 18.9 ± 1.6 17.0 -
1.5:2 LPLA-PEG 14.5 ± 0.8 11.1 -
4:2 PLA-PEG 15.1±3.5 11.3 16.2 
6:2 PLA-PEG 20.8 ± 3.8 15.1 20.0 
Poloxamer 407 29.1 ± 0.5 12.6 ± 6.0 -
Table 3.9 
Micellar Sizes o/Similar Copolymers as Measured by DLS 
Copolymer Theoretical Temperature Size (nm) Reference 
PEOMw (DC) 
Poloxamer 407 4000 (x2) 25 29.1 ± 0.5 -
EOw POw-E025 (P85) 1125 (x2) 37 14.6 ± 0.6 Kabanov et aI, 1995 
EOI44-POS6-EOI44 (F I 08) 6480 (x2) 37 35.0 ± 5.0 Kabanov el ai, 1995 
B33 EI:15 6075 25.3 45.0 Sun el ai, 1991 
B1,E50 2250 20 17.2 Bedells et ai, 1993 
E58 BI7 E58 2610(x2) 30 13.8 ± 0.6 Nicholas er ai, 1993 
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Critical micelle concentrations (cmcs) can be determined by several dif1erent methods. 
Some of these methods involve the concept of solubilisation. whereby a hydrophobic 
compound is chosen which can be solubilised into the core of micelles. Thus. an 
increase in the solubility of a hydrophobic compound indicates the formation of 
micelles. Examples of this method are given by Goodhart and Martin ( 19(2). who used 
benzoic acid as the solubilisate. Furton and Norelus (1993). who used the oil-soluble 
dye. 1-(2-pyridylazo )-2-naphthol. and Schmolka and Raymond (1965). who used the dye 
benzopurpurin 48. A similar method involves the solubilisation of a hydrophobic 
fluorescent probe, such as that described by Alexandridis el af (1994). Here, the 
fluorescence efficiency of diphenylhexatriene, DPH, in different Pluronic copolymers 
was studied. The fluorescence efficiency ofDPH in a hydrophilic environment is zero, 
whereas that in a hydrophobic environment (such as a micelle core) is unity. providing 
a sensitive indicator of when micelles are formed. These experiments were also 
corroborated with differential scanning calorimetry (DSC). Giiveli et al (1981), Reddy 
et af (1990) and Wanka et al (1990) have employed static light scattering studies to 
determine the cmc value, and Wanka et 01 (1990) also performed interfacial tension 
studies for comparison, whilst Giiveli et 01 (1981) compared with viscosity 
measurements. These last three groups have also used surface tension studies to elicit 
cmc values, which is the method that will be performed on the PLA-PEG micelles and 
is described below. 
The dye solubilisation method described above (either with fluorescent probe or 
hydrophobic dye) and the surface tension method of determining cmc are the most 
widely used. The dye solubilisation method has the drawback that partial exhaustion of 
the dye can occur, so that the results need careful analysis (Schmolka and Raymond, 
1965). Also the presence of the dye/probe could theoretically affect the cmc result, 
although providing the solubilisate is hydrophobic, it should be located in the micelle 
core and should therefore have a negligible effect on the cmc value (Furton and Norelus. 
1993). However, the measurement of surface tension avoids this potential problem. 
The surface tension method works on the theory that an increase in surfactant 
concentration leads to a decrease in surface tension according to the Gibbs' isotherm of 
adsorption. with micelle formation at the cmc causing a break in this dependence 
(Kabanov et al. 1995). The cmc value is therefore determined by plotting the logarithm 
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of the concentration against the surface tension, which should give two straight lines 
hefore and after the break in dependence. The point at which this hreak occurs. and 
therefiJre where the two lines cross, is the cmc. The method employed to find the cmc 
hy this method has heen descrihed previously by many authors (including Bedells 1.'/ al. 
1993; Alexandridis 1.'/ al. 1994) and is outlined in section 2.7.1. 
However. it must be remembered in this experiment that due to the nature of block 
copolymers, no sharp cmc value is observed. as even those with a narrow distribution 
of molecular weight still have some appreciable heterogeneity (see section 3.3.5). Also, 
large differences may be noted between cmc values determined by difTerent methods, 
as their sensitivity to unimers and micelles and the nature of the average quantity 
estimated can be quite different (Zhou and Chu, 1987). 
3.6.2 CMC of Polysorbate (Fween) 80 Micelles 
The cmc of Tween 80 was determined using surface tension measurements to provide 
a control for the experimental determination of the cmc of the 1.5:2 and 2:5 PLA-PEG 
micelles. Polysorbate 80 was chosen as a surfactant where the literature value of the 
cmc was readily available (Wan and Lee, 1974) and as it had a similar HLB value to the 
PLA-PEG micelles (HLB of polysorbate 80 = 15.0; 2:5 PLA-PEG = 14.3; 1.5:2 PLA-
PEG = 11.5). Solutions of Tween 80 were prepared using HPLC grade water and 
chromic acid cleaned glassware at concentrations ranging from 0.0005% w/v to 0.005% 
w/v. The results are shown in Figure 3.13 as the logarithm of the concentration against 
surface tension. This shows that there is a definite change in slope between the 
concentrations 0.001% w/v and 0.0015% w/v. The point of intersection of the two lines 
is at 0.00135% w/v, which becomes 0.0014% w/v (to two significant figures). A 
literature value stated by Wan and Lee (1974) is also 0.0014 %w/v for the cmc of 
Polysorbate 80, showing very good agreement. It is interesting to note that the surface 
tension values after the point of intersection still show a slight decrease. whereas they 
would be expected to remain constant. as the surface excess concentration of surfactant 
molecules is expected to be approximately constant in the presence of micelles. This 
could perhaps be due to experimental error or to "ageing" of the sample due to 
hydrocarbon contamination, which would cause the surface tension readings to appear 
lower than for a pure sample, and also cause a decrease of surface tension with time. To 
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Figure 3.13 - Plot of Log Concentration of Tween 80 against 
Surfac e Tension for the Determination of the CMC 
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test for this. a further control experiment was performed on solvent used (the IIPLC 
grade water). with the glass slide held at zero immersion for a period of onc hour. No 
decrease in the force reading was seen over the onc hour period. indicating that the 
solvent was free from hydrocarhon contamination and the s u r f ~ l c e e tension readings \'.ere 
valid. 
3.6.3 CMC oj'PL4-PEC Micelles 
This experiment was performed in triplicate for a range of concentrations from 0.001% 
w/v to 0.05% w/v. The plots of surface tension against log concentration (% w/v) for 
aqueous solutions of fractionated 1.5:2 PLA-PEG and 2:5 PLA-PEG copolymers are 
shown in Figures 3.14 and 3.15 respectively. Both these graphs show a distinct change 
in slope at 0.0035% w/v, which was taken to signify the formation of micelles. This 
indicates that the cmc of both 1.5:2 and 2:5 PLA-PEG micelles appears to be around 
0.0035% w/v (0.035 gll). For both samples, the surface tension after the point of 
intersection decreases slightly. 
Table 3.10 shows a comparison of cmc values from the literature ofPluronic copolymers 
(nomenclature discussed 111 section 1.5.1) and block copolymers of 
oxyethylene/oxybutylene, with the PLA-PEG copolymers and the comparison between 
authors and techniques. The table clearly shows the discrepancy between the different 
authors and different techniques, with that between the authors showing the larger 
variation. One of the reasons for these variations is the difficulty in interpreting results. 
With the Pluronic copolymers, for surface tension experiments two inflection points can 
often be seen, and sometimes a step-like curve between these points that can be 
smoothed out as the temperature is increased. It is therefore necessary to attempt to 
explain what causes these steps/inflections, and which one corresponds to the cmc. 
Different authors have advanced several theories. Prasad et al (1979) suggested that the 
first point of inflection is due to the formation of unimolecular micelles in the bulk due 
to the collapse of the PPO chains. so that the PPO chains were shielded from the 
aqueous environment by the PEO chains. However, Alexandridis et al (1994 (2» has 
pointed out that this has no apparent thermodynamic reasoning at low concentrations and 
is therefore very unlikely. Also, the increase in temperature should increase the 
likelihood of these unimolecular micelles, whereas the curve is smoothed out at higher 
106 
-E 
".. 
Z 
E 
-
c 
0 
Cl) 
c 
CD 
I-
(I) 
0 
0 
-j 
en 
Figure 3.14 - Determination of the CMC of 1.5:2 PLA-PEG 
Copolymer using Surface Tension Measurements 
54 1 
52 j 
... 
50 
48 
---------c 
46 
l 
44 
42 
40 -Y---i I I I I I 
.001 .01 .1 
Concentration of PLA-PEG Solution (%w Iv) 
107 
E 
-:z 
E 
-
c 
0 
.,. 
c 
Q) 
0-
Q) 
0 
0 
-:::J 
en 
Figure 3 . 15 
58 
56 
54 
52 
50 
48 
46 
44 
42 
40 
.001 
- Determination of CMC of 2:5 PLA-PEG Micelles 
using Surface Tension Measurements 
.01 . 1 
Concentration of PLA-PEG Solution (%W'/v) 
108 
temperatures and not therefore consistent with this theory (BloB et ai, 1992). Another 
possibility discussed by Hecht and Hoffmann (1994) is that the steps are due to 
polydispersity of the Pluronic copolymers. [fthis were the reason, then there should be 
a gradual decrease in slope rather than a steplike decrease (Kabanov et aI, 1995). Also, 
Linse (1994) has shown that copolymer impurities (that is the homopolymers and 
diblock copolymers) only marginally affect the cmc. Kabanov et al (1994) concluded 
that the most likely explanation is that there is a concentration-dependent change in the 
configuration of the block copolymer at the air/water interface. This is a theory 
advanced by Alexandridis et af (1994 (2» that there is some structural transition of the 
block copolymer resulting in its compaction, which gives a change in the slope of the 
surface tension curve. Kabanov et af (1995) suggested that there was no experimental 
data to support the second inflections of surface tension curves corresponding to the 
cmc, and that the best estimate of cmc was to ignore the steps and determine the crossing 
point of the straight lines from the data before and after the steps. As to the differences 
between measurements, they suggested that it might be due to differences in kinetic 
effects, particularly the histories of the samples prior to the measurements. The large 
differences reflected in Table 3.] 0 between the DPH ··probe" data from Alexandridis et 
af ( 1994) and the measurements from other authors is suggested by Kabanov et at (] 995) 
to be due to a time dependence effect of the fluorescence. This can cause the cmc to 
appear 10 times higher after one hour than after sixteen hours (Alexandridis et af (1994) 
measured their data after three hours). The data at sixteen hours was consistent with 
other measurements. This "relaxation" of the micellar solutions is thought to be due to 
the formation of DPH complexes and their complexationldecomplexation during 
incorporation into the Pluronic micelles. 
Another point to consider is that the cmc shows a strong dependence on temperature, 
especially at low concentrations (Almgren et aI1995). For the Pluronics, an increase 
in temperature decreases the cmc, by decreasing the hydration of the Pluronic chains and 
thus increasing the hydrophobicity of the micellar core. The micellar cores near the cmc 
value are very swollen by solvent, and as the concentration or temperature increases, 
solvent molecules are driven out of the micellar core, resulting in a more hydrophobic, 
smaller core (Gao and Eisenberg, 1993). 
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Raymond ( 19(5) noted that although the higher molecular v.eight copolymers studied 
decreased in cmc as the ethylene oxide content increased. the lower mob.:ular weight 
copolymers did not follow this trend. showing a decrease and then an increase with 
increasing ethylene oxide content. However. El Eini et 01 (1975) observed that the more 
ethylene oxide in a copolymer. the higher the cmc value. They attributed this to solute-
solvent interactions being greater with longer polycthylene oxide chains. so that the 
solubility of the monomer would be increased and the driving forces that lead to 
micellisation would also decrease. Several groups, including Schick et 01 (1962) and 
Gilveli et of (1981 ). share this view. 
Alexandridis et al (1994) compared the values of several different Pluronics and found 
that the cmc decreased with increasing PPO content (and therefore increasing 
hydrophobicity), whereas increasing the PEO content increased the cmc but to a much 
lesser extent. They therefore concluded that the more hydrophilic the copolymer 
molecule (that is the more PEO), the less likely micellisation was, but the effect on cmc 
of the hydrophobic PPO group was more pronounced, suggesting that the PPO is the 
primary factor in the micellisation process. Drawing comparisons with the PLA-PEG 
copolymers, the 2:5 PLA-PEG has a higher PEG content than the 1.5:2 PLA-PEG, but 
also has a longer PLA block (2000 Mw compared with 1500). From the PEG groups, 
the cmc of the 2:5 PLA-PEG would be expected to be higher than that of the 1.5:2 PLA-
PEG. This is not the case. It must therefore be assumed that, like the Pluronic 
copolymers, the influence ofthe PEG group is less important. and the net effect of this 
increased PEG molecular weight and increased PLA molecular weight cancel each other 
out to give the same value for both copolymers. The 2:5 PLA-PEG also has a higher 
molecular weight. and Alexandridis et al (1994) noted that for molecules with the same 
PPO/PEO ratio. those with higher molecular weight formed micelles more readily. 
Although the ratio of PLA to PEG in the copolymers is not the same, the higher 
molecular weight of 2:5 PLA-PEG may still be a contributing factor. 
Comparing the values of the cmcs in Table 3. \0 for other copolymers with the PLA-PEG 
copolymers. it can be seen that there is very good agreement with the values for Wanka 
et af (1990), which have similar PEO weight contents to the PLA-PEG copolymers (40% 
and 70% for P104 and FI27 respectively). The much higher value for FI27 found by 
Alexandridis et (If (1994) is unlikely to be valid. as explained ahove. The values from 
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TaM! 3.1 () 
(·.\/C /'u/ucs ojRe/alec/ C ( } I ' ( ) ~ r l l 1 e r s s
Copol:- mer PEO Method Temperature CMC Rekrcllcc 
Weight % CC) (% \V/v) 
1.5:2 PLA-PEG 60 ST 20 0.0035 -
2:5 PLA-PEG 70 ST 20 0.0035 -
PI23 30 ST 25 0.0015 Wanka et aI, 1990 
PI23 30 Probe 20 0.18 Alexandridis et aI, 1994 
PI03 30 Probe 20 0.7 Alexandridis el aI, 1994 
PI04 40 ST 25 0.003 Wanka et aI, 1990 
PI04 40 Probe 20 2 Alexandridis et aI, 1994 
PI04 40 Dye 25 0.0073 Schmolka and Raymond, 1965 
PI05 50 Probe 20 2.2 Alexandridis et aI, 1994 
P84 40 Probe 25 2.6 Alexandridis el aI, 1994 
P84 40 Dye 25 0.0040 Schmolka and RaYl11ond, 1965 
P85 50 Probe 25 4 Alexandridis el al. 1994 
P85 50 Dye 25 0.0037 Schmolka and RaYl11ond, 1965 
P85 50 S1' 25 0.03 - Kabanov el al. 1995 
0.04 
P85 50 Probe 25 0.04 Kabanov el aI, 1995 
FI08 80 Probe 25 4.5 Alexandridisclal.1994 
FI08 80 Dye 25 0.0073 Schmolka and Raymond. 1965 
FI08 80 ST 25 0.03 - Kabanov et al. 1995 
0.05 
1 I 1 
Copolymer PLO Method Temperature CMC Reti:relKc 
Weight % CC) (% w/v) 
FIOS SO Probe 25 0.03 Kabal1O\ L'I al. 1995 
FI27 70 S1' 25 0.004 Wal1ka L'I 0/. 1990 
FI27 70 Probe 20 4 Alexal1dridis et al. 1994 
E508,; 70 S1' 20 0.003 Bedells et al. 1993 
E50B '1 70 ST 40 0.001 Bedells et al. 1993 
E24 B1o 60 ST 40 0.0023 Bedells et a/, 1993 
EmB}) 70 ST 25.5 0.0070 Sun et ai, 1991 
E58B '7 E58 75 SLS 30 0.030 Nicholas et ai, 1993 
E132B5.1Em 70 SLS 30 <0.002 Nicholas et ai, 1993 
Key: "ST" is surface tension technique, "dye" is the dye solubilisation technique and 
"probe" is the DPH probe solubilisation, as explained in the text. 
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Bedells el 01 (1993) for the diblock polyoxyethylenelpolyoxybutylene copolymers 
(ExBy) are also in good agreement. being of a similar order of magnitude. The value flJr 
["oB IJ which has similar hydrophobic and hydrophilic contents to 2:5 PLA-PUj (7011'0 
Pl-:O by weight. E.j.tl.27) and measured at the same temperature as the PLA.-PEG 
copolymers is very close. It is therefore clear that the cmc values obtained for the PLA-
PEG copolymers are reasonable considering their composition. 
3.7 ULTRACENTRIFUGATION ANALYSIS 
3.7. 1.1 Sedimentation Velocity 
Analytical ultracentrifugation has been used as a technique for characterising 
macromolecules for a number of years. Such experiments can give information on the 
molecular weight of the macromolecule (detailed below in 2.8.2) and on the 
conformation and homogeneity of the sample with sedimentation velocity experiments. 
In sedimentation velocity analytical ultracentrifugation runs, the speed is sufficiently 
high to cause the macromolecules to sediment, creating boundaries between the sample 
solution and the solvent, which can be used to give information about the sample 
macromolecules (Harding, 1993). This experiment is therefore a measure ofthe velocity 
of the movement of these boundaries, and as well as showing the homogeneity of the 
samples, a sedimentation coefficient, s, can be calculated, which gives an indication of 
the size, shape and molecular weight of the aggregates. The sedimentation coefficient, 
s, is defined by: 
dr/dt v 
s=--=--, , 
0./ r «/ r 
where (J) is the angular velocity (radian S-I) of the rotor, 
r is the distance of the boundary, measured from the axis of rotation, 
and v is the velocity of the boundary. 
The sedimentation coefficient is therefore the distance in cm, covered by a 
macromolecule during 1 second under the effect of a "force" of 10-2 Nkg-I, and is usually 
given in Svedbergs, S. where 1 S = 10- 13 s (Price and Dwek. 1986). 
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The sedimentation coefticient. s. can also be used to calculate the molecular weight of 
the macromolecule by the Svedberg equation: 
where M is the molecular weight. 
T is the temperature (Kelvins). 
D is the diffusion coefficient (m2s"), 
v is the partial specific volume (m3kg"), 
and p is the density of the solvent (kg m,3). 
Rh 
D( 1- vp) 
However, this experiment assumes that all measurements are performed at infinite 
dilutions «0.1 % w/v). otherwise corrections are required to give a realistic estimate of 
the molecular weight. In practice, it is much easier to use sedimentation equilibrium 
experiments to assess the molecular weight of macromolecules. This process IS 
therefore used for the PLA-PEG copolymers and is outlined in section 2.8.2. 
For sedimentation velocity experiments, a specially designed sector shaped cell is used 
with transparent end windows. The macromolecule solution to be analysed is placed in 
this cell and a light source positioned below the ultracentrifugation rotor to transmit 
monochromatic light through the solution and then on to be detected by other 
appropriate optical components. The moving boundary detected is then recorded and 
interpreted by computer. A more detailed introduction to this method can be found in 
van Holde (1985), and Price and Dwek (1986). 
3.7.2 Sedimentation Velocity Experiments 
Figures 3.16 to 3.19 show the sedimentation velocity absorbance profiles for the PLA-
PEG copolymers. All of the PLA-PEG copolymers showed a single sedimenting 
boundary. indicating homogeneity of the samples. 
The sedimentation coefficients will be discussed in section 5.3. 
3.7.3 Sedimentation Equilibrium 
In contrast with sedimentation velocity experiments. sedimentation equilibrium analysis 
is not a transport method. In these experiments. a low rotor speed is chosen so that the 
114 
--Vo 
$ 
u 
c:: 
all 
.c 
... Q 
.! 
-< 
Figure 3.16 - Sedimentation Velocity Profiles of 1.5:2 PLA-PEG Micelles at an Absorbance of231 nm 
0.5 
O.O __ ' ~ I I
6.4 6.6 6.8 
Radius (cm) 
Figure 3.17 - Sedimentation Velocity Profiles for 2:5 PLA-PEG Micelles at an Absorbance of225 run 
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Figure 3.18 - Sedimentation Velocity Profiles of 4:2 PLA-PEG Particles at an Absorbance of227 nm 
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Figure 3.19 - Sedimentation Velocity Profiles of 6:2 PLA-PEG Particles at an Absorbance of227 nrn 
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forces of sedimentation and dillusion on the macromolecular solute arc comparable. and 
an equilihrium distrihution of the solute is achieved (Harding, 1993). This equilihrium 
distribution can be produced after a period of between 2 and 96 hours depending on the 
macromolecule, the solvent 
and the run conditions. As there is no net transport of matter in the ultracentrifuge cell. 
and therefore no flow. an analysis of the final equilibrium distrihution will give an 
estimate of the absolute weight average molecular weight of the macromolecule. 
independent of particle shape and hydration (van Holde, 1985). The determination of 
the molecular weight of aggregates, as produced by this technique also allows the 
determination of the number of subunits in the aggregate. 
The sample in the ultracentrifuge cell is analysed by interferometric optics in an 
experiment similar to that described for sedimentation velocity in section 2.8.1, and the 
data fed to a computer for interpretation. A full introduction to this method is given in 
van Holde (1985) or Price and Dwek (1986). 
3.7.4 Sedimentation Equilihrium Analysis 
The partial specific volume, v, for each copolymer is given in Table 3.11. This 
parameter was used in the calculation of the weight average molecular weight of the 
micelles/particles and is a measure of the change in volume (in ml) of the solution per 
gram of solute. 
Apparent whole-cell weight-average molecular weights, calculated for the fractionated 
PLA-PEG copolymers, and also Poloxamer 407, are presented in Table 3.11. The 
association numbers of the PLA-PEG micelles and particles were calculated using the 
weight average molecular weight values for the individual copolymer molecules 
estimated from size exclusion chromatography analysis given in the section 3.2.1, and 
are also shown in Table 3.11. 
Table 3.11 shows that the 2:5 PLA-PEG copolymer, with the 5000 PEG chain length as 
opposed to the 2000 PEG chain length of the other PLA-PEG copolymers. has a 
noticeably smaller association number and molecular weight than the other PLA-PEG 
copolymers. Similarly, Poloxamer 407 also has a much reduced association number. 
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3.7.5 DisclIssion 
Sedimentation equilibrium is a lIseful method for determining the molecular weight of 
micelks/particles. Other methods used include static light scattering (SLS). which 
involves extrapolation to zero concentration and can be ambiguous in systems showing 
complex association behaviour (Almgren el al. 1995). SLS can also give association 
numbers that are too low and incompatible \vith results from other methods. Another 
method employed is the time-resolved fluorescence quenching method. TRFQ. but this 
too has proved dimcult with pure Pluronic copolymers due to slow quenching under the 
conditions used (Almgren el al. 1991). Dye solubilisation has also been attempted for 
estimation of association numbers. but the results obtained disagreed markedly with 
other methods. This was thought to be due to the false assumption that at saturation. all 
micelles would solubilise the same number of dye molecules (Jacobs et al. 1971). 
Considering the trend of association numbers of the PLA-PEG copolymers, there is a 
pronounced decrease between the PLA-PEG copolymers with a PEG chain length of 
2000 and the 2:5 PLA-PEG copolymer with a PEG chain length of 5000. This is to be 
expected for copolymers containing PEG. where groups working with micelles have 
observed an decreased association number and micellar weight with increased PEG 
content (Becher. 1961; El Eini el al. 1975; Stubicar and Petres, 1981). Furthermore, 
Stubicar and Petres (1981) noted that for Tritons with the same hydrophobic group but 
increasing hydrophilic content. there was a linear relationship between the logarithm of 
the association numbers and the number of oxyethylene groups. Similarly, Poloxamer 
407 with its two PEO groups. and similar PEG content to 2:5 PLA-PEG ( ~ 7 0 % ) , , also 
has a much lower association number. 
For the hydrophobic groups of micelle-forming polymers, Amarson and Elworthy (1981 ) 
have shown that the association number is linearly related to the number of carbon atoms 
in the hydrocarbon chain for long chain c"E- surfactants, where C represents the number 
of carbon atoms (x) in the hydrocarbon chain and E represents the number of ethylene 
oxide groups (y) in the polycthylene oxide chain. Bahadur el al (1985) also found that 
micelle association number and total micellar weight increased with increased size of 
the insoluble block for styrene-isoprene block copolymers. An increase in the 
hydrophobic group of the PLA-PEG copolymer molecules (i.e. the PLA group) would 
therefore be expected to increase the association number. 
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Tah/e 3. / / 
A1o/n'lI/ar Weighl /)ola/()I' ( ' ( } / ) ( ) ~ l ' l I / e r r Aficel/e.I-//)arlicles ohlainedjrom ,)'edimenlalion 
Equilihrium i:\perimellls 
Copolymer Molecular Partial specilic M icelle/particle Association 
weight volume, v (mlg'l) molecular weight number 
1.5:2 PLA-PEG 3947 0.822 520,000 ± 20,000 132±5 
4:2 PLA-PEG 6433 0.804 1,000,000 ± 50,000 155 ± 8 
6:2 PLA-PEG 7017 0.810 1,500,000 ± 100,000 214 ± 14 
2:5 PLA-PEG 6987 0.797 330,000 ± 30,000 47±4 
Poloxamer 407 12600 0.808 200,000 ± 10,000 16 ± I 
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Comhining these data with the DLS data (Tahle J.12) shows that the micelles formed 
with the Poloxamer 407 and 2:5 PLA-PFG copolymers have much lower association 
nUl11hers per micelle than the 1.5:2 PLA-PEG copolymer. yet with a larger micellar size 
heing detected for Poloxamer 407. This suggests that the Poloxamer 407 micelles fom1 
less densely packed micelles relative to the smaller micelles observed with PLA-PEG 
copolymers. Indeed, Saito and Sato (1985) noted that an increase in polyoxyethylene 
chain length led to a decrease in compactness of micelles, which caused an increase in 
micellar inner polarity. The association number for the 4:2 PLA-PEG particle-forming 
copolymer is slightly higher than for the 1.5:2 PLA-PEG but with a similar 
micelle/particle size, indicating still closer packing of the copolymer molecules. The 6:2 
PLA-PEG copolymer has a significantly larger association number than the 1.5:2 PLA-
PEG and 4:2 PLA-PEG micelles/particles, suggesting further closer packing. 
3.8 SUMMARY 
The physicochemical properties of copolymers of polylactide and poly( ethylene glycol) 
(PLA-PEG), which either self disperse in water to form spherical non-ionic micelles 
(1.5:2 and 2:5 PLA-PEG) or form more "solid-like" particles during the solvent-
precipitation process (4:2 and 6:2 PLA-PEG and 1.5:2 LPLA-PEG), have been 
investigated. These copolymers are defined by the molecular weight ratios of their 
polylactide to poly(ethylene glycol) components and gave two peaks when purified by 
gel permeation chromatography (GPC). The first peak consisted of spherical 
micelles/particles with diameters in the range 14.5 nm and 20.8 nm for the different 
copolymers as determined by dynamic light scattering (OLS). Analysis by transmission 
electron microscopy (TEM) and atomic force microscopy (AFM) for 4:2 and 6:2 PLA-
PEG copolymers were in good agreement with these values. The second peak produced 
by GPC was a PLA-depleted species resulting from the synthesis and did not form 
micelles. 
The cmcs of the micelle-forming PLA-PEG copolymers (1.5:2 and 2:5 PLA-PEG) were 
determined using surface tension measurements and both copolymers fomled micelles 
at 0.0035% w/v, which compares reasonably with values for similar copolymers. 
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Tahie 3. 1 :1 
, " ' l I m m ( / / ~ \ ' ' ojJ)L'" and Sedimentation £"lJllilihrillm Data 
Copolymer Diameter, DLS (nm) MicellclpaI1icle Association 
molecular weight numher 
1.5:2 PLA-PEG 15.6±0.9 520,000 ± 20,000 132 ± 5 
4:2 PLA-PEG 15.1±3.5 1,000,000 ± 50,000 155 ± 8 
6:2 PLA-PEG 20.8 ± 3.8 1,500,000 ± 100,000 214 ± 14 
2:5 PLA-PEG 18.9 ± 1.6 330,000 ± 30,000 47 ± 4 
Poloxamer 407 29.1 ± 0.5 200,000 ± 10,000 16 ± 1 
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relatively homogeneous. Molecular weights of the micdles/pa!1icles were determined 
using sedimentation equilibrium experiments. From the molecular weights of the 
micelles/particles and the molecular weights of the individual copolymer molecules. the 
number of copolymer molecules per micelle/particle v·:as calculated. These showed the 
expected trend with the longer chain length of the 2:5 PLA-PHJ resulting in a decreased 
association number and the longer hydrophobic PLA length of the 6:2 PLA-PLG giving 
a higher association number. 
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CHAPTER FOUR 
SURFACE CHARACTERISATION OF PLA-PEG COPOLYMERS 
4.1 INTRODUCTION 
The previous chapter concentrated on the properties of the PLA-PEG systems as a 
whole, considering their purity, and the characteristics of the micelles and particles 
produced by the different PLA-PEG copolymers. This chapter now studies in more 
detail a specific part of the PLA-PEG systems, namely the surface characteristics of these 
systems. 
Surface characterisation is a growing tool in the analysis of biomedical polymers, and in 
this chapter, four different methods of examin\ng the surface of the PLA-PEG 
copolymers will be discussed. The first teclmique uses rheological measurements to 
obtain a value for the length of the PEG layer thickness. Two complementary 
techniques, static secondary ion mass spectrometry (SIMS) and X-ray photoelectron 
spectroscopy (XPS), are then discussed, which give chemical and elemental infonnation 
of the surface and allow some degree of quantification of the surface density of PEG in 
the samples. Finally, cloud point temperatures, which give an indication of the steric 
stability of a copolymer system are considered. These four teclmiques therefore allow 
different aspects of the PLA-PEG surface to be studied and an overview of the properties 
of this surface can be obtained. As discussed previously in chapter one, the surface 
properties of drug delivery systems are very important in determining the in vivo 
biodistribution of the system, by influencing the adsorption of proteins (opsonins and 
dysopsonins) from plasma. The surface composition can also determine the rate of 
biodegradation and release of drug molecules in vivo, which can have toxicological 
implications for the patient (Davies et aI, 1989). The measurements were perfonned as 
described in chapter two. 
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4.2 DETERMINATION 01- PUi LA YI R r1IICK.NLSS BY RIIEOLOGICAL 
MEAS U REMENTS 
4.2.1 The Sign[jicance (d/he PL"0 layer Thickness 
In chapter one, the potential rapid response from the reticuloendothelial system (RES) 
to remove colloidal particles injected into the body from the circulation was discussed. 
This is thought to be due to the adsorption of circulating proteins and blood components 
(opsonins) onto the particle surface, which causes the recognition and subsequent 
engulfment by the macrophages of the RES. The steps taken to prevent the extent of 
uptake were discussed in chapter one and depend on the physicochemical characteristics 
of the particles, such as their size, surface charge and the presence of a hydrophilic 
surface layer (for example, polyethylene glycol) to provide steric stabilisation. This 
steric barrier influences the identity and quantity of the plasma proteins adsorbed, and 
by that, the interaction of the nanoparticles with the phagocytic cells. This was 
illustrated by Harper el al (1991 ), who showed a reduction in the uptake of polystyrene 
microspheres by rat Kupffer cells when polyethylene oxide (PEO) was covalently 
grafted to the microspheres, or physically adsorbed as Poloxamer 238. The effectiveness 
of the PEO as a hydrophilic steric barrier has been shown to be affected by both the 
surface density of the PEO chains and the chain layer thickness of the PEO chains. This 
was demonstrated by Dunn el (If (1994), who showed that increased density of PEO 
chains at the surface of microspheres reduced their uptake by the Kupffer cells in in vitro 
studies, and by the RES in in vivo studies in the rat model. Also, IlIum el al (1987) 
established that the length of the PEG chains affected the uptake of the particles by 
mouse peritoneal macro phages. with longer PEG layer thicknesses resulting in less 
uptake. This was illustrated by relative phagocytic uptake of Poloxamer 407 coated 
particles with an adsorbed layer thickness of 154 A being 21.6%, compared with 
particles coated with Poloxamer 188 with an adsorbed layer thickness of 76 A giving 
95.4% relative phagocytic uptake. The length of the PEG layer thickness is thus an 
important parameter in determining how effective a potential drug delivery system will 
be in vivo and the knowledge of this value should allow comparison between different 
copolymer systems in the light of their in "i1"O performance. 
4.2.2 Measurement of PEG layer Thickness 
In order to design systems that are effective ill vivo, it is necessary to obtain information 
on the thickness of the steric barrier, as this gives a direct measure of the extent of the 
steric repulsion. A DLS measurement will give a value for the hydrodynamic radius of 
the particle core plus the stabilising PEG layer, but cannot yield any information on the 
barrier thickness. Previously, when non-biodegradable polystyrene particles were used 
with copolymers physically adsorbed to the surface, the thickness of the stabilising PEG 
layer was estimated using DLS. This was achieved from a knowledge of the 
hydrodynamic radius of the particle in the presence and absence of the polymer layer, 
such that the adsorbed layer thickness could be obtained by subtraction. This should be 
further corrected, taking into account the curvature and surface of the particle (Killmann 
and S apuntzj is, 1994). Other techniques also allow estimation of the PEG layer 
thickness, including force-distance measurements between adsorbed layers (Klein and 
Luckman, 1982; Cohen Stuart et ai, 1986), small-angle neutron scattering (SANS), 
which also allows determination of the segment density and the particle core radius 
(Almgren et al, 1995), and viscometry measurements (Cohen Stuart et ai, 1986). SANS 
allows the estimation of the PEG layer thickness for block copolymers, by yielding the 
radius of the aggregate core, thus allowing the PEG layer thickness to be obtained by 
subtraction from the hydrodynamic radius (Kabanov et ai, 1995). 
Recently, Tadros and collaborators (Liang et ai, 1992; Miano et ai, 1992; Pingret et ai, 
1992) have established a simple rheologica1 technique to obtain the thickness of an 
adsorbed or grafted layer on the surface of a colloidal particle. Basically, parameters 
such as viscosity or modulus are measured as a function of the volume fraction of the 
dispersion. When the surface-to-surface distance between the particles approaches twice 
the adsorbed (or grafted) layer thickness, strong interaction occurs and the system 
becomes predominantly more elastic than viscous. Thus by measuring the storage (G') 
and loss (G") moduli as a function of volume fraction, <1>, an intersection point is obtained 
at a critical volume fraction, <l>elf, which determines the onset of elastic interaction. From 
a knowledge of <I> at the crossover point, the adsorbed layer thickness can be calculated. 
Rheological measurements have also been used to compare between the adsorbed layer 
thicknesses of poly( ethylene oxide )-poly(propylene oxide) copolymers, with Kim and 
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Luckham (1992) observing a greater adsorbed layer thickness of Pluronic F 127 over 
Pluronic PI 05 when adsorbed onto polystyrene particles. 
4.2.3 Rheological Data/or PLA-PEG Copolymers 
Rheological studies were carried out on 1.5:2 PLA-PEG, 1.5:2 LP LA-PEG, 4:2 PLA-
PEG, 6:2 PLA-PEG and 2:5 PLA-PEG as described in section 2.8. 
Figure 4.1 shows typical strain sweep results (at a frequency of 1 Hz) for a dispersion of 
1.5:2 LPLA-PEG with a volume fraction 4> = 0.148. The results show a linear region up 
to a strain value of 0.04. Above this strain value, the complex modulus, G*, and the 
storage modulus, G', decrease, whereas the loss modulus, G", increases. This is typical 
for a viscoelastic system. At this volume fraction, G' is greater than G", and this indicates 
interaction between the PEG layers in the dispersion. Strain sweep results for a range 
of volume fractions were also obtained showing that the trend obtained depended on the 
volume fraction. At a volume fraction of 4> = 0.066, the loss modulus, G", is greater than 
the storage modulus, G', showing weak interaction in the dispersion. 
Figure 4.2 shows the frequency sweep results for a 1.5:2 LPLA-PEG dispersion with 4> 
= 0.148. It can be seen from this figure that G' > G" over the whole frequency range. 
This, as mentioned above, is due to the elastic interaction between the PEG chains on 
close approach. However, both G* and G' show significant dependence on frequency. 
This implies that the interaction is not sufficient to produce an "elastic gel". Therefore, 
it is likely that the PEG chains have undergone some penetration in this case, without any 
compressIOn. 
As the volume fraction of the dispersion is further increased, the frequency dependence 
ofthe modulus becomes smaller. This is illustrated in Figure 4.3, which shows the results 
for 4> = 0.26. In this case, G'»G" and the slope of the G* or G' versus frequency is 
smaller than that shown in Figure 4.2. This implies more penetration of the chains on 
closer approach. However, there does not seem to be any compression, which in most 
cases would lead to an "elastic gel". This is indicated as G* and G' for LPLA-PEG are 
still dependent on frequency, even at high volume fractions, whereas if there was 
compression (and an "elastic gel" formed), there would be little dependence of these 
parameters on frequency. 
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Figure 4.2 - Frequency Sweep for 1.5:2 LPLA-PEG with a 
Volume Fraction of 0.148 
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Figure 4.4 shows plots of G*. (J' and G" (at 0.1 I-lz) as a function of the LPLA volume 
fraction for 1.5:2 LPLA-PEG. At ~ ~ < 0.054. G" > G'. Below this volume fraction. the 
surface-to-surface distance between the particles is probably larger than twice the PEG 
layer ihickness. This produces weak interaction between the particles and the dispersion 
shows more viscous than elastic response. At ~ ~ > 0.054. G' > G" and the viscolls 
component stays low. Under these conditions. the surface-to-surface distance becomes 
smaller than twice the PEG layer thickness. This results in strong interaction. with 
possible overlap of the chains and the dispersion becomes more elastic than viscous. 
Rheological measurements performed on the other PLA-PEG copolymers (1.5:2 PLA-
PEG. 4:2 PLA-PEG, 6:2 PLA-PEG and 2:5 PLA-PEG) showed a similar trend, with low 
volume fractions showing a more viscous than elastic response (G" > G') and higher 
volume fractions again showing an elastic response (G' > G"), but again no indication 
of an "elastic gel". 
The Figures 4.5 to 4.8 show the plots of G*, G' and G" (at 0.1 Hz) as a function ofthe 
volume fraction ofPLA for 1.5:2 PLA-PEG, 4:2 PLA-PEG, 6:2 PLA-PEG and 2:5 PLA-
PEG respectively. Again, these show similar results to the LPLA-PEG dispersion with 
the change from a viscous (G" > G') to an elastic dispersion (G' > G") apparent for all 
systems with an increase in volume fraction. This behaviour has also been demonstrated 
by Pluronic P-94 for both increased volume fraction and temperature, with oscillatory 
measurements (Bahadur and Pandya, 1992). 
4.2.4 Dynamic Light Scattering Results/or Concentrated PLA-PEG Dispersions 
These analyses were carried out for dispersions with concentrations of 10% w/v. Table 
4.1 shows the results, after analysis by DLS. of the samples used in the rheological 
experiments. The values for the PLA-PEG micelles/particles after analysis at this 
concentration are very similar to those measured at the lower concentration and 
discussed in section 3.5. Indeed. the values for 1.5:2 PLA-PEG. 2:5 PLA-PEG. 4:2 
PLA-PEG and 6:2 PLA-PEG are not significantly different from the values at the lower 
concentration. No significant dependence of hydrodynamic radius on copolymer 
concentration has been observed for both poly( oxyethylene/oxypropylene/ oxyethylene) 
1"1/ 
-'-
C 
Il.. 
...... 
,... 
N 
:z: 
..-
0 
(!) 
Figure 4.4 - Pl o t o f G *, G ' and G " vs Volume 
Fraction at a Frequenc y o f 0 .1 Hz for 1.5 :2 LPLA-PEG 
10000 
1000 
100 
10 
.1 
0 .0 1 0 .0 3 0 .05 0 .07 0 .09 
LPLA Volume Fraction 
133 
0.11 
• G * 
.to G ' 
• G" 
FiQure 4 .5 - Plot of G*, G' and G" vs Volume 
Fraction at a Frequency of 0.1 Hz for 1.5:2 PLA-PEG 
100000 
10000 
1000 
C 
no 
-. 
100 ,.. N 
:J: 
0 -< 
~ ~
10 
.1 
.01 
T I 1 1 
0 .05 0.06 0.07 0.08 0 .09 0.10 0 . 11 0.12 0.13 0 . 14 
PlA Volume Fraction 
134 
• G * 
• G ' 
• G" 
Figure 4,6 - Plot of G* , G' and G" vs Volume 
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figure 4.7 _ plot at G', G' and G" vs Volume 
fraction at 0 frequencY at 0.1 \1z tor 6:2 PLA-PEG 
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copolymers (Alexandridis and Ilattoll. 1 t)<):')) and poly(ox) butylcncioxyethylcne) 
copolymers (Sun e/ al. Il)l)l). 
For 1.5:2 LPLA-PEG. there is a small incrl'ase in particle size tor the fractionated 
material. However. in section 3.4.2.5. the problems attending the estimation of the 
particle size for 1.5:2 LPLA-PLG particles \\ere described. It is therefore difficult to 
ascertain whether the increase in size with the fractionated material at 10% w/v over the 
lower concentration of LPLA-PEG analysed is a "rear' effect, or whether it is due to the 
difficulty in obtaining discrete pm1icles and the consequent presence of aggregated 
particles in the dispersion. which will bias the z-average particle size to give a larger 
value. 
The difference between the unfractionated and fractionated 1.5:2 LP LA-PEG particle 
size values is however more likely to be a "real" effect given that, as previously 
discussed in section 3.5.2, there appears to be a difference between the unfractionated 
and fractionated micelle sizes for 1.5:2 and 2:5 PLA-PEG. In this instance, the 
difference between the unfractionated and fractionated samples is even more 
pronounced. With the LPLA-PEG unfractionated samples, GPC analysis shows a 
significant amount of the second peak material (more than 20%) which appears to be 
having an effect on particle size. 
4.2.5 Calculation of PEG Layer Thickness 
The critical volume fraction, ~ c l r , , at which overlap just begins, i.e. at which G' = G", can 
be used to obtain the PEG layer thickness. Assuming that the particles are spherical and 
are arranged in a random packing fashion. then the effective volume fraction should be 
approximately equal to 0.64. This assumes that the micelles/particles can be treated as 
hard spheres, an assumption generally taken to be valid for such systems (Lobaskin and 
Pershin, 1993; Chu el ai, 1994; Streletzkyand Phillies, 1995), and that all measurements 
are carried out below the critical strain where structural changes start to occur (i.e. in the 
viscoelastic region) (Kim and Luckham. 1992). From a knowledge of the actual 
maximum volume fraction. 4>. obtained experimentally from where G' = G" (i.e. the 
crossover point), and from the hydrodynamic radius. Rh. the PEG layer thickness, 11, can 
be obtained from the following equation (Faers and Luckham. 1994): -
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Using the values for ~ ~ obtained from DLS (Table 4.1), the values of ~ ~ can be calculated 
and are shown in Table 4.2. All volume fraction values assume that the density of the 
PLA-PEG copolymers is approximately 1 gcm-3. 
4.2.6 Discussion 
All PLA-PEG copolymer systems showed the expected behaviour oflow moduli values 
at low volume fractions, with a rapid increase in G* and G' as the volume fraction was 
increased. The increased volume fraction also brings about a change from viscous to 
elastic flow (i.e. from GIt> G' to G'>GIt) for all the PLA-PEG copolymers at the critical 
volume fraction, 4>, (the crossover point) where G'=GIt • This is due to the start of 
repulsive interaction between the PEG layers of adjacent particles/micelles, caused by the 
loss of configurational entropy and/or an increase in the enthalpy of mixing of the PEG 
chains (Faers and Luckham, 1994). An increase in moduli thus occurs as the 
particles/micelles are not able to relax from the applied deformation and therefore store 
the energy elastically. 
The crossover point is affected by the composition of the copolymer being studied, with. 
the molecular weight of an adsorbing copolymer at the particle surface playing a role, 
particularly the length of the PEG chain. It· has been shown that the critical volume 
fraction (where G'=GIt) decreases with an increase in PEG chain length (Liang et ai, 
1992; Pingret et ai, 1992; Faers and Luckham, 1994) for particles with PEO adsorbed 
or grafted to their surface. This occurs as the increased number of EO units in the chain 
causes an increase in the PEG layer thickness, which leads to stronger steric interactions 
at greater separation distances between the particles (pingret et ai, 1992). The increase 
in PEG layer thickness with increased number of ethylene glycol units has been 
demonstrated by several authors, including Pingret et al (1992), and Faers and Luckham 
(1994). Thus, the thicker the adsorbed/grafted layer of PEG, the more elastic the 
polymer system (Tadros, 1992), as the steric repulsion becomes longer in range. 
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Table 4.1 
DLS Analysis of 10% w/v PLA-PEG Dispersions 
Copolymer Sample Diameter Size (run) ~ ( n m ) )
1.5:2 LP LA-PEG Unfractionated 30.4 ± 0.8 15.2 
1.5:2 LPLA-PEG Fractionated 21.0 ± 1.8 10.5 
1.5:2 PLA-PEG 17.2±0.7 8.6 
4:2PLA-PEG 14.1±0.9 7.1 
6:2 PLA-PEG 16.8 ± 0.8 8.4 
2:S PLA-PEG 23.8 ± 1.S 11.9 
Table 4.2 
PEG layer Thickness Measurements Estimated from Rheological Measurements 
Copolymer PEG Hydrodynamic Volume Fraction PEG Layer 
Chain Radius ( ~ ) ) of Core at Thickness (L\) 
Length (nm) Crossover (<1» (nm) 
I.S:2 LPLA-PEG 2000 lS.2 0.054 8.S3 
1.5:2 PLA-PEG 2000 8.6 0.091 4.11 
4:2 PLA-PEG 2000 7.0S 0.202 2.25 
6:2 PLA-PEG 2000 8.4 0.233 2.40 
2:5 PLA-PEG SOOO 11.9 0.033 7.47 
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Applying this to the PLA-PEG copolymers, it can be seen that the volume fraction at the 
crossover point for 2:5 PLA-PEG is less than for the other copolymers, as would be 
expected due to its longer PEG chain length of 5000 over 2000 for the other PLA-PEGs. 
The value of the PEG layer thickness for 2:5 PLA-PEG is also much greater than for the 
other PLA-PEG copolymers, except for the 1.5:2 LPLA-PEG. 
The seemingly anomalous result with the 1.5:2 LPLA-PEG is most likely due to the 
pronounced increase in size with increase in concentration seen with this copolymer that 
did not occur with the other PLA-PEG copolymers (with the possible exception of2:5 
PLA-PEG). Increased particle size has been shown to affect the PEG layer thickness, 
A. For example, for polystyrene particles grafted with PEO chains, an increase in particle 
core size gave an increased value of A for constant PEO chain length (Liang et aI, 1992). 
Also, the LPLA-PEG used in this experiment was unfractionated, and the presence of 
a significant amount of peak two material (which is predominantly PEG) in the sample 
will probably have affected the results. 
The difference between the values of A for 4:2 and 6:2 PLA-PEG particles is negligible, 
considering that the value of A is derived from the hydrodynamic radius, ~ , , measured 
by DLS. However, the 4:2,6:2 and 1.5:2 PLA-PEG copolymers all have a PEG chain 
of2000, yet the chain layer thickness of the 1.5:2 PLA-PEG micelles is slightly larger. 
This is also reflected in the lower value of the volume fraction of 1.5:2 PLA-PEG at the 
crossover point. This may be due to a confonnational difference between the micellar 
structure of 1.5:2 PLA-PEG, and the more stable particle structure of 4:2 and 6:2 PLA-
PEGs. 
Table 4.3 shows comparative values of PEG layer thickness, A, for similar polymer 
systems, but obtained by different methods. Also shown in this table are values for the 
micelle/particle core radii, Rc, which were calculated for the PLA-PEG copolymers from 
the numerical difference between the hydrodynamic radius obtained by DLS and given 
in section 4.2.4, and the PEG layer thickness, A (i.e. the shell thickness of the 
micelles/particles). 
Considering the core radii values of the PLA-PEG copolymers, the values for 1.5:2 PLA-
PEG and 4:2 PLA-PEG are very similar, in common with their similar size but despite 
the increased molecular weight of the PLA block of 4:2 PLA-PEG. 1.5:2 PLA-PEG 
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PEG differs in showing a larger PEG layer thickness, as illustrated by the value of 6. 
Comparing the similar 4:2 and 6:2 PLA-PEG copolymers shows that while the values 
of 6 are very similar, the core radius is slightly larger with 6:2 PLA-PEG, which may 
he expected due to the larger PLA component, and indeed, the ratios of the core radii to 
the PEG layer thickness for 4:2 and 6:2 PLA-PEG copolymers are similar to the ratios 
of the component blocks. 
However, there seems to be no definite trend between the PLA-PEG copolymers, 
possibly as a result of the different structures of the "micelles" with the more stable 
"particle" structures. A wider range of copolymers within the micellar or particular 
range may reveal a clearer trend. 
Comparing the PLA-PEG copolymers with some of the Pluronic copolymer range (Table 
4.3), which are also known to form micelles, shows that the values of R: and 6 are of 
a similar magnitude for all systems. Pluronic P85 compares well with 1.5:2 PLA-PEG, 
which has similar hydrophilic and hydrophobic block contents, whereas 2:5 PLA-PEG 
compares well with Pluronics Fl 08 and F68, with both the block sizes and the value of 
6 for 2:5 PLA-PEG lying between the respective values for the two Pluronic 
copolymers. A triblock copoly( oxyethylene/oxybutylene/oxyethylene) also shows a 
similar value for PEG layer thickness, 6, but has a lower value for the core radius, which 
may reflect the difference in conformation of triblock copolymers over diblock 
copolymers. All values for core radiuses are likely to be on the low side, as the method 
of calculation used (Zhou and Chu, 1988a) neglects the possible penetration of water and 
PEa into the micellar core. Thus the value of the core volume, from which the radius 
is calculated, is at the lower limit (Zhou and Chu, 1988b). Mortensen and Pedersen 
(1993) showed, to a good approximation, that the micellar core of Pluronics could be 
thought to consist of completely dehydrated propylene oxide units, covered by a dense 
monolayer of ethylene oxide units. Linse and Malmsten (1992) found similar behaviour, 
but also noted the presence of some EO inside the core. The core sizes of the PLA-PEG 
copolymers are possibly also at the lower limit, as again the contribution of PEG and 
water to the core is not taken into consideration. 
The PEG layer thickness values for 4:2 and 6:2 PLA-PEG are smaller than those seen 
with 1.5:2 PLA-PEG and the copolymers considered in Table 4.3. As the copolymers 
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Table 4.3 
Comparison oj PEG layer Thicknesses oj PLA-PEGs with Similar Copolymer Systems 
Copolymer PEG Mw PLAor Temp 
PPOor ('C) 
PBMw 
1.5:2 LPLA-PEG 2000 1500 25 
1.5:2 PLA-PEG 2000 1500 25 
4:2PLA-PEG 2000 4000 25 
6:2PLA-PEG 2000 6000 25 
2:5PLA-PEG 5000 2000 25 
PlUToniC P85 1150x2 2200 37 
PlUTonic F I 08 6640x2 3250 37 
PlUTOniC F68 3580x2 1740 54 
E.wB1sE4o 1800x2 1200 20.5-
22.5 
Polystyrenel P 1 03 9OOx2 3250 20 
Polystyrenel PI 05 1665x2 3250 20 
Polystyrenel F I 08 5800x2 3250 20 
R, = core radius of micelle/particle. 
~ ~ = hydrodynamic radius of micellelparticle. 
~ ~ = PEG layer thickness. 
~ ~ R 
(nm) (nm) 
15.2 6.7 
8.6 4.5 
7.1 4.8 
8.4 6.1 
11.9 4.4 
7.3 3.7 
17.5 2.5 
7.8 2.5 
6.7 1.7 
44.0 33.5 
46.0 33.5 
47.0 33.5 
• Estimated by calculation as described by Zhou and Chu (1988a). 
b Estimated by DLS. 
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~ ( n m ) ) Reference 
By By Other 
Rheology Method 
8.5 -
-
4.1 - -
2.3 - -
2.4 - -
7.5 
- -
-
3.68 Kabanov et ai, 
1995 
- 15.08 Kabanov et ai, 
1995 
- 5.38 Kabanov et ai, 
1995 
- 5.08 Luo et ai, 1993 
8.9 1O.5b Faers and 
Luckham, 1994 
9.3 12.5b Faers and 
Luckham, 1994 
10.3 13.5b Faers and 
Luckham, 1994 
considered in Table 4.3 are micelle-forming (except for the polystyrene coated particles), 
this again suggests difficulty in correlating between these two different structures. 
Above it was noted that for particles with adsorbed or grafted PEG on the surface, the 
longer the PEO chain, the greater the adsorbed layer thickness (i.e. ~ ) . . Table 4.3 
illustrates this, with the ~ ~ values for polystyrene particles coated with physically adsorbed 
Pluronics increasing with increasing ethylene oxide chain length (while PPG remains 
constant). Generally, the PEG layer thicknesses appear greater for copolymers physically 
adsorbed onto the surface of polystyrene particles, compared with PEG layer thicknesses 
for self-forming micelles and particles with similar PEG chain lengths. This may be a 
function of the increased particle size of the polystyrene particles ~ = 4 4 4 nm - 47 nm) 
over the much smaller copolymer micelles and particles (RJ.=6.7 nm - 17.5 nm), which 
can affect 11. (Liang et ai, 1992), or could be due to conformational differences in the 
PEG chains. 
Faers and Luckham (1994) also compared the values of ~ ~ acquired from the rheology 
work with values measures by DLS, as shown in Table 4.3. The DLS-measured values 
were slightly higher, which may be expected as this measurement is sensitive to the distal 
regions of the adsorbed copolymer. Pingret et al (1992) also noted comparable values 
between DLS and rheological measurements for adsorbed layer thicknesses, 11.. 
Table 4.4 shows further calculations of the dimensions of the PEG chains of the PLA-
PEG copolymers. The number of ethylene glycol (EG) units, b, was calculated by 
dividing the PEG molecular weight (Mw=2000 or 5000) by the molecular weight of a 
single ethylene glycol unit, Mw=45, and the association number of copolymer molecules 
in a micelle/particle, Nw, was determined as described in section 3.7.2. Using the 
hydrodynamic radius, ~ , , and the core radius, Rc, from Table 4.3, this allowed the mean 
volume occupied by a PEG chain, VPEG, and the mean volume occupied by an ethylene 
glycol unit, VEG, in the micelle/particle shell to be determined by the following equations 
(Luo et ai, 1993; Kabanov et ai, 1995): -
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47r( R ~ ~ R ~ ) )
VPEG = 
3Nw 
47r( R ~ ~ - R ~ ) ) VPEG 
VEG= 3b --b-
Nw 
These equations assume that the micelles/particles are spherical, a reasonable assumption 
from the TEM data discussed in section 3.4.2. No values could be calculated for 1.5:2 
LPLA-PEG as the association number was not determined for this copolymer. 
The values for the PLA-PEG copolymers of VEG are of a similar magnitude to those 
quoted by Kabanov et al (1995) for the Pluronic P85 (0.49 run3), Zhou and Chu (I988b) 
for Pluronic F68 (0.19 nm3) and Luo et al (1993) for EroBlSE40 (1.29 run3 at 20.5 - 22.5 
°C). The corresponding value for VEG in unswollen liquid poly( ethylene glycol), assuming 
that the density of PEG s::::: 1.0 gcm-3, is VE = 0.073 nm3 (Luo et aI, 1993). As this value 
is an order of magnitude smaller than the values calculated for the PLA-PEG copolymers, 
this indicates that the PEG shell of the micelles/particles is swollen and has an open 
structure that can physically trap water molecules, in addition to the two molecules that 
can bind by hydrogen bonding to the ether oxygen of each EG unit (Zhou and Chu, 
1988a; Luo et ai, 1993; Kabanov et aI, 1995) .. The average number of water molecules, 
Nwater, that are associated with each ethylene glycol unit can be calculated from the values 
ofvEG by taking the mean volume occupied by a water molecule as Vwater s::::: 0.030 nm3, 
and using the following equation (Luo et aI, 1993):-
N = VEG-VE water 
V water 
Table 4.4 shows the resulting values, calculated for the PLA-PEG copolymers, from this 
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equation. The values of VPEG, VEG and Nwater clearly show a difference between the 
micelle-forming l.5:2 and 2:5 PLA-PEG copolymers and the particle-forming 4:2 and 
6:2 PLA-PEG copolymers. It is apparent from Table 4.4 that the PEG shells of the 1.5:2 
and 2:5 PLA-PEG micelles are much more hydrated than the corresponding PEG shells 
of the 4:2 and 6:2 PLA-PEG particles. The hydration is more noticeable with 2:5 PLA-
PEG which, from the rheology results, has the longest PEG layer thickness, 11. 
Conversely, the 4:2 and 6:2 PLA-PEG particles are only slightly more hydrated than 
would be expected due to the hydrogen bonding that occurs with the ether oxygen 
molecules of PEG (i.e. there are three water molecules associated per EG unit rather than 
two). 
The value for VEG can also give some indication of the configuration of the PEG chains 
in the micelles/particles. Two models are considered to represent the possible 
configurations of PEG chains. These are the "zig-zag" model and the "meander" modeL 
In the "zig-zag" model, the PEG chain is fully extended, with the length and width of an 
ethylene glycol unit being 3.6 and 2.5 A respectively, whereas in the "meander" model, 
the PEG chain is twisted into an expanded helical coil form with the ethylene glycol unit 
length and width being 2.0 and 4.5 A respectively. If the PEG chains were presumed in 
the zigzag form, then the PEG layer thickness would be expected to be about 16 nm for 
2000 PEG copolymers and about 40 nm for 5000 PEG copolymers, which are much 
larger than any of the values observed. If a meander configuration is assumed, the PEG 
layer thickness values would be about 9 nm for 2000 molecular weight PEG chains and 
22 nm for 5000 molecular weight PEG chains, which while still larger than the values 
measured, are more reasonable. Also, it is thought that for an aqueous solution of PEG 
chains, with more than ten ethylene glycol units per chain, the meander configuration 
predominates (Rosch, 1967). Faers and Luckham (1994) observed that the increase in 
11 with ethylene oxide chain length scaled with nEOY1(where n is the number of EO units 
in the PEO chain), which showed that the EO chains were arranged as elongated coils 
in the adsorbed layer, rather than as linear chains (which would scale with nEO). It 
seems likely therefore that the meander configuration of the PEG chains in the PLA-PEG 
micelles/particles is the best approximation. 
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Table 4.4 
Molecular Dimensions of PLA-PEG MicellesParticles 
Copol}mer Number Association Rn Volume of Volume of Number of H2O 
ofEG number, Nw (nm) PEG chain, EG unit, Molecules 
units, b vPEG(nm3) vEG(nm3) Associated with 
each EG, NW • 1eT 
1.5:2 PLA-PEG 44 132 8.6 17.3 0.39 11 
4:2 PLA-PEG 44 155 7.05 6.7 0.15 3 
6:2 PLA-PEG 44 214 8.4 7.2 0.16 3 
2:5 PLA-PEG 111 47 11.9 142.6 1.28 40 
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4.3 ANALYSIS OF SURFACE CHEMISTRY AND STRUCTURE 
4.3. J Static Secondary Ion Mass Spectrometry (SSIMS) 
Static secondary ion mass spectrometry (SSIMS) is the mass spectrometry of particles 
emitted by a surface when that surface is bombarded by energetic primary particles, 
which may be electrons, ions, neutrals or photons (Vickerman, 1988). The secondary 
ions that are detected are either emitted from the surface in ionised state, or emitted as 
neutrals and post-ionised before analysis. Static SIMS uses a primary beam with a very 
low current density so that secondary ions are emitted from areas not previously 
damaged and the surface monolayer lifetime is much greater than the time needed for 
analysis (Vickerman, 1988). This process is described in detail by Vickerman (1988) and 
Briggs (1986, 1991). 
Static SIMS allows both the elemental composition and chemical structure of the surface 
to be studied, as cluster ions are emitted as well as elemental ions, to give a surface mass 
spectrum (Vickerman, 1988). This is produced by directing a noble gas ion beam 
(usually of Ar + or Xe) at the sample surface, which causes material to be sputtered into 
an ultra-high vacuum (Briggs, 1986). When this beam interacts with the surface atoms, 
energy is transferred and the atoms in the near-surface region undergo collision 
sequences. Some of these collisions cause the energy to be dissipated in the bulk sample, 
whereas others return to the surface causing the emission of secondary ions, atoms or 
molecules (Vickerman, 1989). These secondary emissions are then extracted into a mass 
spectrometer and are analysed in terms of their masS/charge ratio (mlz) to provide in 
sequential experiments, the positive and negative secondary ion mass spectra respectively 
(Briggs, 1986). It has been shown that the detected secondary ions emerge from a depth 
of about 1 0 ~ ~ indicating that SIMS is highly surface specific (Ream et aI, 1987; Briggs, 
1989). 
4.3.2 Static Secondary Ion Mass Spectrometry (SSIMS) of PLA-PEG Particles 
In recent years, SIMS has been employed as a tool for studying polymers considered as 
potential drug delivery systems, including copolymers (Davies and Lynn, 1990a and 
1990b). SIMS was noted as being able to provide a "fingerprint" of chemical information 
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about both pure polymers and copolymers to a high degree of molecular specificity 
(Davies et aI, 1987), and this "fingerprint" also allows the detection of homopolymers 
within a copolymer structure (Davies and Lynn, 1990a). Therefore, the SIMS spectra 
of the PLA-PEG copolymers would be expected to show ions from both monomer units. 
The PLA-PEG copolymers (4:2 and 6:2 PLA-PEG) were analysed as described in section 
2.9.1. The analysis was performed on both the unfractionated copolymer dissolved in 
acetone, and on nanoparticles in aqueous dispersion. The spectra produced in each case 
were identical between the solutions of the copolymer in chloroform and as nanoparticles 
in aqueous solution. Figures 4.9 and 4.10 show the positive and negative ion spectra 
respectively for 4:2 PLA-PEG nanoparticles for m/z of 0 to 100, where m/z is 
masS/charge. The results represent a combination of the PLA and PEG homopolymer 
spectra, with diagnostic peaks from both polymers present in the PLA-PEG spectra. On 
analysis by SIMS, most polymers produce multiple ions that correspond to structures 
arising from the intact monomer unit, its side chain (if present) and fragments of these 
species (Davies and Lynn, 1990a). PLA and PEG are no exception to this, and in the 
following discussion, "M" is used to denote the appropriate monomer repeat unit. 
In the low mass region of the positive ion spectra, ion peaks corresponding to PLA are 
seen at m1z 71/73 due to (MpLA ±Hr and m1z 55 due to [MPLA - OHr. PLA also forms 
an intense cluster at m1z 99/100/101, which corresponds to [2MpLA - CO2- Hr, [2MpLA 
- C02]" + and [2MpLA - CO2 + H]+ (Davies et ai, 1989) and is seen in the PLA-PEG 
spectra. Ion peaks are also readily detected in the higher mass region (m1z> 100) from 
the PLA block showing monomer multiples of these ions, for example [nMpLA ± Hr for 
n = 1 to 4. 
Most positive ions detected are of the "even electron" type where there is loss of a 
bonding electron during fragmentation. However, "odd electron" ions were also formed 
where the electron lost in. the formation of an ion was a non-bonding electron, i.e a 
radical cation (Davies and Lyon, 1990a). With PLA homopolymer, radical cations are 
seen at m1z of 128,200 and 272, corresponding to [nMpLA - 0]"+ for n=2 - 4. As strong 
peaks are noted in the PLA-PEG spectra at all these values, it seems likely that these 
cations are formed on SIMS analysis of the PLA-PEG samples. 
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Figure 4.9 - Positive Ion SIMS Spectrum for 4:2 PLA-PEG NanoparticJes 
r - - - - - - - - - - - - - - - - - - - ~ - - - - - - ~ ~ i i
., 
~ ~
-,; 
" .... ...§ 
• 
" Ii i 
u 
... 
• 
-
0 
ri ..., c 
-Ii 
• 
.. 
.. . ~ ~ III ~ ~ J:: 11 • III i1i Cl • ..; 0 
- -
.. .. 
-
.. • • .. .. ... )( 
PUO:J·S ".d •• unoo 
150 
Figures 4.10 Negative Ion SIMS Spectrum for 4:2 PLA-PEG Nanoparticles 
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The presence of PEG in the positive ion spectra was detected by the ion peaks at mlz 
43/45, which corresponds to [MpEG ± Hr. Although peaks are expected for PLA also 
at m1z 43/45, with PLA homopolymer the peak at 43 would be dominant, whereas in the 
PLA-PEG spectra, the peak at m1z 45 is dominant indicating PEG. Ions are also 
expected for PEG and are present in the PLA-PEG spectra at m1z 59, 73, 103 and 117, 
corresponding to an additional one or two CH2 groups (Davies and Lynn, 1990a). From 
analysis of the PEG homopolymer, the signals for these ions is expected to be low 
(Bridgett, 1993), but the PLA-PEG copolymers do show peaks at these values, with the 
peak at 59 being particularly intense, providing further evidence of the PEG component 
at the surface. No radical cations are observed with the PEG component. 
Peaks due to PLA at m1z 71/73 and rnIz 87/89 were seen in the negative ion spectra 
corresponding to the ions [MPLA ± HT and [MJ>LA + 0 ± H]- respectively. These dominant 
ions seen with both the -positive and negative spectra are likely to be formed by ester 
chain cleavage (Davies et ai, 1989). The ions expected from PLA homopolymer in the 
low mass range at m1z values of 12, 13, 16, 17,24,25,41,43, and 45, are also present 
in the PLA-PEG spectra and correspond to C, Clf, 0-, Olf, C2-, C2lf, C2HO-, C2H30-
and CH02-, respectively (Davies et ai, 1989). As with the positive ion spectra, ion peaks 
were determined in the higher mass region, and corresponded to multiples of the 
monomer repeating unit. Similarly, ion peaks were detected due to the PEG component 
at 43/45, and corresponded to [MPEG ± Hr. The signal at mlz 71173 could correspond 
to [MPEG + 2Me ± HT, but is more likely to be due to the PLA component which gives 
a stronger signal. 
Both copolymers tested, 4:2 and 6:2 PLA-PEG, gave similar positive and negative 
spectra in chloroform and aqueous dispersions. 
As already stated, SIMS analysis tests the top loA of the sample surface. It is clear 
from the above discussion that both PLA and PEG are found at the surface in all of the 
samples tested. It is possible that, as suggested by Heam et al (1987) for polyurethanes 
segmented polymers, the suggestion of highly segregated polymers with pure soft 
segment at the surface is an oversimplification. It is therefore conceivable that there 
could be PLA groups at the surface of the PLA-PEG systems, in addition to PEG. 
However, the chloroform-dissolved samples also show PEG at the surface, indicating 
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that the surface orientation of this component is still towards the surface, even when the 
surface chemistry is disrupted (Brindley et aI, 1992). 
Although SIMS gives good molecular specificity of chemical structure, quantitation of 
the surface composition remains difficult due to matrix effects influencing secondary ion 
yields and hence ion intensities (Davies et aI, 1989). These factors that are responsible 
for matrix effects include the polymer film thickness and uniformity, sample charging 
(during analysis) and the type of substrate used (Davies et aI, 1989). Quantitation has 
been attempted by comparing the relative intensities of ions characteristic to the 
individual components of a copolymer (Davies and Lynn, 1990a; Brindley et ai, 1992). 
However, this would also prove difficult with the PLA-PEG copolymers as the 
diagnostic ion usually used for PEG, mlz=45, also has a contribution from PLA. The 
complementary technique of X-ray photoelectron spectroscopy (XPS) is usually 
employed to provide quantitative data and will therefore now be discussed. 
4.3.3 X-Ray Photoelectron Spectroscopy (XPS) 
X-ray photoelectron spectroscopy (also known as ESCA or electron spectroscopy for 
chemical analysis) is the application of energy analysis to the electrons emitted from a 
surface illuminated by X-rays and exhibiting a photoelectric effect (Smith, 1994). The 
process has been described in detail by Watts (1990a) and Smith (1994) and has been 
used for surface analysis of biodegradable copolymers in conjunction with SIMS (Davies 
and Short, 1988). In this technique, X-rays are applied to the sample surface and the 
energy carried by the incoming X-ray photon is absorbed by the target atom and raises 
it into an excited state. The atom relaxes again by emitting a photoelectron, and as these 
photoelectrons are emitted from all energy levels of the target atom, a characteristic 
electron energy spectrum is produced for that atom type (Smith, 1994) by analysis by an 
electron spectrometer. The spectrometer measures the kinetic energy of the electron, but 
as this is not an intrinsic property of the material, this value is converted into the binding 
energy, which identifies the electron specifically, both in tenns of its parent element and 
atomic energy level (Watts, 1990a). Lines in the spectrum can then be labelled according 
to which energy level they originated from. 
The intensities of the photoelectron lines produced are important and allow quantification 
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of the material, so that XPS allows quantitative as well as qualitative analysis. The 
precise energy and shape of a particular line of the spectrum also reflects the local 
environment and chemical state of the emitting element (Smith, 1994). Any effect that 
alters the energy levels of atoms in the surface region will also alter the XPS spectrum, 
giving rise to chemical shifts in energy. 
Therefore, XPS provides element and chemical state identification for atoms in the top 
few atomic layers of the sample (the top 10 - 100 A in depth are studied depending on 
the electron take-off angle (Ratner, 1988», and can also give some structural information 
under certain conditions. XPS is therefore not as surface specific as SIMS. 
4.3.4 X-ray Photoelectron Spectroscopy of PLA-PEG Particles 
XPS can be used to provide evidence that PEG is present at the surface of the PLA-PEG 
samples, and the samples (4:2 and 6:2 PLA-PEG) were analysed as described in section 
2.9.2. This was illustrated by Brindley et al (1992), who prepared polystyrene particles 
with PEG grafted to the surface. Subsequent XPS analysis of these particles showed two 
main carbon environments due to the hydrocarbon carbon, C-C/C-H, attributable to the 
polystyrene backbone, and the ether carbon, C-O, arising from the PEG groups at the 
surface with a small contribution from the sulphate end groups on the polystyrene chains. 
Brindley et al (1994) also noted an increase in the ether carbon content with an increase 
in PEG density. Similarly, Lee and Andrade (1988) have observed an increase in the 
ether carbon peak with an increase in the amount ofPEO-PPO-PEO surfactant adsorbed 
onto dimethyl dichloro silane (DDS) surfaces. 
Dunn et al (1994) have mentioned the difficulty in obtaining PEG density values for 
grafted particles (and hence block copolymers) compared with physically adsorbed 
systems, where the density of PEG on a particle surface can be calculated from the 
plateau levels of adsorption isotherms. However, XPS measurements allow a 
comparative indication of the amount of PEG at the surface by measuring the percentage 
of ~ - O O bonds within the 1 s carbon spectra for different systems. XPS has been 
performed on the 4:2 and 6:2 PLA-PEG copolymers prepared from fractionated material 
as nanoparticles in water and as unfractionated copolymer in chloroform. Figure 4.11 
gives the structures of the PLA and PEG monomers, with the carbon atoms numbered 
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Figure 4.11 - Structures of the PLA and PEG Monomers (carbon and oxygen atoms 
numbered to aid interpretation) 
2 
-CH-C-O-
I I III 
CH3 0 
PI,A Monomer 
4 
-CH..,-CH2-O-
PEG Monomer 
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Figure 4.12 - Carbon C 1 s Envelopes for XPS Analysis of 4:2 PLA-PEG 
Nanoparticies 
CARBOXYL 
285 287 289 291 293 
Binding Energy / eV 
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to aid interpretation. 
Figure 4.12 shows the carbon C 1 s envelopes for XPS analysis of 4:2 PLA-PEG 
nanoparticles. This clearly shows the presence of both PLA and PEG at the surface. 
The three peaks expected for PtA are present. corresponding to hydrocarbon ( ~ H 3 - C H ) )
(1), ester ( C - ( C H J ) ~ - O ) ) (2) and carboxyl (C-O-C=O) (3) environments, as well as the 
peak expected for PEG. corresponding to the ether environment (C-C-O-C) (4). 
However, the binding energy values of these peaks are different to the expected values 
for PLA homopolymer and PEG homopolymer. as shown in Table 4.5. This is probably 
as a result of the insulating properties of the copolymers. When X-rays are fired at the 
copolymer samples, electrons are emitted and collected, and this can leave the sample 
with a positive charge that appears as a change in binding energy (Watts, 1990b). The 
values of the peaks with respect to each other are also shifted for both PLA and PEG. 
This is likely to be due to secondary shifts caused by the inductive effects of the 0 
groups bonded to carbon, which delocalises the electrons and thus makes the 0 groups 
more negative. There is therefore no distinct hydrocarbon environment, as all the carbon 
atoms in the PLA monomer are close to oxygen groups. As the peaks are referenced 
against the hydrocarbon environment. when this peak is shifted, all other peaks are 
shifted accordingly (Watts, 1990b). These chemical shifts can be up to 0.4 eV for the 
functional groups present in the PLA-PEG. 
Table 4.6 shows the quantitative values for the four peaks from the XPS studies, and 
demonstrates from the values of carbon in the ether carbon environment, C-C-O-C, that 
there is more PEG at the surface of the 4:2 PLA-PEG than the 6:2 PLA-PEG. Table 4.6 
also clearly shows the hydrocarbon contamination present in the unfractionated samples 
prepared in chloroform by the greatly increased ~ I - h - C H H environment detected for the 
PLA with respect to the carbon detected for the other carbon groups present in PLA (all 
should be equal), and also with respect to the corresponding values for samples in water. 
Hydrocarbon contamination has previously been noted with PLA samples (Davies et 
ai, 1989), and varies from sample to sample. It is likely that the GPC process removes 
this contamination and hence, no raised hydrocarbon values are seen with the PLA-PEG 
samples in water prepared from fractionated material. 
Tables 4.7 and 4.8 show the stoichiometry results for the 4:2 and 6:2 PLA-PEG 
copolymers. for carbon and oxygen present from the C I sand 0 1 s spectra respectively. 
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Table 4.5 
Binding ~ n e r g y y Valuesfor PLA and PLA-PEG Copolymers 
Sample PLA C Is Binding Energy (eV) PEG C Is 
Binding 
(1) (2) (3) Energy (eV) 
PLA Homopolymer 285.0 287.0 289.0 -
PEG Homopolymer - - - 286.5 
4:2 PLA-PEG in water 287.0 289.2 291.2 288.1 
6:2 PLA-PEG in water 287.0 289.0 29l.1 288.0 
Table 4.6 
){PS Analysis of 4:2 and 6:2 PLA-PEG Copolymers 
Sample XPS C Is Envelope Ratios (%) 
CH3-CH (1) C-C-O-C (4) C-(CH3)C-O (2) C-O-C=O (3) 
4:2 PLA-PEG in water 23 30 23 23 
4:2 PLA-PEG in 37 30 17 17 
chloroform 
6:2 PLA-PEG in water 26 21 26 26 
6:2 PLA-PEG in 55 19 13 13 
chloroform 
PurePLA 33.3 - 33.3 33.3 
Pure PEG - 100 - -
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Table 4.7 
Stoichiometry of 4:2 and 6:2 PLA-PEGfor Carbonfrom XPS Carbon Is Spectra 
Sample % C from Polylactide: % C from Polyethylene Glycol: 
experimental (theoretical) experimental (theoretical) 
4:2 PLA-PEG in water 69 (65) 30 (35) 
4:2 PLA-PEG in 71 (65) 30 (35) 
chloroform 
6:2 PLA-PEGin water 78 (73) 21 (27) 
6:2 PLA-PEG in 81 (73) 19 (27) 
chloroform 
Table 4.8 
Stoichiometry of 4:2 and 6:2 PLA-PEGfor Oxygenfrom XPS Oxygen 1s Spectra 
Sample % 0 from Polylactide: % 0 from Polyethylene Glycol: 
experimental (theoretical) experimental (theoretical) 
4:2 PLA-PEG in water 78 (71) 22 (29) 
4:2 PLA-PEG in 67 (71) 34 (29) 
chloroform 
6:2 PLA-PEG in water 82 (78) 18 (21) 
6:2 PLA-PEG in 72 (78) 29 (21) 
chloroform 
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These sho\\ reasonahle agreelllent \\ ith the tlh.'nrctical values ohtained for the 
nanoparticles, with the PEG values heing slightly hmer. From Table 4.8 it appears that 
more PEG is present at the s u r t ~ l c e e in the chlnrottmn samples than in water. However, 
this may be due to the second PLA-depkted (PEG-rich) species present in the 
unfractionated material in chloroform that would not be present in the fractionated 
material used to prepare the nanoparticles. Table 4.9 shows a comparison of the two 
PLA-PEG nanoparticle samples with prc\iolls results for polystyrene particles grafted 
with PEG 2000 (Dunn el ai, 1994) and PLGA particles coated with physically adsorbed 
poloxamer 407 and poloxamine 908 (Scholes, 1994). Surface density of PEG is an 
important factor for a potential drug delivery system as it has been shown to be related 
to the uptake ofnanoparticIes by the reticuloendothelial system (RES) in in vivo studies 
(Dunn et ai, 1994). These studies were perfonned using the polystyrene (PS)-PEG 2000 
particles, where the PEG was grafted to the polystyrene particle surface with different 
densities of PEG denoted as a to d, where a was equivalent to the lowest density and d 
the highest. Decreasing uptake of particles by the liver was seen with increasing surface 
density, with PS-PEG 2000a particles giving little reduction in liver uptake whereas a 
significant decrease in uptake is seen with PS-PEG 2000 particles b, c and d. The 
authors noted that little significant improvement was seen with PS-PEG 2000d particles 
over PS-PEG 2000c particles and concluded that only a certain density of PEG on the 
particle surface was necessary to give the desired result (Dunn et aI, 1994). The PLA-
PEG nanoparticles could be expected to be similar to the grafted PS-PEG particles, and 
it can be seen from Table 4.9 that the % C -0 lies between the results seen for PS-PEG 
2000b particles and PS-PEG 2000c particles. The surface density of the PLA-PEG 
copolymers could therefore be expected to be sufficient to prevent uptake by the liver, 
but this is only one of a number of i111pol1ant factors which determines the 
biodistribution profile of nanoparticles, and the implications will be discussed further 
in section 6.3. Similarly. extended blood circulation times have been noted in vivo for 
PLGA nanoparticles coated with poloxamer 407 and poloxamine 908 and the % c-o for 
the ether environment seen is similar to that obtained for the PLA-PEG nanoparticles 
(Dunn et ai, 1994; Scholes, 1994). 
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Table 4.9 
Comparison of PLA-PEG Nanoparticles with Coated PLGA Nanoparticles and 
Polystyrene Particles with Grafted PEG 2000 of Differing Swface Densities 
Sample XP S C 1 s % Ether Carbon (% C-O) 
4:2 PLA-PEG nanoparticles 30 
6:2 PLA-PEG nanoparticles 21 
PLGA coated with Poloxamer 407 1 29 
PLGA coated with Poloxamer 4072 31 
PLGA coated with Poloxamine 908 1 28 
PLGA coated with Poloxamine 9082 25 
Polystyrene-PEG 2000a 8 
Polystyrene-PEG 2000b 15 
Polystyrene-PEG 2000c 41 
Polystyrene-PEG 2000d 51 
1 _ particles produced by the Fessi method followed by physical adsorption of surfactant 
to the surface of the nanoparticle. 
2 _ particles produced by the Fessi method in the presence of surfactant. 
a - d indicates increased surface density of PEG 2000 from a to d, due to differing input 
molar ratios of styrene to ethylene glycol. 
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4.4 THE STABILITY OF PLA-PEG AQUEOUS DISPERSIONS TO ADDED SALT 
4.4.1 Theory oiC/oud Point Testing 
When the temperature of an aqueous solution of non-ionic surfactant micelles is raised, 
the solution becomes turbid over a narrow temperature range. The temperature of the 
onset of this turbidity is known as the cloud point, T c (or also the critical flocculation 
temperature in certain cases). Above the cloud point, the system separates into two 
isotropic phases, one of which is an almost micelle-free dilute solution of the surfactant, 
with the other phase being a concentrated surfactant phase which only occurs above the 
cloud point (Hinze and Pramauro, 1993). This phase separation is usually reversible on 
cooling, when a clear solution is again formed. 
The cloud point temperature is a function of the structure of the aggregate, and is 
affected by the size of both the hydrophilic and hydrophobic chain length, and the chain 
packing density, surface coverage and molecular structure of the hydrophilic chain 
(usually polyethylene glycol (pEG» (fadros and Vincent, 1980). Therefore, Tcgives an 
indication of the steric stability of the aggregate and thereby its performance in vivo, 
where the properties of the hydrophilic PEG chain are important in determining the 
biodistribution (mum et ai, 1987). 
Cloud point temperatures are affected by the presence of other materials, and certain 
electrolytes are used to decrease the cloud point. This feature is utilised in the 
measurement of the cloud point temperatures ofPLA-PEG micelles/particles to ensure 
that the T c values are in the measurable temperature range of the instrument. 
4.4.2 Mechanism of Clouding of P EG-Stahilised Aggregates 
Cloud points are usually more influenced by the anions of added electrolytes than the 
cations (Tokiwa and Matsumoto, 1975). The effect of electrolytes on the steric stability 
of nonionic micelles/particles can be considered in terms of two factors: -
i) the hydration of ions, with the consequent change of the nearby water structure, which 
affects the affinity of the water molecules for the ether oxygens of the amphiphile, and 
ii) the binding of ions or salts of polyvalent metals to ether oxygens via cation 
complexation at high concentrations, leading to an increase in amphiphile solubility 
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(Schott, 1973). 
In the first category, are the anions such as sulphates, chlorides, iodides and thiocyanates, 
whereas in the second category, are cations, such as dioxane (Schott and Han, 1976). 
The effect of an additive on the cloud point can be assessed by its lyotropic number, 
where the lower the lyotropic number below 11.7 (Schott and Han, 1976), the greater 
the depression of the cloud point (otherwise known as salting out). Similarly, higher 
lyotropic numbers indicate an elevation of the cloud point. Sodium sulphate was chosen 
for the determination ofPLA-PEG cloud points due to its low lyotropic number of 1.60 
(Finnan et al, 1985). 
Several theories have been advanced throughout the years to account for cloud points 
(the onset offlocculation). Flocculation is generally thought to be due to the decreasing 
solvency of the dispersion medium for the stabilising PEO chains. This results in contacts 
between molecules of the dispersion medium and between PEO chains becoming 
energetically more favourable than dispersion medium-PEO chain contacts (Nap per, 
1968; Napper, 1970a). Suggestions have been made that this may be due to a 
competitive binding process between the ions and the polymer for the water molecules; 
as ion hydration increases, less solvent is available to dissolve the PEO chains (Boucher 
and Hines, 1976; Napper, 1970b). However, this theory does not explain all 
observations, which led to a further suggestion that to explain clouding in the presence 
of electrolyte, the structure of the water must be considered. In the presence of an 
electrolyte, water consists of three regions (Boucher and Hines, 1976; Napper, 1970b). 
Region A consists of the innermost polarised water molecules around the ion, which 
move with the ion. Region B is partially ordered by the electric field of the ion, 
concentric with the ion and contains water molecules with greater mobility compared 
with pure water, as the hydrogen bonding is destroyed. Region C behaves as bulk water 
with hydrogen bonding present. The extent of region B compared with A and C is a 
measure of the structure-breaking ability of the ion. As region A is impenetrable to the 
PEO chains, only regions Band C are available to dissolve the PEO, which leads to 
decreased solvency for the P E ~ . . The flocculating ability of an added salt is due to how 
the salt affects the bulk water, the water-polymer interaction and the polymer-polymer 
interactions. Therefore with sulphate ions, which are powerful flocculants, a large B 
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region is seen with negligible A region (Tadros and Vincent, 1980), whereas chlorides 
are highly hydrated (large A region) and need increased concentration to be effective. 
Although this theory has been generally accepted, there is still debate within the literature 
about the cause of clouding. Rupert (1992) studied clouding in terms of a Flory-Huggins 
approach, and concluded that clouding was the result of a change in the balance between 
the hydrophobic and hydrophilic interactions of a micelle with its surroundings with 
increasing temperature. The theory suggested that the unfavourable interactions between 
hydrophobic groups and water were responsible for clouding, and not a sudden 
dehydration. Another theory proposed is that clouding is caused by a change in PEO 
head group conformation, which reduces the dipole moment of an ethylene oxide group 
and makes the head group less hydrophilic (Karlstrom, 1985). 
4.4.3 Cloud Point Temperatures of PLA-PEG Micelles/Particles 
Poloxamer 407 was chosen as a comparable species to the "PLA-rich" fraction (peak 
one). PEG 8000 is comparable to the total PEG content of Poloxamer 407, and was 
chosen so that the contribution of PEG to the miceUe stability could be determined. PEG 
8000 also serves as a comparator to the PEG portion of the PLA-PEG copolymers (Mw 
2000 and 5000), and to the "PLA-depleted" fraction of the PLA-PEG copolymers. The 
experiments were performed as described in section 2.10. 
For PEG 8000 solutions, a sharp increase in turbidity was seen, as the temperature 
increased, followed by a plateau region, extending to the end point of the experiment 
(80°C) (Figure 4. 13 a). This turbidity was reversible, clearing rapidly on cooling of the 
solution. Reversibility is generally noted for this type of incipient phase separation in 
polymer solutions (Napper, 1969; Hinze and Pramauro, 1993). No further phase 
separation was observed for PEG 8000 solutions during testing to 80°C. 
Poloxamer 407 showed a different pattern of behaviour compared with PEG 8000. A 
sharp increase in absorbance at the cloud point (Tc) was followed by a plateau region, 
as with PEG 8000. However, a marked fall in absorbance was then observed 
corresponding to separation ofa solid phase (Figure 4. 13b). Examination of samples at 
80°C, after testing, revealed a collection of solids at the surface of clear liquid, with 
reversibility exhibited at all stages of turbidity. The point of decrease in turbidity after 
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the plateau region allowed the assignment of a solid phase separation temperature (Ts) 
for the surfactant. The unfractionated PLA-·PEG materials showed similar behaviour to 
Poloxamer 407, albeit with lower associated cloud point temperatures (Tc). Retained 
background turbidity gave rise to a second stable plateau region, which is considered to 
be due to the PLA-depleted species within the material and therefore appeared to behave 
similarly to the PEG 8000 homopolymer (Figure 4. 13 c). The cloud point curves for the 
fractionated PLA-PEG micelle fonning materials were again similar, but showed a larger 
drop in turbidity to the second plateau region relative to the unfractionated PLA-PEG 
copolymers. Reversibility was displayed for both fractionated and unfractionated PLA-
PEG copolymers. 
Table 4.10 shows that the cloud point temperatures (Tc) and the solid phase 
temperatures (Ts) for the fractionated PLA-PEG copolymers, the unfractionated 1.5:2 
PLA-PEG copolymer, and Poloxamer 407, decreased with increasing salt concentration 
in line with the expected behaviour of PEG -containing copolymer solutions. Cloud point 
temperatures are lower than those measured for PEG 8000 by approximately 30 0c. It 
is interesting to note the very much reduced rate of decline ofTs compared with Tc with 
salt addition for the block copolymer. This could indicate that the thermodynamic factors 
which drive the separation of solid phase have a weaker temperature dependence than 
the "salting out" process of the hydrophilic PEG component which leads to the cloud 
point. 
The lower cloud point temperatures (Tc) seen with the 1.5:2 and 2:5 PLA-PEG micelles, 
compared with Poloxamer 407, indicate r ~ u c e d d solvency of the stabilising PEG 
component associated with PLA-PEG relative to that in Poloxamer 407 (Table 4.10). 
This implies that the Poloxamer 407 micelles have greater "steric" stability than the 1.5:2 
PLA-PEG micelles. This may be expected due to the higher proportion of the stabilising 
PEG moiety in the poloxamer 407, which has two PEG chains of Mw 4000, as opposed 
to the one PEG chain (Mw 2000 or 5000) on the PLA-PEG copolymers. 
Table 4.11 shows the cloud point temperatures for the unfractionated 1.5:2 and 2:5 PLA-
PEG copolymers compared with the material from both GPC peaks. There was little 
difference between the Tc's ofunfractionated and fractionated micelle forming species. 
Comparison of the 1.5:2 and 2:5 PLA-PEG fractionated micelle forming material 
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Table -1.1 () 
Cloud Poinl Tempera!w'e.\· (Tc)/(Jr 1% \1'/)' FLA-Pl:'(J Copolymers in !he Presence ot' 
Na2S04 
Na2S04 1.5:2 PLA-PEG 1.5:2 PLA-PEG 2:5 PLA-PEG Poloxamcr 407 PEG 
Cone. Un fraetiona tcd Fractionated Fraetionated 8000 
(M) 
Te ("C) Ts ("C) Tctc) Ts ("C) Te (0C) Ts (DC) Te (DC) Ts ("C) Te ("C) 
0.1 77.6 - 76.7 - 81.8 - - - -
0.2 68.2 75.6 62.7 73.7 69.4 80.5 74.4 - -
0.3 58.7 69.3 55.4 67.2 56.6 74.6 61.5 73.4 -
0.4 42.7 65.7 43.4 65.6 39.8 70.3 48.8 65.3 73.1 
0,5 24.0 52.8 26.4 59.4 27.3 65.0 31.7 59.5 58.2 
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Table 4.11 
Comparison of Cloud Point Temperaturesjor rractionated and Unfractionated PLA-
PEG 
Sample Elution Na2S04 Concentration (M) 
Peak 
0.1 0.2 0.3 0.4 0.5 
1.5:2 PLA-PEG - 77.6 68.2 58.7 42.7 24.0 
1.5:2 PLA-PEG 1 76.7 62.7 55.4 43.4 26.4 
1.5:2 PLA-PEG 2 83.3 71.2 61.6 49.3 44.5 
2:5 PLA-PEG - 83.2 70.5 56.2 45.3 21.4 
2:5 PLA-PEG 1 8l.8 69.4 56.6 39.8 27.3 
2:5 PLA-PEG 2 87 74.9 60.9 48.6 36.4 
Poloxamer 407 - - 74.4 61.5 48.8 31.7 
PEG 8000 - - - - 73.1 58.2 
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revealed that the difference between these copolymers was not significant. However, the 
material from peak two (PLA-depleted) from GPC analysis shows significantly higher 
cloud points than the micelle-forming materials but not as high as the PEG 8000 control. 
The values are intermediate between the two types of sample (micelle-forming and PEG 
8000 solutions), as would be expected for a sample with an increased PEG content 
(Ganong and Delmore, 1991). Cloud point temperatures have been shown to be affected 
by the structure of the nonionic species (Hinze and Pramauro, 1993), with an increase 
in the number of EO groups increasing the cloud point, and to also be affected by the 
length of the hydrophobic chain (Rupert, 1992), with a decrease in hydrophobe chain 
increasing the cloud point for a homologous series of surfactants (Hinze and Pramauro, 
1993). 
Similar cloud point studies were performed with 4:2 and 6:2 PLA-PEG particles. The 
cloud point curve was similar to that seen previously with the 1.5:2 and 2:5 PLA-PEG 
copolymers and also Poloxamer 407. After clouding and flocculation had occurred, 
reversibility was not seen and the dispersions remained cloudy/flocculated. This could 
be due to the lack of solubility in water or due to the attractive forces between the 
particles being stronger than the attraction of the PEG chains for the dispersion media. 
It could also indicate incomplete coverage of the PLA groups by the surface PEG 
(Nap per, 1970a). The structure of the micelles/particles at the cloud point and beyond 
is not clear, and the concentration at which they change structure (if such a change 
occurs) is also not yet known. 
Figure 4.14 shows the cloud point temperatures for the 4:2 and 6:2 PLA-PEG 
dispersions against 1.5:2 and 2:5 PLA-PEG for comparison. This shows that the cloud 
point temperatures for the 4:2 and 6:2 PLA-PEG particles are very similar to 1.5:2 PLA-
PEG at the lower sodium sulphate concentrations. This may be expected as the 
molecular weight of the PEG chain is 2000 for all three copolymers, so the steric stability 
is expected to be similar. At 0.4 M sodium sulphate, the 6:2 PLA-PEG shows a greater 
decrease in stability in the presence of salt compared with the 4:2 and 1.5:2 PLA-PEG. 
This could indicate that the 6:2 PLA-PEG particles are less sterically stable than the 4:2, 
1.5:2 and 2:5 PLA-PEG particles and micelles. 
Considering the change in the cloud points of the PLA-PEG micelles/particles with 
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increasing sodium sulphate concentration, Figure 4.14 shows that the decrease in cloud 
point appears to be approximately linear for each copolymer. A linear change has also 
been noted with Pluronics P85 and L64 (Bahadur el ai, 1993), and the salts tested had 
a strong effect on the cloud point, as is seen with the PLA-PEG copolymers. Cloud 
point temperatures for Pluronic copolymers have been widely tested and a summary is 
provided by Alexandridis and Hatton (1995) in their review paper of the cloud points 
of 1% w/v dispersions of several Pluronics. Generally, for Pluronics with similar PEG 
contents and chain lengths to the PLA-PEG copolymers, the cloud point temperatures 
are over 100 QC, which is similar to the PLA-PEGs. Similarly, the 
oxyethylene/oxybutylene copolymers, E38BI2 and E21BIIE21, did not show clouding up 
to a testing limit of 95 QC (Yang et ai, 1995). 
4.4.4 Implications o/Cloud Point Temperatures 
The cloud point temperatures of the PLA-PEG copolymer micelles and particles indicate 
steric stability in the presence of salt. This can be taken as an indication of PEG at the 
surface of the micelles/particles (Maste et ai, 1994). PLA-PEG micelles and particles 
show increased steric stability as compared with uncoated PLGA particles and similar 
steric stability to PLGA particles coated with poloxamers and poloxamines. Scholes 
(1994) noted that uncoated PLGA particles flocculated in 0.1 M sodium sulphate 
solution, at room temperature, whereas poloxamer 407 coated particles remained stable 
to salt addition of up to 0.5 M sodium sulphate. Poloxamine 908 coated particles 
showed reduced stabilising ability compared to Poloxamer 407, despite their long PEG 
length. This was thought to be due to conformational changes and differences in chain 
packing density of the PEO chains. However, both poloxamer 407 and poloxamine 908 
give extended blood circulation times in vivo in the rat model, which suggests that the 
steric stability of PLA-PEG micelles and particles should be sufficient to give some 
degree of protection against the reticuloendothelial system (RES) of the liver (IlIum et 
al. 1987). 
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4.5 SUMMARY 
This chapter has discussed four different methods of studying the surface of the PLA-
PEG copolymers. Surface analysis studies of SIMS and XPS have indicated that PEG 
is indeed present on the surface of these structures and that the density of the PEG is 
equivalent to that previously achieved with systems that have shown promising in vivo 
studies. Cloud point temperatures have further confirmed the presence of PEG at the 
micelle/particle surface by the illustration of steric stability on addition of sodium sulphate 
to all systems. 
Rheological measurements allowed the PEG layer thickness to be calculated for the PLA-
PEG systems. Differences in the resulting values were seen, with the micelle-forming 
1.5:2 and 2:5 PLA-PEG copolymers having longer PEG layer thicknesses than the 
particle-forming 4:2 and 6:2 PLA-PEG copolymers. This may prove an important factor 
in the in vivo behaviour of these copolymers. 
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CHAPTER FIVE 
DRUG LOADING POTENTIAL OF PLA-PEG MICELLES AND PARTICLES 
5.1 INTRODUCTION 
So far, the physicochemical properties ofthe PLA-PEG systems have been considered 
with respect to their suitability as drug delivery systems, and their possible use in drug 
targeting by avoidance of the reticuloendothelial system (RES) in vivo. The ability of the 
PLA-PEG systems to incorporate drug molecules must now be considered, so that the 
drug loading and hence drug delivery potential of the micelles and particles can be 
assessed. Comparing quantitatively the incorporation of two model drugs of different 
hydrophobicity between the PLA-PEG systems will d6 this. An in vitro release study in 
phosphate buffered saline (PBS) under physiological conditions of pH 7.4 and 37 QC is 
then described for one of these systems. 
5.2 "MODEL" DRUGS 
5.2.1 Sudan Black B 
Sudan Black B (SBB) (Mw 456.6) is the most popular of the Sudan azo dyes. It has 
been used for many years as a universal lipid stain in histology and pathology, where it 
stains both apolar (neutral) lipids and polar. (Phospho-) lipids (Tas et ai, 1980). The 
structure of SBB is shown in Figure 5.1a and consists of five aromatic rings and two 
secondary amine groups that give it basic properties (pfiiller et ai, 1977; Horobin, 1981). 
Sudan black B has previously been used in ultracentrifugation studies on micellar 
systems due to its ease of incorporation and useful absorbance spectrum. It has also been 
used as a model drug with PLA and PLGA implants (Katayama et ai, 1995). The water 
solubility of SBB is very low due to its high lipophilicity and SBB would therefore be 
expected to incorporate in the core of a PLA-PEG micelle or particle, with little present 
in the aqueous solution. A log P value of7.6 has been calculated for SBB (Saunders, 
1993), using the CLogP computer program (version 3.54), and is similar to 
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another calculated value of 7.2 found in the literature (Juarranz et ai, 1986). 
Determining values of log P above 7.0 experimentally is not feasible (Craig, 1990). 
5.2.2 Testosterone 
Testosterone (Mw 288.4) is an androgenic hormone that controls the development and 
maintenance of the male sex organs and secondary sex characteristics. It has a steroidal 
structure, which is shown in Figure 5.1b. Testosterone was chosen as a second model 
drug to give an example of a pharmaceutically relevant compound of lower 
hydrophobicity than SBB. Other groups (Thakkar and Hall, 1967; Malcolmson and 
Lawrence, 1993) have also previously incorporated testosterone into micelles and 
particles. 
Similarly to sudan black B, the hydrophobicity of testosterone was assessed by 
determination of its octanoVwater partition coefficient- (log P). The calculated value of 
3.35 compared well with an experimentally determined value of3.32 (Craig, 1990). 
5.3 DRUG LOADING OF TESTOSTERONE AND SUDAN BLACK B INTO PLA-
PEG MICELLES AND PARTICLES 
5.3. J Method of Drug Incorporation 
Solutions of testosterone (1 mg/ml) and sudan black B (SBB) (20 mg/ml) in acetone 
were added to fractionated dispersions of the 1.5:2 and 2:5 PLA-PEG micelles (1% w/v 
for testosterone, 0.25% w/v for SBB), and 4:2 and 6:2 PLA-PEG particles (0.25% w/v 
for both drugs). The higher copolymer concentration used with the PLA-PEG micelles 
was part of earlier studies, where a higher PLA-PEG concentration was used to ensure 
adequate absorbance ofthe incorporated testosterone on UV analysis. As the results are 
expressed as weight of drug over weight of polymer, the studies were not repeated at the 
lower concentration. The acetone was allowed to evaporate during incubation overnight 
at 25°C. The copolymer/drug dispersions were then centrifuged using a Centaur 2 
(MSE, Sussex, U.K.) centrifuge (840 g, ten minutes), followed by a Micro Centaur 
(MSE, Sussex, u.K.) centrifuge (11,600 g, five minutes). After removal of the 
supernatant, the precipitate of drug that had neither incorporated into the 
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micelles/particles nor dissolved in the supernatant was dissolved in ethanol (SBB) or 
purified water (testosterone). The absorbance of each solution was measured by UV 
spectroscopy (Uvikon, Kontron Instruments, Tegimenta, Switzerland) at 257 nm to 
determine testosterone concentrations, and 587 nm to determine SBB concentrations. 
Testosterone concentration was detennined at a longer wavelength than the A.nax (A=240 
nrn), as the PLA-PEG dispersions also absorb significantly at this wavelength. Similarly, 
the second maximum for SBB in ethanol was evaluated and used for measurements, due 
to PLA-PEG absorbance at the first maximum (A - 230 nm). Aqueous solubility was 
determined similarly by adding a solution of drug in acetone (I ml) to water and then 
centrifuging off the excess. The absorbance of the supernatant was then measured. This 
sample also acted as a control. Extinction coefficients for testosterone and SBB were 
calculated from the absorbance of aqueous dilutions of ethanolic stock drug solutions. 
The amount of drug incorporated was then calculated by subtraction, as described below 
in section 5.3.3. 
5.3.2 Verification of Drug Loading by Sedimentation Velocity Experiments 
5.3.2.1 Method 
This experiment was performed as described in section 2.8.1, but with testosterone and 
sudan black B (SBB) incorporated into dispersions offractionated PLA-PEG material. 
For 1.5:2 and 2:5 PLA-PEG solutions, PLA-PEG/testosterone-loaded dispersions were 
prepared by adding a solution of testosterone in acetone (1 ml, 0.5 mg/ml) dropwise to 
an aqueous solution offractionated PLA-PEG (5ml, 0.2% w/v). The dispersions were 
stirred overnight to remove the solvent by evaporation. Sudan black B (10 mg) was 
incorporated by addition of the SBB directly to an aqueous solution of fractionated PLA-
PEG (5 ml, 0.2% w/v) and sonicating for ten minutes at room temperature. The different 
loading methods used to incorporate SBB and testosterone in this experiment reflect 
earlier work on drug loading performed before the work described in this thesis. The 
resulting suspensions were then filtered through a 0.2 ~ m m filter to remove excess 
testosterone/sudan black B. Earlier control experiments showed that the entire free drug, 
apart from that dissolved in solution, was removed by the filtration process (data not 
shown). The runs were performed at 20oe, with the PLA-PEG/testosterone system run 
176 
at 40,000 revs/minute and the PLA-PEG/SBB system at 30,000 revs/minute. Both these 
dispersions were scanned at two wavelengths, the first to detect the micelles plus model 
drug, and the second, where the micelles are transparent, to evaluate whether 
sedimentation boundaries were still produced. For the testosterone systems, 1.5:2 PLA-
PEG was scanned at 232 nm (AI) and 258 nm (A2), and 2:5 PLA-PEG was scanned at 
226 run (AI) and 258 run (A2). For the SBB system, 1.5:2 PLA-PEG was scanned at 231 
nrn (AI) and 510 nm (A2) and 2:5 PLA-PEG at 225 nm (A 1) and 510 run (A2). 
Sedimentation coefficients (S20) were then determined for all the samples (Harding, 
1984), where S20 represents the sedimentation coefficient at 20°C. 
Similarly, the experiment was performed for 4:2 and 6:2 PLA-PEG particles with 
testosterone (1 m!, 1 mglml) and sudan black B (SBB) (1 ml, 10 mglml) incorporated into 
0.25% w/v dispersions. In this experiment, the drugs were incorporated as described 
above in section 5.3.1. Dilution of the PLA-PEGlSBB samples by a factor offifty (to 
an approximate concentration ofO.005% w/v) was needed to give suitable absorbance 
values of the sedimenting boundaries. The runs were then performed at 20°C and 20,000 
revs/minute. Again, these dispersions were scanned at two wavelengths. For 
testosterone, the dispersions were scanned at 226 nm (AI) and 258 run (A2), and for 
sudan black B, at 226 nrn (AI) and 599 nm (U). Sedimentation coefficients (S20) were 
then determined for all the samples. 
5.3.2.2 Calculation and Implications of Sedimentation CoeffiCients 
The sedimentation coefficients (S20) (in Svedbergs (S), where IS=IxIO-13 seconds) 
calculated for the fractionated PLA-PEG copolymers alone are listed in Table 5.1, along 
with the micelle/particle molecular weights estimated from the sedimentation equilibrium 
experiments, as described in section 3.7. The sedimentation coefficient values show an 
increase with increased micelle/particle molecular weight. 
Sedimentation coefficients, s, are related to molecular weight by the following equation:-
-
MO-vp) 
S=---'---'-
NAf 
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where M is the molecular weight, 
v is the partial specific volume (m3g- 1), 
p is the density of the solvent (kg m-3), 
NA is Avogadro's number, and 
f is the frictional coefficient (kg S-I). 
This implies that s is linear with molecular weight. However, since f is related to the 
effective hydrodynamic radius of the micelleJparticle, which in turn depends on the cubic 
root of the micelleJparticle volume, then if all other parameters are constant, it is more 
true to say that s varies with M213 for micelles or particles of similar shape, solvation and 
partial volume (Rowe, 1992). 
This relationship between a molecular weight and sedimentation coefficient depends, 
however, on the sedimentation coefficient being corrected for pressure effects and being 
extrapolated to zero concentration (Suzuki, 1992). These corrections have not been 
performed for the PLA-PEG copolymer systems. This method of calculating molecular 
weight assumes that each species sediments independent of the others, an assumption that 
is not supported by experimental data (Suzuki, 1992). Therefore, absolute values of the 
molecular weight cannot be obtained from the sedimentation coefficient. Hence, 
although the sedimentation coefficients will follow this relationship in an approximate 
manner, deviations are expected to occur, but the plot of sedimentation coefficient 
against M213 is approximately linear. 
The sedimentation coefficients (S20) (in Svedbergs (S), where IS=IxIO-13 seconds) 
calculated for the fractionated 1.5:2 and 2:5 PLA-PEG copolymers alone and in the 
presence of the two model drugs, testosterone and SBB, are listed in Table 5.2. Figure 
5.2a illustrates an example of the single sedimenting boundary observed for 2:5 PLA-
PEG material alone, indicating homogeneity. Both PLA-PEG dispersions with 
testosterone also showed single boundaries at the wavelength scanned for PLA-PEG 
(AI), but a significant amount of material was found to be absorbing but not sedimenting 
with these systems. This is most likely due to free testosterone dissolved in the aqueous 
solution, or testosterone bound to free non-associated copolymer, which had too Iowa 
molecular weight to sediment under the experimental conditions. At the testosterone 
specific wavelength, sedimenting boundaries were not observed, suggesting that the 
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testosterone was not incorporated into the micellar core. However, earlier experiments 
performed at a concentration of 1% w/v did show the presence of sedimenting 
boundaries at both wavelengths, but the absorbance measured at the PLA-PEG 
wavelength (AI) was too high at this concentration to give acceptable sedimentation 
boundaries. All further experiments with testosterone were thus conducted at a 
concentration of 0.2% w/v, but this consequently lowered the testosterone absorbance, 
causing difficulty in detecting the presence of testosterone within the micelles. This was 
especially a problem since the testosterone wavelength maximum (A=240 nm) overlaps 
with the PLA-PEG UV absorbance spectrum and therefore could not be used for 
measurements. 
Sedimenting boundaries were observed with PLA-PEG dispersions incorporating SBB, 
but there appeared to be a second sedimenting species with the 2:5 PLA-PEG system, 
which was not seen with the 2:5 PLA-PEG alone (Figures 5.2a and b). This behaviour 
pattern may suggest polydispersity of the micelles. Assuming the conformations of the 
PLA-PEG/SBB and PLA-PEG systems are the same (spherical micelles), it can be 
speculated that the differences in sedimentation coefficient (Table 5.2) reflect differences 
in molecular weight, M (for spherical particles S20 is approximately proportional to M 2I3). 
The difference between the sedimentation coefficients of the polymer alone and with 
drug incorporated probably represent differences in size with the 2:5 PLA-PEG system, 
but it is unlikely that the differences between these S20 values for the 1.5:2 PLA-PEG 
systems are significant. They are more likely to be due to thermodynamic non-ideality 
(arising from co-exclusion or unsuppressed.polyelectrolyte phenomena from the PLA 
blocks). Sedimentation coefficients of the PLA-PEG micelles at the first wavelength (AI) 
were not measured due to excessively high absorbance values (as the SBB contributed 
to the absorbance at this wavelength), but sedimenting boundaries indicating micelles 
were seen with both copolymers. 
The sedimentation coefficients (S20) (in Svedbergs (S)) calculated for the fractionated 
PLA-PEG particles, with and without the incorporation of testosterone and SBB, are 
listed in Table 5.3. Figures 5.3a and 5.3b clearly show the presence of sedimenting 
boundaries for 6:2 PLA-PEG particles alone and with SBB incorporated and measured 
at A2 (599 nm). Similar results were seen with 4:2 PLA-PEG, and the SBB has plainly 
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Table 5.1 
Sedimentation Coefficients of PLA-PEG Copolymers 
Copolymer Micelle/particle molecular Sedimentation Coefficient, S20 (S) 
weight (Mean ± s.e., n = 3) 
2:5 PLA-PEG 330,000 ± 30,000 7.99 ± 0.38 
1.5:2 PLA-PEG 520,000 ± 20,000 8.51 ± 0.14 
4:2 PLA-PEG 1,000,000 ± 50,000 16.0 ± 0.27 
6:2PLA-PEG 1,500,000 ± 100,000 34.4 ± 0.99 
Table 5.2 
Sedimentation Velocity Analysis of Fractionated P LA -PEG Micelles 
Copolymer Sample Sedimentation Coefficient (S), S20 
(Mean ± s.e., n = 3) 
1.5:2 PLA-PEG 8.51±0.14 
1.5:2 PLA-PEG with Testosterone (AI) 9.57 ± 0.11 
1.5:2 PLA-PEG with Sudan Black B (A2) 9.76 ± 0.20 
2:5 PLA-PEG 7.99 ± 0.38 
2:5 PLA-PEG with Testosterone (AI) 7.36 ± 0.10 
2:5 PLA-PEG with Sudan Black B (A2) 10.88 ± 0.18; 6.55 ± 0.14 
A 1 -wavelength for detecting PLA-PEG and drug. 
A2 - wavelength specific for detecting incorporated drug. 
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been incorporated into the particles and is sedimenting with them. As seen with the 
micelle-forming copolymers, these studies show that the absorbance of the testosterone 
incorporated is low, leading to difficulty in detecting it at the second wavelength (A = 
257 nm), which is specific for testosterone. 
Comparing the sedimentation coefficients of the testosterone incorporated PLA-PEG 
systems over the values for the PLA-PEG alone, there is a small difference that, as 
discussed above with the micelles, is unlikely to be significant for this technique 
(especially in view of the standard error values). The difference between the 
sedimentation coefficient values for the SBB incorporated samples over the PLA-PEG 
alone is larger. This may reflect an increase in molecular weight of the particles. 
However, comparing these values is difficult as the concentrations of the measured 
samples were different, namely 0.2% w/v for PLA-PEG particles alone and 0.005% w/v 
for PLA-PEG particles incorporated with SBB, due to the dilution necessary for the SBB 
systems to allow measurable absorbance values. Concentration has been shown to affect 
sedimentation coefficients, with increased polymer concentration leading to a decrease 
in sedimentation coefficient (Lavrenko et aI, 1992). The sedimentation coefficient 
values measured for the more concentrated PLA-PEG dispersions are lower than the 
corresponding values for the more dilute dispersions with SBB incorporated. Therefore, 
it is not possible to conclude from these results whether a size increase has occurred. 
5.3.3 Quantitation of Drug Loading 
The amount of drug incorporated in P L A - P ~ G G micelles and particles was calculated as 
follows:-
Drug in PLA-PEG micelles/particles = 
{ amount of drug added} - {amount of drug not incorporated + amount of drug soluble 
in water} 
where the amount of drug added was known, and the amount of drug not incorporated 
was calculated from the UV absorbance of the solutions of drug precipitate excluded 
from the PLA-PEG micelles/particles. This calculation was performed using the Beer-
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Lambert equation: -
where c is the concentration (mol cm-3), 
A is absorbance, 
I is the length of the cell (cm), and 
A c ~ ~ , ,
1& 
E is the molar extinction coefficient of the drug (cm2 mor I ). 
Aqueous solubilities for testosterone and sudan black B were also calculated from the 
Beer-Lambert equation, and were found to be 23 mg cm-3 and 1.2 mg cm-3 respectively. 
From the concentration and aqueous solubility of each drug, the mass of drug not 
incorporated was calculated, allowing the %w/w drug loading of the PLA-PEG micelles 
and particles to be determined. 
Table 5.4 shows the results of the drug loading into the PLA-PEG micelles and particles. 
Values are also given for the percentage of added drug incorporated, which is also 
known as the incorporation "efficiency", and is a measure of how effectively the system 
takes up the available drug. It is dependent on both the concentration of the copolymer 
and the amount of drug added to the dispersion. Comparison of this value can therefore 
only be made between samples at the same concentration of both copolymer and drug. 
So, the efficiency ofPLA-PEG micelles (1.5:2 and 2:5) in taking up testosterone cannot 
be compared with the efficiency of the PLA-PEG particles (4:2 and 6:2), but comparison 
can be made between the two micellar copolymers or between the two particular 
copolymers. Similarly, no comparison can be made between the testosterone and SBB 
results, but comparing between the SBB values is valid. 
Another measure of the effectiveness of incorporating drug is the molar incorporation 
ratio (MIR), which is defined as the number of moles of drug incorporated per mole of 
copolymer, for a given drug. From this molar ratio and the association number of 
copolymer molecules in a micelle/particle, the number of drug molecules associated with 
the micelle or particle can be calculated, and these values are also given in Table 5.4. 
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Tahle 5.3 
Sedimentatioll Velocity Analysis (?f J.ractiollated PLA-PEG Particles 
Copolymer Sample Copolymer Sedimentation Coefficient, 
Concentration S20 (S) 
(% w/v) (Mean ± s.e.) 
4:2 PLA-PEG 0.2 16.0 ± 0.27 
4:2 PLA-PEG + Testosterone Al 0.2 18.1 ± 0.01 
4:2 PLA-PEG+ SBB Al 0.005 28.8 ± 0.50 
4:2 PLA-PEG + SBB A2 0.005 31.2 ± 0.38 
6:2 PLA-PEG 0.2 34.4 ± 0.99 
6:2 PLA-PEG + Testosterone Al 0.2 30.0 ± 0.82 
6:2 PLA-PEG + SBB Al 0.005 45.6 ± 1.04 
6:2 PLA-PEG + SBB A2 0.005 45.4 ± l.31 
A I - wavelength for detecting PLA-PEG and drug. 
A,2 - wavelength specific for detecting incorporated drug. 
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5.3.4 DisclIssion 
The results in Table 5.4 show that higher drug loading was observed for the particle-
forming 4:2 and 6:2 PLA-PEG copolymers compared with the micelle-forming 1.5:2 and 
2:5 PLA-PEG. Clearly, the sudan black B (SBB) incorporated was significantly higher 
than testosterone for all copolymers. For both drugs, a general trend between the 
percentage of drug incorporated by weight (%w/w) and the molecular weight of the 
micelle or particle is seen (as determined from sedimentation equilibrium experiments in 
section 3.7.2.). This trend shows an increase in drug loading with an increase in 
micelle/particle molecular weight, particularly the PLA molecular weight. A decrease in 
%w/w drug loading is seen with the increased PEG content, when 2:5 PLA-PEG is 
compared with the other PLA-PEG copolymers (1.5:2,4:2 and 6:2 PLA-PEG). 
Previously with Pluronic micelles, increased drug loading of hydrophobic drugs has been 
observed with increased hydrophobicity of copolymer (i.e. an increase in PPO) (Hurter 
and Hatton, 1992; Kabanov et ai, 1995). Increase in polyoxyethylene chain length has 
previously shown a decrease in % w/w drug loading, for micelle-fonning polyoxyethylene 
stearates (Goodhart and Martin, 1962) and for polyoxyethylene cetyl ethers and 
monostearates (Saito and Sato, 1985). Thus it can be observed, particularly with 
testosterone, that the drug loading increases as follows: -
2:5 PLA-PEG < 1.5:2 PLA-PEG < 4:2 PLA-PEG < 6:2 PLA-PEG 
The differences in the drug loadings of SBB between the copolymers are not as 
pronounced as the differences seen with the testosterone. 
From the fourth column of Table 5.4, which lists the molar incorporation ratio (MlR), 
it may seem curious that with SBB, the value of MlR for 2:5 PLA-PEG is greater than 
that for 1.5:2 PLA-PEG. This reversal has also been noted by other authors (Goodhart 
and Martin, 1962; Gouda et ai, 1970; Saito and Sato, 1985; Goldenberg et ai, 1993). 
The MlR for 2:5 PLA-PEG implies that the solubilising efficiency of this copolymer is 
greater than that for 1.5:2 PLA-PEG and comparable with 4:2 PLA-PEG, despite the 
greater hydrophilicity of2:5 PLA-PEG. This contradiction with the %w/w drug loading 
values has been attributed to the decrease in micelle molecular weight that occurs when 
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Table 5A 
Drog Incorporation Studies of Testosterone and Sudan Black B into J<ractionated PLA-
PEG Micelles and Particles 
% Added Number of drug 
%w/wDrug drug molecules per 
Copolymer incorporated incorporated MIR* micelle/particle 
1.5:2 PLA-PEG + 0.74 ± 0.01 73.9 ± 0.7 0.1O± 0.0 13 ±O 
Testosterone 
4:2 PLA-PEG + 0.93 ± 0.09 23.7 ± 1.9 0.21 ± 0.0 33 ±3 
Testosterone 
6:2 PLA-PEG + 1.96 ± 0.31 49.1±7.1 0.48±0.1 102 ± 16 
Testosterone 
2:5 PLA-PEG + 0.34± 0.02 34.2 ± 2.3 0.08 ± 0.0 4±1 
Testosterone 
-
1.5:2 PLA-PEG + SBB 63.9± 0.1 79.8 ±O.O 5.5 ± 0.0 729±0 
4:2 PLA-PEG + SBB 68.9± 0.1 86.1 ± 0.1 9.7 ± 0.0 1505 ± 2 
6:2 PLA-PEG + SBB 70.9± 0.6 88.6 ± 0.7 1O.9±0.1 2332 ± 19 
2:5 PLA-PEG + SBB 59.0±0.9 73.7 ± 1.1 9.0 ± 0.1 424±6 
* -MlR is the molar incorporation ratio, i. e. the number of moles of drug incorporated 
per mole of copolymer. 
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the PEG chain length is increased. This causes a decrease in the amount of drug per 
micelle, but is compensated for by an increase in the number of micelles present (Barry 
and El Eini, 1976). The higher amount of SBB incorporated in 1.5:2 PLA-PEG micelles 
over 2:5 PLA-PEG micelles is clearly illustrated in the last column of Table 5.4, which 
shows the number of drug molecules associated with each micelle or particle. The 
difference in MIR for testosterone between the two copolymers is much less pronounced 
and ANOV A statistical analysis performed at the 5% confidence level shows that the 
difference is not significant. 
Drug uptake into the particle-forming 4:2 and 6:2 PLA-PEG is greater than that with the 
micelle-forming 1.5:2 and 2:5 PLA-PEG copolymers for both drug compounds. As well 
as the increased hydrophobicity of these copolymers (i.e. more PLA), this may be partly 
due to the greater stability of the 4:2 and 6:2 PLA-PEG particles over the micelles 
formed with 1.5:2 and 2:5 PLA-PEG. It should be remembered that the number of drug 
molecules per micelle is an average value for the micellar solution. The micelle can act 
as a dynamic entity, with a fluctuating size, and drug molecules can therefore pass back 
and forth between the micelle and the aqueous solution (Jacobs et ai, 1972). This may 
make micelles potentially less able to retain drug than the more stable particles. 
The effect of incorporating drug on the properties of PLA-PEG micelles and particles 
must be considered. MukeIjee (1980) observed that the presence ofa solubilisate inside 
a micelle can affect the monomer-micelle equilibria, the stability and the size of the 
micelle to various degrees. A solubilised substance will generally increase the size of 
micelles, not only by its incorporation but also by causing an increase in association 
number of copolymer molecules in the micelle. An increased micelle size was noted with 
poloxamers, when hexane was solubilised (Al-Saden et ai, 1982) and was concluded to 
be due to an increased association number. Size increases have been observed with other 
micelles when substances have been incorporated into their cores (Oranli et ai, 1985; 
Goldenberg et ai, 1993; Quintana et ai, 1995). It may be expected that the incorporation 
of testosterone and SBB would increase the micelle/particle size. DLS studies on PLA-
PEG micelles and particles with testosterone incorporated showed no significant increase 
in particle size over PLA-PEG alone, and these results were confirmed by TEM studies. 
DLS studies were not possible on micelles and particles incorporated with SBB, but 
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Figure 5.4 shows a typical TEM picture for PLA-PEG particles after incorporation with 
SBB. This picture clearly shows the presence of some structures that are larger than the 
majority of particles present. It is unclear as to whether these structures are particles, 
aggregated SBB or artefacts of the TEM process. Mukerjee (1980) refers to the 
presence of swollen spheroidal micelles in a system where aromatic solubilisates are used 
at high concentrations of surfactant. However, before these spheroidal structures were 
seen, the system became highly viscous, then less viscous when the swollen micelles 
predominated. Therefore, this is unlikely to be the reason for these large structures as 
the concentration of the PLA-PEG micelles and particles is fairly low and no change in 
viscosity is observed. However, Bjerrum et al (1980) incorporated SBB into Triton X-
100 micelles, and when this system was analysed by GPe, two populations of micelles 
were seen to be associated with SBB. The first population had a higher molecular weight 
than the micelles alone, and the second population were of similar molecular weight to 
the micelles without SBB. In section 5.3.2.2, the sedimentation velocity results showed 
the presence of two species for 2:5 PLA-PEG micelles. This could confirm that there is 
heterogeneity of the PLA-PEG samples with SBB incorporated, similar to that noted by 
Bjerrum et al (1980). However, two sedimenting species were not apparent with the 
other PLA-PEG copolymers (1.5:2, 4:2 and 6:2), whereas larger structures are still noted 
on the TEM picture. This may be due to the dilute solutions used for 4:2 and 6:2 PLA-
PEG particles (-0.005% w/v), and the lower concentration of SBB in the 1.5:2 PLA-
PEG micelles of the sedimentation velocity experiment (-1-2 % w/w) compared with the 
drug loading experiments. The larger structures seen in the TEM picture are in the 
minority, and therefore may not be visible in sedimentation velocity experiments, 
especially at the lower concentrations. Otherwise, these large structures may be artefacts 
ofthe TEM process and would not exist to be detected by sedimentation velocity. 
The only other possibility for these large structures is that some SBB is not incorporated 
in the micelles and particles and has aggregated. This is unlikely, as control experiments 
for the in vitro release studies described below showed no significant difference in the 
UV absorbance of SBBIPLA-PEG particles measured before and after chromatographing 
on a hydrophobic propyl agarose gel column. If free SBB were present as aggregates, 
it would have bound to the hydrophobic gel leading to a change in absorbance. 
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Figure 5.4 - TEM picture of 4:2 PLA-PEG Particles with SBB Incorporated 
(Magnification = 200K) 
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From the above, drawing any definite conclusions regarding these large structures seen 
after the incorporation of SBB is difficult. The majority of the particles and micelles are 
similar in size to those observed without the presence of SBB, implying that any increase 
in size due to increased association number is small, as expected for small micelles 
(MukeIjee, 1980). Fessi et al (1989) also noted that the size of poly(D,L-lactide) 
nanocapsules loaded with indomethacin did not change. 
Drug loading in micelles is usually low, as indicated by Barry and El Eini (1976). They 
investigated the solubility of several steroids, including testosterone, in long chain 
polyoxyethylene surfactants (polyoxyethylated cetyl alcohols), showing that only 2 - 9 
molecules were associated with each micelle at 25°C, representing a maximum of 3 % 
of the micellar weight. This is similar in magnitude to the results observed for the 
incorporation of testosterone into the PLA-PEG micelles, but the values for SBB are 
considerably greater. A much increased drug loading was achieved with the hydrophobic 
dye SBB over the steroid testosterone, which is apparent with all PLA-PEG copolymers. 
This may be partly explained by the greater hydrophobicity of SBB over testosterone. 
SBB has a log P (octanoVwater) of7.2 compared with a log P for testosterone of3.35 
(calculated values, CLogP version 3.54). However, from the above results, it is unclear 
how significant the hydrophobicity is in determining the drug loading into PLA-PEG 
micelles/particles. Further studies have been performed to investigate this factor by using 
a range of testosterone esters of varying hydrophobicity but similar structure, in order to 
define how important hydrophobicity is for drug loading into PLA-PEG copolymers. A 
strong correlation between the micelle-water partition coefficient and log P has been 
described previously for Pluronics (Hurter and Hatton, 1992). 
5.4 INFLUENCE OF HYDROPHOBICITY ON DRUG LOADING 
5.4.1 Testosterone Esters 
To investigate the effect of hydrophobicity on drug loading, testosterone esters were 
chosen for incorporation into 4:2 PLA-PEG particles. These compounds have differing 
hydrophobicity but similar chemical structures, and provide a continuation of the 
testosterone result already measured. Furthermore, testosterone esters have been 
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employed to study the effect of drug hydrophohicity previously (Noguchi et aI, 1985; 
Malcolmson and Lawrence, 1993). The testosterone esters chosen for this experiment 
were testosterone propionate (log P=4.88), testosterone isocaproate (log P=6.34) and 
testosterone enanthate (log P=7.0). Log P values for the testosterone esters are for 
octanol/water, and are calculated values (Daylight, version 3.6) (Shute, 1995). Figure 
5.5 shows the chemical structures of the testosterone esters. 
5..1.2 Quantitation of Drug Loading of Testosterone Esters 
A range of testosterone esters (1 ml, 1 mg/ml in acetone) were incorporated into 4:2 
PLA-PEG particles (0.25% w/v) by the method described previously in section 5.3.1. 
Aqueous solubility and extinction coefficients in ethanol of the testosterone esters were 
also determined as before. The unincorporated drug was dissolved in ethanol and the 
UV absorbance measured at 241 nm for all three drugs. The drug loading into the 4:2 
PLA-PEG particles was then calculated as described in section 5.3.3 and the results are 
given in Table 5.5. ANOVA (analysis of variance) statistical analysis was performed 
on the testosterone ester results at the 5% confidence level. 
5.4.3 Discussion 
Table 5.5 shows that although the more hydrophobic testosterone enanthate incorporates 
more readily than the other testosterone esters (that are less hydrophobic than 
testosterone enanthate), the incorporation is not of the same magnitude as that seen with 
SBB (Table 5.4). No obvious trend is seen between the hydrophobicity (as measured 
by log P values) of the testosterone esters and the drug loading into PLA-PEG particles. 
ANOV A statistical analysis shows that the difference between the incorporation of 
testosterone propionate and testosterone isocaproate is not significant. The difference 
in drug loading between these two esters and testosterone is also not significant. 
However, the difference between the testosterone enanthate and the other testosterone 
esters and testosterone is significant. Therefore, the hydrophobicity of the drug molecule 
is not the major factor in influencing uptake into PLA-PEG particles, although it may 
sti 11 have a small role. 
A different explanation is therefore needed to account for the much higher drug loading 
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Figure 5.5a - Structure of Testosterone Propionate 
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Figure 5.5b - Structure of Testosterone Isocaproate 
Figure 5.5c -Structure of Testosterone Enanthate 
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Table 5.5 
Drug Incorporation Studies of Testosterone E-sters into Fractionated 4:2 PLA-PEG 
Particles 
Drug Incorporated LogP % w/w Drug Incorporation Efficiency 
(%) 
Testosterone 3.35 0.93 ± 0.09 23.7 ± 2.7 
Testosterone Propionate 4.88 0.55 ±0.06 13.9 ± 1.6 
Testosterone 6.34 0.57± 0.04 14.3 ± 0.9 
Isocaproate 
7.0 2.52 ± 0.11 62.9 ± 2.8 
Testosterone Enanthate 
7.2 68.9 ± 0.1 86.1±0.1 
Sudan Black B 
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achieved with SBB compared with testosterone and its esters. Examination of the 
chemical structures of the drugs (Figures 5.1 and 5.5) provides a probable explanation 
ofthis result. These show that SBB is more aromatic than testosterone and its esters. It 
has been shown that aromatic compounds are solubilised in greater quantities and 
selectively over more aliphatic compounds (Nagarajan et aI, 1986), and whereas SBB 
contains five aromatic rings, testosterone only contains unsaturated bonds. The 
difference in the magnitude of drug loading between the aromatic benzene and aliphatic 
hexane for poly( ethylene oxide-propylene oxide) micelles (Nagarajan et ai, 1986), is 
similar to that seen between testosterone and SBB into the PLA-PEG systems. They 
explained this greatly increased drug loading with the aromatic compounds as due to the 
lower interfacial tension against water of aromatic molecules compared with aliphatic 
molecules. This leads to a lower free energy of formation per unit area of the micellar 
core-water interface. Therefore, a larger micelle· or particle can be formed, containing 
more aromatic molecules compared with aliphatic molecules of similar size, for a given 
free energy of formation and a given number of copolymer molecules. It is also possible 
that the aromatic planar structure of the SBB allows the SBB molecules to stack flat on 
each other, increasing the number of molecules that can be incorporated. 
Even between aromatic molecules, there is selectivity of how much drug compound is 
incorporated into micelles or particles. Kumar and Singh (1992) showed that sudan IV 
was solubilised into Triton X-lOO micelles preferentially to anthracene. Sudan IV is a 
hydrophobic dye, similar in structure to sudan black B, but with one less aromatic ring, 
an OH group and no secondary amine groups. Anthracene consists of three fused 
aromatic rings. They explained this selectivity by concluding that the drugs were 
solubilised into different areas of the micellar core. Sudan IV was thought to incorporate 
in the outer region of the core due to hydration of its hydroxyl group, whereas the more 
hydrophobic anthracene would be confined to the centre of the core. Sudan black B 
could also be incorporated in the outermost region of the core due to hydration by 
possible hydrogen bonding of the nitrogen atoms of its amine groups with the water 
present in the PEG shell. However, compared with the effect of the aromatic ring, this 
is unlikely to contribute significantly to the increased drug loading of SBS over 
testosterone, as testosterone and its esters also have hydrophilic groups (carboxyl and 
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hydroxyl groups), which could hydrogen bond to water. 
5.5 COMPARISON OF DRUG LOADING BETWEEN PLA-PEG AND SIMILAR 
SYSTEMS 
Micelles and particles have been widely researched in recent years as possible drug 
delivery systems. The PLA-PEG micelles and particles compare favourably with drug 
loading into micellar systems reported in the literature. Several groups have exploited 
the ability of micelles to solubilise hydrophobic substances, which would otherwise be 
insoluble in aqueous media. Saito et al (1994) showed that the solubility of estriol was 
increased when Pluronic L-64 was added to the system. Another drug substance, 
diazepam, has also been solubilised into Pluronic L-64, with a drug loading of 2.28% 
w/w at 40 QC. Kabanov et al (1989) achieved a drug loading of 7% w/w with haloperidol 
into Pluronic P85 miceUes, and subsequently showed an increase in the neuroleptic 
activity of this drug when injected intraperitoneally into mice. Similarly, incorporation 
of salicylic acid into poly( oxyethylene/oxybutylene/oxyethylene) (E40BlSE40) gel gave a 
drug loading of3.6% w/w (Luo et ai, 1993). These last three drugs have some aromatic 
character, which may facilitate their uptake into these micellar systems. Another example 
of drug loading into miceUes is of adriamycin, an anti-cancer drug, into poly( ethylene 
oxide-co-J3-benzyl L-aspartate) (pEO-PBLA) miceUes, where a drug loading of 10010 w/w 
of adriamycin was achieved (Kwon et ai, 1995). The PLA-PEG systems thus show 
comparable drug loading to that achieved with these systems, and much higher drug 
loading with SBB. 
A direct comparison can be made with work performed by Malcolmson and Lawrence 
(1993), where the incorporation of testosterone and its esters was studied for micelles 
and microemulsions prepared from the surfactant Brij 96 (polyoxyethylene-l0-0Ieyl 
ether). In this work, Brij 96 micelles were studied at concentrations of 10, 15 and 20% 
w/w, with these concentrations also used to prepare microemulsions. The PLA-PEG 
copolymers compare well with the results of this paper, with the drug loading for 
testosterone being slightly higher than that seen with the Brij micelles for all PLA-PEG 
systems. Drug loading for testosterone into the 4:2 and 6:2 PLA-PEG particles is also 
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higher than for the microemulsions. The drug loadings of the esters are similar between 
the Brij micelles, microemulsions and 4:2 PLA-PEG particles for testosterone propionate 
and slightly better for the Brij micelles and microemulsions for testosterone enanthate. 
However, an increased drug loading with the 4:2 PLA-PEG particles might be expected 
if the experiment were performed at the higher concentrations used for the Brij surfactant 
studies. 
Table 5.6 shows an overview of drugs that have previously been loaded into PLA and 
PLGA particles. Wide ranges of drug compounds have been incorporated by different 
authors, with widely varying drug loadings. There is no obvious trend in the results, with 
aromatic compounds not being loaded significantly more than aliphatic compounds. An 
example of this is the work by Gref et al (1994), where the aromatic lidocaine gave 
similar drug loading to the steroid prednisolone, in studies in PLGA-PEG particles. 
However, comparing all these compounds directly with the PLA-PEG systems is difficult, 
due to their widely differing size distributions and the different methods of preparation 
of the drug loaded particles. 
5.6 IN-VITRO RELEASE OF SUDAN BLACK B FROM 4:2 PLA-PEG PARTICLES 
5.6.1 Introduction 
In this chapter, it has been shown that drug loading ofPLA-PEG systems is possible and 
relatively high loading can be achieved. It is now important to detennine whether this 
drug can be released from the PLA-PEG system, and the duration of this release. The 
in-vitro release study described below is similar to that usually employed to elucidate the 
release of drug from particles and micelles, and will provide a basis for future work in this 
area. 
5.6.2 Method of In-Vitro Release 
The hydrophobic interaction gel, propyl agarose (Sigma Chemical Company, St. Louis, 
USA), was packed into a PDIO column, using phosphate buffered saline (PBS) (pH 7.4 
at 25°C, 0.01 M phosphate buffer) as the eluent. A dispersion of 4:2 PLA-PEG particles 
in PBS (0.25% w/v, 1 ml) was passed down the column, and the fractions collected and 
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Table 5.6 
Review of Drug Loading into PLA and PLGA Particles 
Drug Polymer LogP a 
Savoxepine DL-PLA 6.55 (C) 
Triamcinolone DL-PLA 1.53 (M). 2.70 (C) 
acetonide 
Triamcinolone DL-PLA 2.53 (M). 2.70 (C) 
acetonide 
Rifampicin DL-PLA 2J9(C) 
Bupivacaine DL-PLA 3.38(C) 
Beclomethasone DL-PLA 4.2 (C) 
dipropionate 
5-Fluorouracil DL-PLA -0.89 (M) 
-- ----
I 
Aromaticb Drug Loading Approximate Reference 
(% w/w) Size (nm) 
./ 0.2 - 16.5 230 - 680 Allemann er al. 1993 
x 7.8 500 Krause et al. 19R.5 
x 2.9 710 Krause et al. 1985 
.,; 5.7 1310 D c n k b a ~ ~ et al. 1994 
v' 20.7-23.1 1000 - 5000 Le Corre et al. 1994 
x 24.3 2600 - 4200 Wichert and Rohdewald. 1993 
x 9.4 4300 <;ift9i et al. 1994 
~ ~
~ ~
Drug 
Piroxicam 
Diazepam 
Diazepam 
H\drocorti sonc 
Prouesterone 
Quinidine 
Cis-Platin 
Lomustine 
Progesterone 
Phenobarbitone 
Indomethacin/Benzyl 
benzoate 
Polymer 
DL-PLA 
DL-PLA 
DL-PLA 
DL-PLA 
DL-PLA 
DL-PLA 
DL-PLA 
DL-PLA 
DL-PLA 
L-PLA 
DL-PLNF68/ 
phospholipid _ 
Log P a Aromaticb 
0.26 (M) ,./ 
2.80 (M), 3.18 (C) ,./ 
2.80 (M). 3.18 (C) ,./ 
1.61 av1). 1.86 (C) x 
3.87 (M). 3.85 (C) x 
3 . 4 · ~ ~ (M). ~ . 2 0 0 (C) ,./ 
* x 
2.83 CM12.76(C) x 
3.87 (M). 3.85 (C) x 
1.47 (M), 1.36 (C) x 
4.27 (M), 4.23 (C) ,./ 
_ (Indorl!ethacin) 
Drug Loading Approximate Reference 
(%w/w) Size (nm) I 
9.9 5000 Wagenaar and Muller. 1994 
6.8/29.8 648017760 Pavanetto et al. 1994 
21.1 8000 - 70000 Bodmeier and McGinity. 1987 
12.4 8000 - 70000 Bodmeier and \ 1cGinit\. 198"' 
20.8 8000 - 70000 Bodmeier and ~ I c G i n i t \ . . 1987 
5.1 8000 - 70000 H o J r n e i ~ r r and \lcCiinit\. 1 ()R7 
31. 7 20000 - 50000 Spenlehauer el of. 1986 
19.9 58200 Benito el al. 1984 
31.7 160000 Benito et al. 1984 
9.35 20490 Jail and Nixon. 1989 
5.0 229 Fessi et al. 1989 
- - -- --- - -
Drug Polymer Logpa Aromaticb Drug Loading Approximate Reference 
I (% w/w) Size_(nml 
Taxol DL-PLNF681 2.32 (C) ./ 
I 
2.4 260 Fessi et ai, 1989 
phospholipid ! 
Vitamin K DL-PLAIF68/ * ./ 75 270 Fessi et al. 1989 
phospholipid 
Dexamethasone DL-PLA'F68/ 1.83 (M). 2.2 (C) x 0.96 300 Fessi et ,d. 19RC) 
phospholipid 
Iv g Taxol 50:50DL- 2.32 (C) ./ 0.6 10000-30000 13urt £'1 (//. 1995 
PLA:EVA 
C'c\osporin A PLGA * X 5.98 298 Sanchcz ut 0/. 1 9 9 . ~ ~
Roxithromycin PLGA * X 4.4 354 Ju1iennc cl at. 19R9 
Indomethacin PLGA 4.27 (M). 4.23 (C) ./ 7.24 2400 Conti cl aI, 1995 
Timolol maleate PLGA 1.91 (M), 1.63 (C) x 2.2 9000 Sturesson et al. 1993 
Nifedipine P L G A _ ~ ~ __ ~ 2 . 4 0 0 (C) ./ 18.8 9700 Sansdrap and Moes, 1993 
- - -
10 
-
Drug Polymer Log P a Aromaticb Drug Loading Approximate 
(% w/w) Size (nm) 
Lidocaine PLGA-PEG 2.26 (M), 1.98 (C) ./ up to 45 90 - 150 
- ~ ~
Key 10 Table 5, (j 
'" - ;\ot calculable due to a missing fragment or uncommon structural feature. 
:1 _ \.og P \ a l u ~ s s for l)ctanol \\ ater l a k ~ n n from Craig ( 1990). except for'" which \\'as from Juarranz el a/ (1986), 
(1\.1) - 1\,1casurcd c\pt'rimcntally: (C) - C a l c l 1 l a t ~ d d yaluc, 
" - Aromatic defined. in this context. as possessing at least one aromatic ring. 
Reference 
Gref el al. 1993 
analysed by UV spectroscopy to detemline the elution volume of the PLA-PEG particles. 
A solution of SBB in acetone (1 ml, 10mg/ml) was added to 4:2 PLA-PEG particles 
(0.25% w/v) as before, and the excess drug centrifuged oiT as described above in section 
5.3.1. The supematant was collected and the absorbance of the dispersion determined 
at 587 nm after appropriate dilution with PBS. PLA-PEG particles loaded with SBB 
were then passed down the PO I 0 column as a control experiment, and the UV 
absorbance of the dispersion at 587 nm remeasured. The change in absorbance between 
the two samples was negligible, showing that all the SBB was incorporated stably in the 
particles. 
The 4:2 PLA-PEG particles with SBB were then incubated for 3 hours, 1 day, 3 days, 
7 days, 14 days and 28 days in a water bath at 37 QC under conditions, with stirring 
throughout using a magnetic stirrer. A comparative sample of the unincubated particles 
was measured by UV to provide the absorbance of the SBB in the particles before 
release, Al. After incubation for the required time, the samples were removed and 1 ml 
passed down the propyl agarose packed PD 1 0 column. The particle fractions were 
collected from the column, pooled and assayed by UV spectroscopy at 587 nrn to give 
the absorbance of SBB remaining in the particles, A2• This allowed the percentage of 
SBB remaining in the PLA-PEG particles to be calculated by the following equation: -
AI- A2 % of SBB released = x 100 
AI 
The propyl agarose column was regenerated between samples by washing sequentially 
with 0.5 M sodium hydroxide solution, 0.1 M sodium acetate solution (PH 4.5), purified 
water, 2 M sodium chloride solution and purified water. 
5.6.3 Results and Discussion of In-Vitro Release Study 
Figure 5.6 shows the results of the in-vitro release ofSBB from 4:2 PLA-PEG particles 
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in PBS at 37°C. This shows a small "burst" effect, with about 14 % of SBB being 
released in the first three hours of the study. The release from three hours onwards is 
linear, corresponding to zero order kinetics, with a low release rate of about 0.1 % 
perhour, which offers the possibility of PLA-PEG systems being used for sustained 
release. This type of release has been seen previously with PLA particles (Aso et ai, 
1993; Gupta et ai, 1993; Allemann et ai, 1994; Conti et ai, 1994; Le Corre et ai, 1 994), 
with the durations of the two phases varying with different drugs, particle Slze, 
preparation method and the release media used. 
The small burst release observed may be due to drug at the surface of the particles. If 
the mechanism of this initial release was diffusion from the core of the particles, the in-
vitro release profile should usually show a lag time before release commences (Bodmeier 
and McGinity, 1987). This lag time would allow the buffer media to penetrate into the 
particles. Although no such effect is evident from the in-vitro profile of the PLA-PEG 
particles, it cannot be totally discounted as there is no time point before three hours. 
However, considering that the PLA-PEG particles are already hydrated due to their PEG 
chains, it is unlikely that a significant lag period would occur. In Bodmeier and 
McGinity's . data (1987), the lag periods for the release of quinidine from PLA 
micro spheres are of the order of25 to 50 hours, which do not occur with the PLA-PEG 
particles. They considered that after the penetration of the buffer during the lag period, 
the burst release was then due to a rapid leaching of drug through the pores and channels 
formed by the buffer. For the PLA-PEG particles, it is more likely that the burst release 
is due to drug adsorbed at the surface of the particles, which has been concluded by other 
authors (Krause et ai, 1985; Allemann et ai, 1994; Pavanetto et ai, 1994). Some SBB 
may be associated with the PEG chains due to the presence of its amine groups, and with 
the outer region of the PLA core. This SBB would therefore be able to diffuse out more 
rapidly than the SBB within the PLA core. 
In the linear phase, the drug release may be due to degradation of the particles, drug 
diffusion through the copolymer or both. The linear relationship followed zero-order 
kinetics, and gave a much closer linear fit than the alternative release trend displayed by 
some PLA systems of release directly proportional to the square root of time 
(Spenlehauer et ai, 1986; < ; i f t ~ i i et ai, 1994; Wagenaar and Miiller, 1994). 
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Figure 5.6 - In Vitro Release Profile of Sudan Black B from 4:2 PLA-PEG Particles 
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The degradation ofPLA-PEG copolymers has been studied by several authors (Cohn and 
Younes, 1989; Hu and Liu, 1993; Kissel et aI, 1994; Shah et aI, 1994). Studies have 
concentrated on the copolymers in a filmlimplant state rather than as particles or micelles, 
and most studies have also been performed on LPLA copolymers as opposed to DL-
PLA. However, some indications of how PLA-PEG particles would degrade may be 
deduced from these authors. Generally, the higher the hydrophilic PEG content, the 
greater the hydrolysis of the copolymer (Hu and Liu, 1993). Youxin et at (1994) also 
observed this, but found that for triblock LPLA-PEO-LPLA copolymers the effect of the 
PEO on the degradation rate was much greater during the initial degradation of the fIrst 
week than the subsequent tenninal degradation rate. These authors postulated that the 
degradation of the copolymers was due to preferential scission in the vicinity of the 
LPLAlPEO interface, leading to rapid weight loss over the fIrst twenty-four hours. This 
led to release ofPEO segments and an increase in the LPLA content of the copolymer. 
The degradation of the LPLA in the copolymer after this was slower, but still faster than 
the homopolymer. Conversely, Cohn and Younes (1989) concluded that although 
degradation occurred by chain scission, it was random along the PLA component of the 
PLA-PEG backbone, with the PLAlPEO interface "playing no special role". This is 
despite the end lactide unit being the most hydrophilic position in the PLA chain. They 
did however agree that hydrolysis was the mechanism and that the copolymer became 
more lactide rich as degradation progressed. Thus, it is reasonable to suppose that the 
primary mechanism ofPLA-PEG particle degradation will be hydrolysis. The ability of 
the PEG layer to hydrate and associate with water has already been discussed in chapters 
one and three. This water uptake could facilitate hydrolysis, both of the PEG layer and 
by allowing proximity to the PLA groups in the core. Concluding that the PEG chains 
will be lost from the PLA-PEG particles before the PLA core has fully degraded also 
seems reasonable, but the stability of the particle after such an event is not known. This 
experiment was perfonned over the course of twenty-eight days. Only 11 % of SBB 
remains associated with the PLA-PEG at the end of this time. The condition of the 
particles at this time is not yet known, but it is reasonable to suppose that some 
degradation will have occurred. 
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In a study of the release of SBB from PLA implants (PBS containing Tween 80 (0.6% 
w/v), pH 7.4, 37°C), the SBB release was very slow over the six-day period studied 
(Katayama et ai, 1995). To increase the release rate, a polyoxyethylated castor oil 
derivative (HCO-60) was formulated into the implant, which increased the release rate 
to 13.5 % released after six days. If the burst release of the SBB from the PLA-PEG 
particles is neglected and the linear release considered, this release rate of SBB is in good 
agreement. The increased release rate ofPLA when a hydrophilic component is added 
has also been observed with LPLA-PEO-LPLA copolymers. Here, the presence ofPEO 
increases water solubility and therefore permeability, leading to an increase in drug 
release (Youxin et ai, 1994). With this copolymer, pulsatile release was achieved with 
bovine serum albumin (BSA), with the BSA release rate varying from zero order release 
to a lag period where no drug release occurred. The authors concluded that this was due 
to the destruction of the mechanical properties of the micro spheres due to loss ofPEO 
and chain scission in the amorphous region of the PLA phase; that is that the release was 
degradation controlled. 
Several other factors play a role in influencing the rate of release of drug from a 
copolymer system. The glass transition temperature (T 8)' which is dependent on the 
polymer molecular weight, affects release such that the lower the glass transition 
temperature, the faster the release of drug (Aso et ai, 1993; Le Corre et ai, 1994). A 
value ofTg for PLA has been found to be 55°C (Bodmeier and McGinity, 1987), but will 
decrease with the incorporation of hydrophilic polymers. The temperature at which the 
release study is performed will therefore affect the drug release. For a polymer with a 
glass transition temperature of 55°C, at temperatures below this, the polymeric matrix 
will be glassy, whereas at temperatures above Tg, it will be rubbery ( D e n k b ~ ~ et ai, 
1994). A polymer in the rubbery phase degrades much faster, and diffusion of molecules 
in rubbery polymers is also faster. The glass transition temperature is thus an important 
factor to consider in release studies. 
The drug loading of the particles also influences the rate of release, with higher drug 
loading leading to faster release (Spenlehauer et ai, 1986; Bodmeier and McGinity, 1987; 
Pavanetto et ai, 1994; Uchida et ai, 1996). It has been shown that for PLA 
microspheres, the drug release was inversely proportional to the drug loading level, and 
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the total percentage of drug released increased with greater drug loading (Bodmeier and 
McGinity. 1987). The drug loading orthe 4:2 PLA-PEG particles in this experiment is 
high (- 37% w/w for the 10 mg of SBB loaded). Therefore. the release rate of SBB 
would be expected to decrease with decreased drug loading. 
The pi I of the media and its effect on the drug may also affect the drug release, 
especially with lower molecular weight PLA ( ~ i f t < ; i i el al. 1994). Low molecular weight 
PLA contains high numbers of -COOH and -OH polar end groups, which can lead to 
swelling during the dissolution of the drug. Any ionisation of the secondary amine 
groups ofSBB andlor ionisation of the carboxyl groups ofPLA may also play a role in 
the release (Le Corre et al. 1994). The pH of the media also has a significant effect on 
degradation, and if the release is degradation-controlled, then the pH will noticeably 
affect release. This was illustrated by D e n k b ~ ~ et al (1994), who showed that D,L-
polylactide microspheres degraded faster in alkaline media (pH 9.8) than at neutral pH 
(pH 7.4), with a corresponding increase in the rate of rifampicin release. 
However, it must be noted that SBB is very insoluble in aqueous media and it is possible 
that there is another explanation for the apparent decrease in SBB content of the PLA-
PEG particles, as it is difficult for the SBB to diffuse out under such conditions. 
Generally, the model drug should have some solubility in the dissolution medium in in 
vitro testing, but addition of solvents or lipophilic substances to the media to increase 
SBB solubility may also affect the results of the study and this was therefore not 
attempted. 
5.7 SUMMARY 
Drug loading into both PLA-PEG micelles and particles has been successfully achieved. 
The amount incorporated has been determined, and it was shown that the drug loading 
of the aromatic hydrophobic dye, sudan black B (SBB), was much greater than that of 
the steroidal testosterone and its esters. There was a general trend of increasing drug 
loading with increased molecular weight of PLA-PEG copolymer, but this was less 
pronounced with SBB. A study of the drug loading of testosterone esters of varying 
hydrophobicity (as measured by Log P octanol/water values) showed no clear 
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relationship between drug loading and hydrophobicity. It was concluded that the greatly 
increased drug loading achieved with SBB over testosterone and its esters is most likely 
due to the aromatic structure of SBB. 
An in-vitro release study of the drug release ofSBB from 4:2 PLA-PEG particles was 
conducted. This showed that the SBB showed a small burst release over the first three 
hours, followed by a linear release profile that extended to the end of the experiment at 
twenty-eight days. The burst release was probably due to SBB incorporated in the PEG 
layer at the surface of the particles. The linear release may be diffusion or degradation 
controlled, and further studies are needed to elucidate the mechanism of drug release. 
Therefore, PLA-PEG micelles and particles have the ability to both load and release 
drugs, which gives them good potential for future drug delivery systems. The in-vitro 
release profile over one month indicates that they may be employed as sustained release 
systems. 
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CHAPTER SIX 
IN VITRO AND IN VIVO STUDIES OF PLA-PEG COPOLYMERS 
6.1 INTRODUCTION 
Previous chapters ofthis thesis have presented the physicochemical aspects ofPLA-PEG 
micelles and particles, and have shown the presence of PEG at the surface, which is 
expected to confer "steric stability" to the systems. This chapter will now examine 
whether this steric stability can prevent the uptake of the systems by the 
reticuloendothelial system of an animal model, namely the rat. So far, the PLA-PEG 
systems have shown promise, being of a small size and able to hold and release drug in 
a controlled manner. This ability to load drugs is now exploited in the radio labelling of 
the PLA-PEG systems to allow the distribution of the systems in an in vivo model to be 
assessed. This chapter therefore presents details of the radiolabeUing of PLA-PEG 
systems, the stability of this radiolabel in vitro in serum, and the biodistribution of the 
micelles and particles. 
6.2 RADIOLABELLING OF PLA-PEG COPOLYMERS 
6.2. J Radiolabelling of Colloidal Systems 
Introducing a radionuclide into the system ~ ~ assess the fate of parenterally administered 
particulate systems. The presence of a radionuclide readily allows the monitoring of 
particle uptake by various organs and the rate of elimination from the body. This can be 
achieved either by gamma-scintigraphy or scintillation counting after sacrifice and 
dissection of animals, depending on the nature of the radionuclide emissions. 
A limited number of radionuclides are suitable for radiolabelling in drug delivery studies. 
The factors that affect the choice of radio label include the cost, ease of sample 
preparation and detection, handling risks, the availability of a suitable preparation, and 
the half-life of the radionuclide. This must be long enough to remain at detectable levels 
over the course of the experiment. Either beta or gamma-emitting radiation can be used, 
with gamma radiation preferred due to easier sample preparation for counting. Beta 
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radiation has been successfully employed to study drug release of carbon-14 labelled-
savoxepine from PLA nanoparticles (Allemann et aI, 1994), which also allows the 
biodistribution of the nanoparticles to be followed to some extent. Carbon-14 has also 
been used for labelling poly(alkyl 2-cyanoacrylate) nanoparticles, but problems were 
encountered in this process with the label, including a tendency for the 14C-labelled 
monomer to undergo spontaneous polymerisation when isolated during the initial 
preparation stage, causing a wide particle size distribution (Douglas et aI, 1987). A 
stable gamma-emitting technetium ~ T c ) - d e x t r a n n complex was therefore developed and 
covalently bound to the nanoparticles during polymerisation. PLA nanoparticles have 
also been radiolabelled with technetium for in vivo studies in rats (Krause et aI, 1985) 
and mice ( < ; i f t ~ i i et ai, 1994). Technetium-99 has a half-life of 6.02 hours, and is widely 
used for medical diagnosis. 
Another radionuclide that has been employed in -medicine is indium-III. This isotope 
has been complexed with both oxine (8-hydroxyquinoline) and DTPA-SA (the 
distearylamide of diethylenetriaminepentaacetic acid). The radiolabelling method is 
different here, with radiolabelling achieved by incorporation of an indium-lII complex, 
rather than by covalently attaching the radiolabel as described above for carbon-I3 and 
technetium-99. Indium-llI-oxine (or indium-lll 8-hydroxyquinoline) is a neutral 
lipophilic complex consisting of three molecules of oxine chelated with one ion of indium 
as shown in Figure 6.1. This oxine complex has been used in medical physics, usually for 
radiolabelling leukocytes and platelets (Thakur and McKenney, 1985). In drug delivery, 
our group at Nottingham has used indium-IIl-oxine routinely as a radiolabel. Several 
different systems have been radiolabelled, including PLA particles (Muller et ai, 1988) 
and PLGA particles (Scholes et aI, 1992; Scholes, 1993). The other complex, In-lll-
DTPA-SA, has also been used in drug delivery, for radiolabelling liposomes (Klibanov 
et ai, 1991; Torchilin et ai, 1994), and nanoparticles (Gref et ai, 1994). The half-life of 
In-Ill of2.8 days is suitable for in vivo experiments. 
lodine-I3 I has been successfully employed for the radiolabelling of polystyrene 
nanoparticles by an irradiation method where the iodine is covalently attached to the 
particle surface (Huh et ai, 1974). However, due to its high energy radiation, high 
handling risks are associated with this isotope (Muller et ai, 1988). Difficulties have also 
been experienced in radiolabelling PLA particles with iodine-I3I using this method, with 
labelling efficiency being low and particle aggregation occurring. 
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Figure 6.1 - Structure ofIndium (111) Oxine Radiolabel 
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Conversely, incorporating In-I I I-oxine into the PLA palticles gave a high labelling 
efficiency, which did not affect the particle size and size distribution (Muller et ai, 1988). 
This indicates that In-Ill-oxine complex is a suitable candidate for the radiolabelling of 
PLA-PEG systems. The radioactive indium (Ill) oxine acts as a hydrophobic drug 
model and thus can be readily incorporated into micellar and particulate forms of the 
PLA-PEG copolymer dispersions. Therefore, this was the radionuclide preparation 
chosen for the in vivo studies of these systems. 
6.3 STABILITY OF RADIOLABEL IN PLA-PEG COPOLYMERS 
6.3.1 Methodfor In-Vitro Study of Indium -111-0xine and PLA-PEG Copolymers 
Before perfonning the in vivo studies, the stability of the indium-lll-oxine label in PLA-
PEG micelles and particles was ascertained. This was carried Ollt as follows, by testing 
how much indium-l11-oxine was released by the PLA-PEG particles during in vitro 
incubation at 37°C in 50% v/v rat serum to simulate in vivo conditions. 
Indium-ll1-oxine solution (50 Jlg/ml) was obtained from Amersham International 
(Bucks., UK) with radioactivity of 37 MBq ml-1 at the activity reference date. 
Dispersions of 4: 2 and 6:2 PLA-PEG particles (1 % w/v) were prepared as described in 
section 2.3.4 and the indium-Ill-oxine complex was added with the acetone. Sepharose 
CL-4B was packed into PDIO columns (10 cm) using phosphate buffered saline (PBS) 
(PH 7.4 at 25°C, 0.01 M phosphate buffer) (Sigma Chemical Company, St. Louis, USA) 
as eluent. 
Two initial control experiments were performed, firstly a dispersion of PLA-PEG 
particles (4:2 and 6:2 PLA-PEG, 1 ml, 1% w/v) was applied to a PDlO column, foUowed 
by 0.5 rnl aliquots ofPBS. The eluted aliquots were collected in quartz UV cells and 
analysed at 225 nm by UV spectroscopy (Uvikon, Kontron Instruments, Tegimenta, 
Switzerland) to determine the elution volume of the PLA-PEG particles. Secondly, 50% 
v/v serum in PBS (1 ml) was applied to a similar column, and the collected fractions 
analysed at 280 nm, to detennine where the serum proteins eluted. 
Radiolabelled 4:2 and 6:2 PLA-PEG particles (1 rnI) were then applied to PDlO columns, 
with PBS as the eluent, to separate the radiolabelled particles from any free 
unincorporated label. The eluted aliquots were collected and the radioactivity assayed 
using an LKB compugamma gamma counter (Compugamma, LKB, Wallac, Finland). 
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From the control experiment, the fractions corresponding to the 4:2 and 6:2 PLA-PEG 
particles were determined. These also corresponded to the most radioactive fractions 
indicating good incorporation. From these data, the incorporation efficiency of the 
indium (11 1) oxine complex into the PLA-PEG particles was calculated. The three most 
radioactive fractions were pooled and used for the serum stability experiments by adding 
rat serum to give a serum concentration of50% v/v. Samples of the 4:2 and 6:2 PLA-
PEG particles in 50% v/v serum were then incubated in a water bath for 5 minutes, three 
hours and 24 hours. 
After the appropriate time had elapsed, the samples were removed and applied to a PDI0 
column (0.5 ml) with PBS as eluent. The radioactivity was again analysed using a 
gamma-spectrometer. The stability of the label was then calculated, by expressing the 
radioactivity left associated with the particles after incubation as a percentage of the 
particle initial activity. 
Further controls were also perfonned. The PLA-PEG particles were incubated with PBS 
alone (no serum present) to investigate the effect of the incubation conditions on the 
PLA-PEG particles in the absence of serum. Free III In complex was also incubated with 
serum, to determine where indium-l1 l-oxine released from the PLA-PEG particles 
would bind (i.e. to which serum proteins). In both of these experiments, the incubation 
lasted for three hours. 
6.3.2 Results and Discussion 
Figure 6.2 shows the plot of the control experiments of particles alone (6:2 PLA-PEG) 
and serum alone. This shows that the PLA-PEG particles are eluted first in the void 
volume of the column, as would be expected from the GPC work described in chapter 
three. The serum profile consists of two peaks: one of which has a high molecular 
weight and is eluted in the void volume (with the particles), and the other which elutes 
later and is of smaller molecular weight. While most of the serum components elute 
separately from the PLA-PEG particles, a small proportion overlap and are apparently 
eluted with the particles. The control experiment of indium and serum will give more 
insight into the significance of this and is discussed below. 
Figure 6.3 shows a typical plot for the radio labelled PLA-PEG particles (6:2 PLA-PEG). 
The efficiency of radio label incorporation into the particles was good, at 78.1% ± 2.2% 
for 4:2 PLA-PEG and 89.6% ± 2.6% for 6:2 PLA-PEG. High efficiencies of uptake 
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could be expected due to the hydrophobic oxine. 
Table 6.1 shows that the stability of the indium-lll-oxine label in the PLA-PEG particles 
decreases logarithmically with the length of time incubated in serum. Even at the first 
time point of five minutes significant label has been lost to the serum components, 
indicating that a rapid interaction occurs between the indium label and the serum 
components, illustrated by the presence of a second radioactivity peak after GPC (Figure 
6.4). There is a corresponding loss of the label from the particles. It is interesting to 
note that a significant amount of radiolabel is also lost in the PBS control experiments 
where no serum is present. 
Figure 6.4 shows a typical plot of the radioactivity eluted from 6:2 PLA-PEG particles 
after incubation in 50% v/v serum for all three time points. Two peaks can clearly be 
seen for each time point, with the first peak corresponding to the labelled PLA-PEG 
particles and the second peak corresponding to label- co-eluting with the serum 
components. The first peak decreases with time, and a corresponding increase is seen 
in the second peak. 
The total recovery of radiolabel from the experiments (i.e_ activity both remaining in 
particles and released) was high when serum was present, but fell to 775)% for 4:2 PLA-
PEG particles in PBS and 81.3% for 6:2 PLA-PEG particles in PBS. Although these 
recoveries are still reasonable, it is clear from the particle associated activities of55.4% 
for 4:2 PLA-PEG and 60.9% for 6:2 PLA-PEG that a significant amount of lllIn has 
been released from the particles and not recovered. Scholes (1994) showed that when 
free indium (Ill) oxine was applied to a sepharose-4B GPC column, it was nearly 
completely retained by the column matrix, with virtually no elution of label. This was 
attributed to probable hydrophobic interactions between the oxine complex and the gel. 
It therefore seems likely that this is the reason for the lower recoveries seen with the 
PBS samples. In the serum experiments, higher recoveries are seen as any indium-lll-
oxine released binds preferentially to serum components (J6nsson and Strand, 1992) 
rather than the column matrix. This can be seen from the control experiment of in diu m-
111-oxine incubated with 50% v/v serum (Figure 6.5). In this experiment, the indium-
111-oxine binds readily to the lower molecular weight serum components, with only a 
small proportion (3.8%) binding to the higher molecular weight serum components. The 
recovery in this experiment is thus high at 99.3%, with little residual activity left on the 
GPC column and 93.4% (± 2.6%) associated with the second serum peak. This 
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Figure 6.4 - Serum Stability Data for 6:2 PLA-PEG Particles Incubated in 50% v/v Serum 
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Figure 6.5 - Activity of Indium (111) Oxine After Incubating for Three Hours in 50% v/v Serum 
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experiment also indicates that it is unlikely that the high molecular weight fraction of the 
serum, which elutes with the particle peak, will make a significant difference to the results 
of this experiment. 
Previous work has been performed by the Nottingham research group on the 1.5:2 and 
2:5 PLA-PEG micelles to evaluate their serum stability in 50% v/v serumIPBS, with 
incubation periods of 5 minutes and one hour. The labelling efficiencies of these 
copolymers were 80.2% for 1.5:2 PLA-PEG and 31.3% for 2:5 PLA-PEG. While the 
value for 1.5:2 PLA-PEG is comparable with the 4:2 and 6:2 PLA-PEG labelling 
efficiencies, the value for 2:5 PLA-PEG is much lower. This is probably due to a number 
of factors, namely the increased PEG chain length and decreased hydrophobic content 
of the 2:5 PLA-PEG micelles. Also, the material used had not been cleaned by GPC to 
remove the truncated PLA-PEG fraction (which would not incorporate the label). Also, 
the radiolabel was not added in acetone with the micelles, but added to the preformed 
micelles and left to incubate. This was different from the method used for the 
incorporation of the model drugs as discussed in section 5.3.1., and probably also 
contributed to the decreased efficiency. 
The stability of the lllIn radio label in the PLA-PEG micelles (1.5:2 and 2:5) in 50% v/v 
serum was assessed after incubation for five minutes and one hour. After five minutes, 
77.0% of the radiolabel remained with the 1.5:2 PLA-PEG micelles and 65.6% with the 
2:5 PLA-PEG micelles. At the one hour time point, this had fallen slightly for l.5:2 
PLA-PEG to 75.5% and 53.6% for 2:5 PLA-PEG. Although comparing the one hour 
and three hour time points between the experiments are difficult, the five minute time 
points can be directly compared. At this time point, the micelles retain the label better 
than the particles, although some radiolabel is still lost. It has been suggested (Scholes, 
1994) that differences in the release of radiolabel from colloidal systems are affected by 
protein adsorption from the serum onto the particle surface. PEG is well known to 
reduce protein adsorption, with the length of the PEG chain influencing the quantity and 
quality of the proteins adsorbed, and longer chains generally leading to lower protein 
uptake (Annstrong et aI, 1997). In section 4.2.5, the thicknesses of the PEG chains were 
determined and the 1.5:2 PLA-PEG and 2:5 PLA-PEG micelles shown to have PEG 
layer thicknesses of 4.1 run and 7.5 run respectively. These values were greater than the 
values observed for the 4:2 and 6:2 PLA-PEG particles, which were similar at 2.3 run and 
2.4 run respectively. Scholes (1994) hypothesised that as loss of label to the serum 
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occurred after protein adsorption to the surface of microspheres, then if protein 
adsorption was reduced, the loss of label would also be reduced It is possible therefore 
that the increased retention of the label by the micelles over the PLA-PEG particles is due 
to decreased protein adsorption on account of their increased PEG chain layer 
thicknesses. However, this cannot be the only factor as 1.5:2 PLA-PEG micelles perform 
better than 2:5 PLA-PEG micelles. From the results, it seems likely that the 
hydrophobicity and therefore ability of the micelle/particle to retain drug generally is also 
a factor. The most hydrophobic 6:2 PLA-PEG particles perform significantly better than 
the 4:2 PLA-PEG particles, and the more hydrophobic l.5:2 PLA-PEG performs better 
than 2:5 PLA-PEG. The serum stability of the radiolabel may therefore be partly 
determined by the ability of the micelles/particles to hold onto the indium-ll1-oxine 
through hydrophobic interactions and hydrogen bonding, and the more hydrophobic 
particles/micelles have a greater proportion of PLA available for such interactions. 
The results for the PLA-PEG particles are similar to those found with PLGA particles 
prepared by the solvent precipitation method, radio labelled with indium-lll-oxine and 
coated with Poloxarner 407 (Scholes, 1994). Here, the radiolabel was also released from 
the particles, with increasing time of incubation again giving an increase in label release. 
There was also a considerable release to the PBS in the control sample. This release was 
attributed to the solvent precipitation method used for preparation of the particles leading 
to rapid precipitation of the PLGA polymer causing highly porous nanoparticles. As the 
PLA-PEG particles are also produced by this method, it is reasonable that they would 
also be porous and that would allow the release of the III In, even when no serum is 
present. However, the effect of serum on the release of label from the PLA-PEG 
particles is still significant, with a further 29.8% released when serum is present for 4:2 
PLA-PEG particles, and 20.5% released for 6:2 PLA-PEG particles. 
6.3.3 Implications jar In vivo Experiments 
The leakage of the indium label from the PLA-PEG particles suggests that this radiolabel 
is not ideal, and although in vivo studies with indium-Ill-oxine will give some indication 
of the biodistribution of the particles, there is likely to be some error. Indium-lll-oxine 
is known to have a low stability in serum, due to the ready formation of a complex 
between Illindium and the plasma protein transferrin (Jonsson and Strand, 1992). This 
is because the stability constant of the indium-transferrin is greater than that 
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Table 6.1 
Stability ( ~ f flndium-l 1 l-Oxine Radiolabel ill 4:2 and 6:2 PLA-PEG Particles (mean ± 
s.d) 
Sample Incubation Incubation Radioactivity Retained Recovery (%) 
Media Time by Particles (%) 
4:2 PLA-PEG 50% v/v 5 minutes 40.6±3.1 93.0 ± 0.4 
Serum 
6:2 PLA-PEG 5 minutes 57.9 ± 6.5 90.6 ± 3.5 
50% v/v 
Serum 
4:2 PLA-PEG 50% v/v 3 hours 25.6 ± 0.5 98.4 ± 4.5 
Serum 
6:2PLA-PEG 3 hours 40.4 ± 0.0 95.2 ± 1.9 
50% v/v 
Serum 
4:2 PLA-PEG 50% v/v 24 hours 18.8 ± 0.2 96.2 ± 0.6 
Serum 
6:2PLA-PEG 24 hours 34.1 ±2.8 98.3 ± 4.3 
50% v/v 
Serum 
4:2PLA-PEG PBS 3 hours 55.4 ± 1.1 77.9 ± 1.8 
6:2 PLA-PEG PBS 3 hours 60.9±3.1 81.3 ± 3.5 
Free lllIn 50% v/v 3 hours 3.8 ± 0.4 99.3 ± 2.3 
Serum 
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of indium-oxine (log K's = 30 and 11 respectively) (Thakur and McKenney, 1985; 
Jbnsson and Strand, 1992). Free ionic indium has also been shown to bind quickly with 
transferrin when injected into the blood (Goodwin et aI, 1971; Jbnsson and Strand, 
1992). Therefore, it is important to consider these possible problems when interpreting 
the in vivo data for the PLA-PEG micelles and particles. 
6.4 BIODISTRIBUTION OF PLA-PEG MICELLES AND PARTICLES 
6.4. i introduction 
The in vivo fate ofPLA-PEG micelles and particles will be affected by all the properties 
discussed so far in this thesis and those outlined in chapter one. These include: -
1) the lengths of the hydrophobic PLA block and the hydrophilic PEG block, 
2) the size of the micelle/particle, 
3) the length of the PEG chain at the surface of the micelle/particle, 
4) the density of PEG at the surface, and 
5) the steric stability of the micelle/particle (as detennined by stability in the presence of 
salt). 
The presence of any incorporated drug in the core of the micelles/particles may also 
affect the biodistribution properties of these copolymers, ifit affects the properties of the 
systems. 
Due to the special skills required, the animal studies were performed with other members 
of the research group who were trained in t ~ e e methods and carried them out regularly. 
6.4.2 Preparation of Radiolabelled PLA -PEG Micelles and Particles for Biodistribution 
Studies 
Biodistribution studies on PLA-PEG micelles were perfonned in female wistar rats, with 
the 1.5:2 and 2:5 PLA-PEG copolymers. Two concentrations of the micelle-forming 
PLA-PEG copolymers were selected on the basis that on dilution in the blood, the lower 
concentration system would be expected to revert to a non-associated copolymer, while 
the higher concentration system would be expected to remain above the cmc for a 
significant period in vivo. [Assuming a blood volume of7.5% of body weight and a 150g 
rat, the lower concentration (0.2% w/v, 0.1 mJ) in blood would be at 0.0008% w/v, and 
the higher concentration (5.4% w/v, 0.5 ml) would be at 0.24% w/v in the blood initiaUy 
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(cmc=0.0035% w/v); Vd is not considered in this case since unknown]. For the lower 
PLA-PEG copolymer concentration (0.2% w/v), an aqueous dispersion (1% w/v) was 
prepared by adding 100mg of the PLA-PEG copolymer (1.5:2 and 2:5) to 10 ml of water 
containing a radiolabelled marker, hydrophobic indium-111-oxine complex (0.2 ml, 2.5 
MBq) and shaking until the polymer dissolved. For the higher PLA-PEG concentration 
(5.4% w/v), indium-111-oxine solution (0.005 ml - 0.021 ml) was added to 1% w/v 
dispersions of fractionated PLA-PEG and left for 30 minutes to equilibrate. For both 
concentrations, free indium was separated from incorporated indium using a sepharose 
CL-4B gel permeation column (10 cm) equilibrated with distilled water. At the lower 
concentration, the PLA-PEG dispersions were collected and diluted to the required 
concentration. At the higher concentration, the eluent was monitored and the most 
active fractions pooled for the in vivo experiment. RadiolabeUed dispersions were then 
mixed with concentrated fractionated PLA-PEG polymers to give a dispersion of 5.4% 
w/v. Different preparation methods were used for the two PLA-PEG concentrations 
studied, as at the higher concentration, experiments showed that the PLA-PEG 
dispersion would have undergone significant dilution on the PD 10 column, and resolution 
of the GPC technique was also low. Therefore, an unreasonable amount ofPLA-PEG 
material would have been required to prepare the PLA-PEG dispersion this way, and 
some free indium-l11-oxine may not have been separated from the PLA-PEG micelle 
peak. 
Radiolabelled 4:2 and 6:2 PLA-PEG particles (10 ml, 1% w/v, 0.0025 mllllln) were 
prepared in water as described in the serun:t stability experiment (section 6.3.1). Free 
indium was again separated from labelled particles by GPC using a sepharose CL-4B 
column (10 cm) and purified water as eluent. The most active fractions were pooled to 
be injected for the biodistribution studies. 
6.4.3 Rat Biodistribution Studies 
Radiolabelled 1.5:2 and 2:5 PLA-PEG micelles (0.2% w/v, 0.1 ml; 5.4% w/v, 0.5 ml) 
were injected into groups of three female Wistar rats (150 g ± 10 g) via the tail vein. 
Blood samples (la Jll) were taken from the tail at 0.25, 0.5, 1, 2 and 3 hours post 
injection. At 3 hours post-injection the rats were sacrificed and the liver, spleen, lungs, 
kidneys and one femur removed. The remaining activity in the organs and blood was 
counted using a gamma spectrometer (Compugamma, LKB, Wallac, Finland), and the 
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carcass activity detennined, for the higher concentration study, using a well counter (EG 
and G Ortec, Bracknell, UK). Free indium-l 11-oxine was similarly studied as a control. 
This experiment was performed in collaboration with Susan E. Dunn. 
4:2 and 6:2 PLA-PEG particles were injected (0.3 ml, 1 mg) into groups of three female 
Wistar rats (150 g ± 109) via the tail vein. Blood samples (20 , .. d) were taken from the 
tail at 0.25,0.5, 1,2 and 3 hours post injection. At 3 hours post-injection the rats were 
sacrificed and the liver, spleen, lungs, kidneys and one femur removed. The remaining 
activity in the organs, blood and carcass were counted as for the micelles. Free indium-
111-oxine was again studied as a control. This experiment was performed in 
collaboration with Helen Redhead. 
6.4.4 Results of Biodistribution Studies on PLA-PEG Micelles 
The biodistribution results are presented in Figure 6.6 and the blood clearance in Figure 
6.7, with control values for free indium oxine also included. The results are expressed 
as a percentage of the injected dose and are a mean of the three rats ± standard deviation 
(s.d.) The liver and spleen can be considered to represent the reticuloendothelial system 
(RES). Data for lung, kidney and femur are not presented, since the radioactivity 
associated with these organs was found to be negligible. 
The free indium oxine was partly taken up by the liver, but also circulated in the blood 
at a significant level for the three-hour period of the study. At low concentrations, both 
of the PLA-PEG copolymers appeared to be directed specifically to the liver with no 
increase in spleen uptake levels. Also, blood levels dropped quite rapidly. In contrast, 
at the higher concentrations of copolymer in the blood, there were marked differences 
between the two copolymers. The 2:5 PLA-PEG dispersion showed a similar liver and 
spleen activity levels to that seen with the lower concentrations. However, the 1.5:2 
PLA-PEG exhibited an improved biodistribution, namely a greatly reduced liver uptake 
in comparison to the lower concentration and a corresponding increase in the circulating 
blood levels. The 2: 5 PLA-PEG copolymer at the higher concentration differed from the 
lower concentration only by a slightly higher kidney uptake and attainment of a stable 
blood activity at around 10% of the injected dose. 
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Table 6.2 
Blood Clearance Values for HiKh and Low Concentration PLA-PEG Micelle In vivo 
Studies 
Blood Percentage of Total Dose Injected (%) 
Activity 
lndium- 1.5:2 PLA-PEG 2:5 PLA-PEG l.5:2 PLA-PEG 2:5 PLA-PEG 
111-0xine 5.4 %w/v 5.4 %w/v 0.2 %w/v 0.2 %w/v 
After 1 hour 23.7 ± 14.9 22.7 ± 8.4 14.1±4.9 0.0 ± 3.0 14.2 ± 9.3 
After 2 hours 1l.3 ± 6.1 19.1 ± 5.3 
I 
10.9± 4.2 O.O± 0.0 
I 
O.O±O.O 
After 3 hours 12.1 ± 9.7 19.3 ± 7.6 10.5 ± l.8 2.1 ± 0.0 O.O±O.O 
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Figure 6.6 - Data from Biodistribution Studies of Purified 1.5:2 and 2:5 PLA-PEG Micelles 
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Figure 6.7 - Blood Elimination Curves for 1.5:2 PLA-PEG, 2:5 
PLA-PEG and Indium-111-0xine in the Rat Model 
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6.4.5 Results of Biodistrihutiol1 Studies 011 PLA-PEG Par/ides 
The biodistribution study was performed for the 4:2 and 6:2 PLA-PEG particles, labelled 
with indium (11 1) oxine, and with free indium as a control. Figure 6.8 shows the 
biodistribution results, and Table 6.3 the blood clearance. The results are again 
expressed as a percentage of the injected dose and are a mean of the three rats ± standard 
deviation (s.d.), with the data for lung, kidney and femur not presented as negligible 
radioactivity was associated with these organs. The liver and spleen can be considered 
to approximate to the reticuloendothelial system (RES). These data show that at three 
hours, the particles were directed predominantly to the liver, with 76.5% of the 
administered activity measured as being in the liver for 4:2 PLA-PEG and 68.0% for 6:2 
PLA-PEG, compared with 10.1 % for free indium. The circulating blood levels were 
correspondingly low after three hours, compared with the free indium. Therefore, the 
PLA-PEG particles apparently contain most of the indium label, even at three hours after 
injection, despite the loss of label seen in the serum stability experiment. These results 
were surprising in light of the circulating blood levels achieved previously with the PLA-
PEG micelles (Table 6.2). Saturation of the RES was considered as a possible 
explanation for these differences, due to the high concentration injected in the micelle 
experiment (5.4% w/v) compared with the lower concentration used for the particles 
(AAl3% w/v). However, when the experiment was repeated at this higher concentration 
to allow direct comparison with the micelle data (4:2 PLA-PEG, 0.5 ml, 5.4% w/v), no 
significant difference was seen between the higher and lower concentrations ofPLA-PEG 
particles. With the higher concentration, 1.9'1/0 of the administered dose was found in the 
blood at three hours and 74.4% in the liver, compared with 2.1 % in the blood and 76.5% 
in the liver for the lower concentration. 
6. 4. 6 Discussion 
Two different concentrations ofPLA-PEG copolymer dispersions were investigated as 
delivery systems in vivo in the rat model. Micelles were expected to be present in the 
blood at the higher concentration. The biodistribution results showed improved results 
for the 1.5:2 PLA-PEG compared with the 2:5 PLA-PEG at the higher concentration. 
ANOVA statistical analysis was performed on the results (Dunn, 1995) and showed that 
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Table 6.3 
Blood Clearance Values for PLA-PEG Particle In vivo Studies 
Blood Activity Percentage of Total Dose Injected (%) 
Indium-l1 l-Oxine 4:2 PLA-PEG 6:2 PLA-PEG 
After 1 hour 37.3 ± 5.7 4.8 ± 0.8 3.3 ±0.6 
After 2 hours 29.8 ±9.7 2.7 ± 0.2 I l.8 ± 0.3 
After 3 hours 27.1±4.6 2.1±0.1 1.4 ± 0.4 
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Figure 6.8 - Data from Biodistribution Studies of Purified 4:2 and 6:2 PLA-PEG Particles 
100 
. 4:2 PLA-PEG 
90 1 06:2 PLA-PEG 
-
• Indium (111) Oxine 
~ ~c 80 
'-' 
"'0 
~ ~ 70 I. ~ ~
.... 
fIl 
.. 
. :: 60 e 
"'0 
N -< 
W ~ ~ 50 
0 fIl 0 
~ ~
~ ~ 40 0 
~ ~
~ ~
eo: 30 .... Cl 
~ ~
CJ 
I. 
~ ~ 20 ~ ~
10 
0 
Liver Spleen Blood 
Rat: 3 hours post-injection (mean/s.d); n=3) 
the liver uptake of the higher concentration 1.5:2 PLA-PEG copolymer was significantly 
improved over both 2:5 PLA-PEG systems and the lower concentration 1.5:2 PLA-PEG. 
This difference between the two copolymers probably reflects differences in the stability 
and packing of the copolymer molecules within the micelle structure. The closer packing 
of the 1.5:2 PLA-PEG may lead to an increased surface density of the stabilising PEG 
at the surface of the micelle. Dunn et al (1994) have shown a direct relationship between 
surface density of PEG and the uptake ofa colloidal delivery system by the RES, with 
increased surface density leading to a reduction in uptake. The similarity in Tc values 
between the two PLA-PEG copolymers at higher Na2S04 concentrations also support 
this (section 4.4.3). Despite the longer PEG chain length of 2:5 PLA-PEG (which 
reduces uptake by the RES (Illum et ai, 1987)), the increased PEG surface density 
conferred on the 1.5:2 PLA-PEG micelles by its higher aggregation number and closer 
packing allows comparable steric stabilisation. Free indium-l11-oxine is partly 
eliminated from the circulation by the kidneys, and partly complexed to plasma proteins 
such as transferrin, as described previously. This accounts for the different 
biodistribution profile to that seen with the PLA-PEG copolymers, even though the blood 
levels at the three-hour time point are not significantly different. 
At the lower concentrations, removal of the delivery system from the circulation to the 
liver is more rapid than that for free indium-lll-oxine, suggesting that the oxine remains 
complexed, but in a non-micellar fonn. This is possibly an unimer form where the steric 
shielding would be less effective. ANOVA showed that the 1.5:2 PLA-PEG blood 
circulation result was significantly better at three hours with the higher concentration 
(5.4% w/v injected) than the lower concentration, but that there was no significant 
difference between the two concentrations of2:5 PLA-PEG. No significant differences 
were found with ANOVA between any of the spleen values. 
Differences in the biological behaviour of micelle-forming copolymers with different 
compositions and concentrations have been noted previously. Yokoyama et al (1994d) 
noticed differences in the antitumour activities of PEG-P(Asp(ADR)) micelles, where 
ADR is conjugated adriamycin (section 1.9), between different compositions of 
copolymer conjugates. As the higher anti-tumour activities corresponded to the samples 
with the higher peak ratios of micelles (as measured by GPC), they concluded that only 
the compositions ofPEG-P(Asp(ADR)) which formed micelles were effectively delivered 
to the tumours. Non-associated PEG-P(Asp(ADR)) was not effective in inhibiting 
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tumours in this study and would be expected to exist as free polymer chains and renally 
clear in less than one hour (Kwon et aI, 1993). Free polymer chains with a molecular 
weight of less than 50,000 gmor l have been shown to be renally cleared within minutes 
of intravenous injection (Kwon et ai, 1994b), although this does not occur with the PLA-
PEG copolymer molecules. 
The results for the 4:2 and 6:2 PLA-PEG particles show a large accumulation in the liver. 
There is no significant difference between the two different copolymer systems. This 
similarity between the two systems may be expected due to their similar PEG chain layer 
thicknesses (section 4.2.5) and similar response in the presence of salt (section 4.4.3). 
However, the direction of the PLA-PEG particles predominantly to the liver was not 
expected. Previously in this thesis, the surface characteristics of these particles have been 
studied, and the presence of PEG identified at the surface of the particles. This PEG has 
also been shown (by XPS, section 4.3.4) to be of a similar surface density to that of 
particles coated with poloxamers and poloxarnines, and PEG-grafted particles which have 
avoided the RES. Furthermore, the cloud point experiments (section 4.4.3) 
demonstrated steric stability in the presence of salt ( sodium sulphate), which also 
suggests possibility for avoidance of the RES. It would therefore be surprising if the 
particles were unable to avoid RES capture, as is suggested by the high percentage of the 
injected dose found in the liver in these experiments. A possibility is that the particles 
have succeeded in extravasating through the fenestrations in the endothelium of the liver 
(section 1.3.1). If this occurred, the particles may be taken up by the hepatocytes that 
lie between the sinusoids of the liver. J:.toerdink et al (1984) showed that small 
unilamellar vesicles (diameter 25-80 run) composed of sphingomyelin, cholesterol and 
phosphatidylserine (ratio 4:5: 1) were taken up by the liver after intravenous injection into 
rats. They separated the liver cells into non-parenchymal cells (Kupffer cells), endothelial 
cells and parenchymal cells (hepatocytes) by elutriation centrifugation analysis. They 
found that although Kupffer cells were actively involved in the uptake of these vesicles, 
the parenchymal cells also took up substantial amounts. By comparison, the endothelial 
cells did not associate with the vesicles. Similarly, it is possible that the PLA-PEG 
particles are associating with the hepatocytes as their small size may allow them to 
penetrate through the fenestrations of the endothelial lining of the liver sinusoids. Further 
experimentation was therefore required to investigate the intrahepatic distribution of the 
injected PLA-PEG particles. 
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6.5 LIVER DISTRIBUTION STUDY OF 4:2 PLA-PEG PARTICLES 
6.5.1 Method 
To discover the fate of the PLA-PEG particles in the rat liver after intravenous injection, 
an experiment was perfonned, whereby 4:2 particles were radiolabelled and injected as 
described previously (section 6.4.2) into two female wistar rats (150 g ± 109). The 
livers were removed after three hours, and examined using an adaptation of the method 
for the isolation of non-parenchyma I cells described in Dunn (1995). After three hours, 
each rat was anaethetised using an intraperitoneal injection of pentobarbitone (0.5 ml, 60 
mg/m!) (Sagatal, Rhone Poulenc, Dagenham, UK). Each rat was then secured to a 
surgical board and the liver exposed, cannulated and perfused with HBSS (Hank's 
balanced salt solution) buffer (pH 7.4, 37 QC, 10 mIfmin), while massaging the liver to 
remove residual blood. This was followed by 100 ml ofHBSS buffer containing 0.033% 
w/v collagenase type IV and 0.033% w/v calcium chloride at a slower flow rate of3.2 
ml/min, with continued massaging of the liver to breakdown the liver structure. The liver 
was then removed and washed with ice cold HBSS, before passing through a nylon gauze 
to generate the cellular components. The cell suspension was then centrifuged at 50 g 
for two minutes at 4 QC using a Heraus Christ Minifuge T. Most of the hepatocytes 
collect as a pellet, so the supematants were removed and the pellets resuspended and 
centrifuged for a further two minutes twice at 50g, with the pellets retained, to ensure 
complete removal of the hepatocytes. The activity in the pellets was then measured with 
a gamma counter. The combined supematants were then centrifuged at 2500 rpm for 5 
minutes at 4 QC, with the pellets removed and retained. This was then repeated twice to 
ensure complete removal of cellular components. The remaining supematants were then 
counted for activity using the gamma counter. The pellets were then resuspended in 10 
m! of ice cold HBSS buffer. These pellets contained non-parenchymal cells, erythrocytes 
and other cellular debris. Two tubes containing 7 m1 of Nycodenz density gradient 
(Nycoprep, Nycomed, Sweden) were then taken, and 5 ml of the resuspended pellet 
added to each tube. The tubes were mixed by inversion and 1 ml of cold HBSS buffer 
overlayed onto each tube before centrifuging at 2420 rpm for 15 minutes at 4 QC. The 
non-parenchymal cells collect at the interface of the density gradient and buffer, and were 
removed carefully, using a plastic disposable pipette. The pellet, which had collected at 
the bottom of the Nycodenz tube was separated from the Nycodenz supematant, and 
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both were counted for activity The non-parenchyma! cells were then washed with cold 
HBSS twice (2500 rpm, 5 minutes), resuspended in HBSS and both were counted for 
activity. The results therefore give a percentage of the activity associated with the cells 
and the other stages of the process. 
This experiment was performed in collaboration with Helen Redhead and 10nathan Neal. 
6.5.2 Results 
Table 6.4 shows the results of this experiment, separated into parenchymal cells 
(hepatocytes) and non-parenchyma! cells (Kupffer cells and endothelial cells). The 
difference in the activity in these cells and the total activity in the liver was distributed 
between the supernatant solutions and sedimented pellets of other liver constituents. 
These results show that there does not appear to be significant uptake of the PLA-PEG 
particles by the Kupffer cells of the RES, with less than 2% of the total injected dose 
measured in these cells. Conversely, there appears to be a significant amount of 
radioactivity associated with the hepatocytes. 
6.6 GENERAL DISCUSSION OF IN VIVO STUDIES 
The free indium-lll-oxine control shows a distinctly different biodistribution pattern 
from the PLA-PEG micelles and particles. This indicates that indium-lll-oxine 
incorporated in micelles and particles is sufficiently associated with the PLA-PEG 
polymers throughout the experiments, a l l o ~ n g g the polymer micelles or particles to be 
followed, despite the results ofthe serum stability experiment. Yokoyama et at (1994a) 
noted a similar change in biodistribution patterns between free adriamycin and adriamycin 
conjugated to poly(aspartic acid)-poly(ethylene glycol) micelles, with the biodistribution 
of the adriamycin being noticeably different after micellar incorporation. The blood 
concentration of adriamycin was significantly lower than that for the micelles conjugated 
with adriamycin, and the micelles remained circulating in the blood for a much longer 
time period. 
The micelles and particles give distinctly different biodistribution results when comparing 
the liver values and blood. Particle uptake of the 4:2 and 6:2 PLA-PEG by the liver is 
noticeably higher than the liver uptake for the l.5:2 and 2:5 PLA-PEG micelles, although 
a significant amount of 2:5 PLA-PEG micelles are directed to the 
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Table 6.4 
Location of 4:2 PLA-PEG Particles in the Rat Liver After Differential CentrijuKalion 
Percentage of Accumulated Percentage of Total Dose 
Cell Subtype Liver Dose (%) Injected (%) 
Liver (1) Liver (2) Rat (1) Rat (2) 
Parenchymal cells 33.9 28.1 23.9 21.3 
Non-parenchymal cells 2.1 lA 1.5 1.0 
Total dose in liver (%) - - 70.5 75.9 
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liver. The 2:5 PLA-PEG micelles may behave similarly to the 4:2 and 6:2 PLA-PEG 
particles, considering the significant liver uptake (49.0% of the injected radioactivity 
dose) and the relatively low blood levels (10.5% of the injected radioactivity dose at 
three hours). 
Analysis of the liver distribution experiment described above looks promising with more 
than 20% of the injected radioactivity found to be associated with the hepatocytes. 
Targeting of colloidal carriers to the hepatocytes could lead to better treatments for liver 
diseases such as cancer and hepatitis. However, the above experiment is very much a 
starting point, and the technique of centrifugation may not allow total separation of the 
different groups of cells, which may lead to error. It is also possible that part of the 
indium-Ill-oxine label could be released in these in vitro conditions, as the stability 
study above illustrated the significant release of the complex in vitro, both in PBS and 
serum. As no control was done to show the location of free lllIn in the liver 
(accumulation in the liver was low in the in vivo experiments at 10.1%), there is no 
guarantee that free indium is not affecting the results. This method of separating 
hepatocytes has also yet to be fully validated. It is clear therefore that although these 
results may be promising, further clarification is required. 
The possibility that the radioactivity in the liver is due to some uptake by the RES must 
therefore be considered. It is interesting in the light of the in vivo results to note the 
difference between the 1.5:2 PLA-PEG chain layer thickness and the 4:2 and 6:2 PLA-
PEG thicknesses. A PEG chain layer thickness of approximately 5-6 nm is considered 
reasonable to provide steric stabilisation for colloidal systems (AlIen, 1994b). This 
thickness of the PEG chain would allow a large number of possible conformations of the 
PEG in aqueous solution, a high transition rate from one conformation to another, with 
increased mobility of the chains. This would therefore decrease the probability of the 
proteins in the blood adsorbing to the micelle/particle surface, and hence decrease uptake 
by the RES. With the smaller PEG layer thicknesses involved with the 4:2 and 6:2 PLA-
PEG particles, the mobility, the number of conformations and the transition rate of the 
PEG chains will be reduced, increasing the risk of protein adsorption. If the uptake is by 
the RES, this may be significant in considering why the 1.5:2 PLA-PEG micelles circulate 
for longer time periods in the blood compared with 4:2 and 6:2 PLA-PEG which are 
quickly taken up by the liver. As already discussed, the PEG chain length and layer 
thickness has to be of a requisite value before steric repulsion will occur, and the surface 
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density of the PEG is also important. Although the 4:2 and 6:2 PLA-PEG particles may 
have the required PEG surface density (shown by the XPS results), the PEG chain layer 
thickness is shorter and less hydrated than for the 1.5:2 PLA-PEG micelles, despite 
having the same PEG chain length of2000. Conversely, the 2:5 PLA-PEG micelles have 
a significantly longer chain length of 7.47 nm, but due to this higher hydrophilicity (PEG 
chain length of 5000), it has a lower association number and hence, an expected lower 
surface density of PEG. As the combination of both PEG chain layer thickness and 
surface density are thought to be important, it is conceivable that the PLA-PEG micelles 
and particles are being taken up by the RES. 
The high percentage ofPLA-PEG particles in the liver at three hours may be related to 
particle size. It has been illustrated with liposomes composed of phosphatidylcholine, 
cholesterol and the ganglioside GM. with diameters less than 70 run, that 70% of the 
injected doses were directed to the liver (Liu et ai, 1992), which is similar to the PLA-
PEG results. The authors concluded that this was presumably due to uptake by the 
parenchymal cells. Similarly, for PEG-containing liposomes, regardless of the 
phospholipid composition, it was observed that those with diameters of less than 90 nm 
were predominantly taken up by the liver (AlIen, 1994b). More recently, Litzinger et al 
(1994) used fluorescence microscopy to explore the uptake of smaller liposomes (i.e. less 
than 70 nm diameter) composed of dioleoyl-N-(monomethoxypoly(ethylene 
glycol)succinyl)-phosphatidylethanolamine (pEG-PE) by the liver. The liposomes were 
labelled with DiI (1, 1 '-dioctadecyl-3,3,3',3 '-tetramethylindocarbocyanine perchlorate) and 
used to examine the intrahepatic distribution. Liposomes of less than 70 nm were not 
detected in areas corresponding to the parenchymal cells, but were found to be localised 
in the Kupffer cells. However, it was also considered that due to the spread of the 
hepatocytes over a relatively large area of the liver, any fluorescence associated with the 
hepatocytes might be too dispersed to be detected by this technique. Therefore, it could 
not be conclusively stated that there was no association with hepatocytes by the small 
liposomes, although it appears that Kupffer cell uptake accounts for at least some of the 
liver uptake. Furthermore, Liu et al (1992) investigated the effects of RES blockade with 
dextran sulphate 500 on the fate ofliposomes containing GM!. They found no significant 
difference before and after blockade, whereas if the liposomes were in the Kupffer cells, 
a decrease in the liver uptake would be expected. Litzinger et al (1994) further explored 
their findings by studying protein adsorption to the PEG-PE liposomes. They found that 
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the smallliposomes bound protein much more avidly than the larger liposomes, with the 
ratio of protein to lipid increased to approximately 45-fold more for the smaller 
liposomes than for liposomes of average diameter 151 nm. Experiments where the 
percentage of PEG-PE in the liposomes was altered and then the liposomes exposed to 
the protein streptavidin, gave similar results. For the same concentration of PEG-PE, the 
smaller liposomes bound 20% of the available streptavidin compared with 3% for the 
larger liposomes (PEG-PE concentration of 5.0 mol%). This greater protein adsorption 
by the small liposomes was attributed to an increase in their curvature compared with 
larger liposomes, such that the extended PEG chains splay to a greater degree, allowing 
protein to penetrate to the more hydrophobic surface. This may also explain why the 
1.5:2 PLA-PEG micelles manage to avoid uptake by the liver better than the other PLA-
PEG systems. The increased surface density of PEG of the 1.5:2 PLA-PEG micelles 
over the 2:5 PLA-PEG micelles, combined with the PEG chain layer thickness, prevents 
protein adsorption. However, the surface density of the 2:5 PLA-PEG micelles is not 
enough to prevent the proteins from penetrating to the hydrophobic PLA core, despite 
the longer chain length. 
Although the results for the 1.5:2 PLA-PEG copolymer are encouraging, longer 
circulation times have been obtained with micelles elsewhere. Stable micelles ofless than 
100 nm in size were prepared from an ABA block copolymer, poly( oxyethylene-b-
isoprene-oxyethylene) (pOE-PI-POE), by crosslinking the chains in the hydrophobic 
(polyisoprene) core. These nonbiodegradable micelles were shown to remain In 
circulation in mice with a halflife of more than 50 hours (Rolland et ai, 1992). 
Kwon et al (1993) have demonstrated long circulation times in blood in mice using 
poly(aspartic acid) P(Asp)-poly(ethylene glycol), PEG-P(Asp(ADR)), block copolymer 
micelles, conjugated with adriamycin. For one copolymer (Mw P(Asp) = 2100, PEG = 
12000), approximately 68% and 10% ofthe injected dose were still present in the blood 
after four hours and twenty-four hours respectively. A corresponding low uptake in the 
liver and spleen of28% and 3.5% at twenty-four hours was observed for this copolymer 
conjugate. The long circulation of these micelles in the blood was attributed to the low 
interaction between the PEG corona outer region of the micelles and the biocomponents. 
They noted that relatively longer PEG block lengths and shorter P(Asp) blocks gave 
better circulation times and lower RES uptake. 
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6.7 SUMMARY 
Serum stability studies have been perfonned to investigate the stability of the radioactive 
label, indium-l1 l-oxine, when incubated in 50% v/v rat serum for five minutes, three 
hours and 24 hours at 37 0c. These indicated that although the radiolabel was 
incorporated efficiently into the micelles and particles, a proportion was rapidly released 
on exposure to the serum. This bound to the serum proteins (illustrated by GPC), 
probably mostly to transferrin. The percentage of radio label bound to the serum proteins 
increased as the incubation time increased, with a corresponding decrease in the lllIn 
associated with the PLA-PEG particles. 
However, in vivo studies in the rat showed that the indium-lll-oxine appeared to remain 
associated with the PLA-PEG systems, giving markedly different biodistribution results 
to that offree indium-lll-oxine. PLA-PEG micelles demonstrated extended circulation-
times in the blood during the period of study (three hours). The 1.5:2 PLA-PEG showed 
increased blood levels and lower uptake of the micelles by the liver compared with the 
2:5 PLA-PEG micelles. This is thought to be due to differences in the packing density 
of the copolymer molecules on the micelle surface. 
PLA-PEG particles, however, were directed to the liver. This could be due to their 
ability to penetrate through the fenestrations of the liver sinusoids and hence associate 
with the hepatocytes. A liver distribution experiment with the 4:2 PLA-PEG particles 
showed more than 20% of activity associated with the hepatocyte fraction. However, 
it is still possible that some RES uptake by .the Kupffer cells is occurring, as has been 
shown previously with PEG-PE-liposomes (Litzinger et ai, 1994). 
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CHAPTER SEVEN 
OVERVIEW AND FUTURE WORK 
7.1 SUMMARY 
Previous work in our group in the field of drug targeting has centred mainly on 
nondegradable particles, such as polystyrene. More recently, other polymers have been 
explored in an attempt to reproduce the findings of this earlier work with biodegradable 
polymers. The objectives of the research described in this thesis were to explore the 
potential of a group of biodegradable polylactide (PLA) and poly( ethylene glycol) (pEG) 
AB block copolymers for use as drug delivery systems. A range offour copolymers was 
available and these differed in the ratio of PLA to PEG in each copolymer. These 
copolymers are therefore defined by the molecular weight ratios of their polylactide to 
poly( ethylene glycol) components. This research aimed to characterise these copolymers 
through physicochemical analysis, drug loading and biodistribution in an appropriate 
animal model. 
Copolymers of polylactide and poly( ethylene glycol) (pLA-PEG), which contained a 
higher proportion of the hydrophilic PEG block than the more hydrophobic PLA block 
per copolymer molecule, were able to self-disperse in water to form spherical non-ionic 
micelles. Two peaks were produced when the copolymers, l.5:2 PLA-PEG and 2:5 
PLA-PEG, were purified by gel permeation .chromatography (GPC). The first peak was 
shown by analysis with dynamic light scattering (DLS) and transmission electron 
microscopy (TEM) to consist of spherical micelles, with a diameter of15.6 nm for 1.5:2 
PLA-PEG micelles and 18.9 nm for 2:5 PLA-PEG micelles. The second peak was a 
PLA-depleted species resulting from the synthesis, which did not form micelles. These 
micelle sizes were in the size range required for long circulation in the blood, and were 
also small enough to pass through the fenestrations in the liver endothelium. 
Copolymers of polylactide and poly( ethylene glycol), which contained more of the 
hydrophobic PLA block than the PEG block per copolymer molecule, formed more stable 
"solid particle" structures when prepared by the solvent-precipitation method. These 
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particles were defined as 4:2 and 6:2 PLA-PEG, and again gave two peaks on GPC 
analysis, of which the first peak fonned particles. The second peak was significantly 
smaller than for the micelle-forming copolymers. After analysis by DLS, particle sizes 
of 15.1 nm and 20.8 nm were determined for 4:2 PLA-PEG and 6:2 PLA-PEG particles 
respectively. Particle formation of this magnitude was also noted with TEM and atomic 
force microscopy (AFM). 
Surface analysis studies, by static secondary ion mass spectrometry (SIMS) and X-ray 
photoelectron spectroscopy, of the particle-forming PLA-PEG copolymers (4:2 and 6:2 
PLA-PEG) showed PEG at the surface of both the copolymer in acetone and the particles 
in aqueous media. PEG surface density was also comparable with polymer systems that 
have shown avoidance of the reticuloendothelial system (RES) in the rat in in vivo 
studies. This indicated that the PLA-PEG particles should be able to avoid the major 
RES uptake seen with the hydrophobic PLA and PLGA particles. Stability testing in the' 
presence of salt (sodium sulphate) also suggested that the micelles and particles had 
sterically stabilised surfaces. The PEG chain layer thicknesses were determined by 
rheological measurements for all four copolymers and found to vary from 2.3 om to 7.5 
om. The greatest chain layer thickness of7.5 om was seen with 2:5 PLA-PEG, which 
has a longer PEG chain length of50oo gmor1, compared with 2000 gmor1 for the other 
three copolymers. Despite having the same chain length of2000 gmor\ l.5:2 PLA-PEG 
micelles had a larger PEG chain layer thickness and greater hydration than the 4:2 and 
6:2 PLA-PEG particles. 
Testosterone and Sudan Black B (SBB), which have different hydrophobicities, were 
used as "model drugs" to evaluate the drug loading ability of the micelles and particles. 
Ultracentrifugation sedimentation velocity studies confirmed that the model drugs had 
been incorporated into the micelles and particles. Higher drug loading was obtained for 
the l.5:2 PLA-PEG micelles than for the 2:5 PLA-PEG micelles, and the amounts 
incorporated into the particle forming PLA-PEG copolymers were higher than for the 
micelles. A general trend of increased drug loading with increased molecular weight of 
PLA-PEG copolymers was apparent, but more pronounced for the testosterone loading. 
The amount of aromatic SBB incorporated into the PLA-PEG systems was substantial 
(59.00/0 w/w and over) compared with the steroidal testosterone, which was significantly 
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lower than SBB for all copolymers (less than 2% w/w). To investigate the reason for 
this, a range of testosterone esters of varying hydrophobicity were incorporated into 4:2 
PLA-PEG particles, to study if hydrophobicity was the determining factor in drug 
incorporation. However, the difference in loading between the testosterone esters was 
small in comparison with the large difference observed with between testosterone and 
SBB. Therefore, it can be concluded that although hydrophobicity may play a role in 
drug loading, the aromatic nature of SBB is likely to be the more significant factor. This 
is because it is energetically more favourable to incorporate aromatic than aliphatic 
compounds (Nagarajan et ai, 1986). 
In vitro release studies, using 4:2 PLA-PEG particles loaded with SBB (37°C, phosphate 
buffered saline, pH 7.4), were performed. These showed that after an initial small burst 
release over the first three hours of the study (approximately 14% of the SBB 
incorporated was released), the drug release was linear to the end of the experiment at 
twenty-eight days (when approximately 89% of SBB had been released). The burst 
release was probably due to SBB incorporated in the PEG layer at the surface of the 
particles. The possibility of using PLA-PEG particles as sustained release drug delivery 
systems is therefore illustrated by these results. 
Having established that the PLA-PEG copolymers fonned micelles and particles with 
PEG at the surface, and were able to incorporate and release drug, the in vivo fate of the 
systems was studied. A radioactive marker was needed to allow the biodistribution of 
the PLA-PEG systems to be determined. Indium-l1 l-oxine was chosen, as it had 
previously been used with both PLA (Muller et ai, 1988) and PLGA particles (Scholes 
et ai, 1992), and was a lipophilic complex that should easily incorporate. This radiolabel 
was readily incorporated into the PLA-PEG micelles and particles, with a good 
incorporation efficiency. However, subsequent stability studies performed, at 37°C in 
50010 v/v rat serum, to assess the retention of the label by the particles in simulated in vivo 
conditions, showed that considerable lllindium was lost from the PLA-PEG particles. 
This became bound instead to serum components (most likely the protein transferrin, 
with which indium forms a more stable complex than with oxine). Three time points 
were studied: five minutes, three hours and 24 hours, and the percentage of radiolabel 
bound to the serum proteins increased as the incubation time increased, with a 
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corresponding decrease in particle-associated lllIn. 
However, ill vivo studies in the rat showed that the indium-Ill-oxine appeared to remain 
associated with the PLA-PEG systems, giving markedly different biodistribution results 
to that of free indium-Ill-oxine. PLA-PEG micelles, at high concentration, 
demonstrated extended circulation times in the blood during the period of study (three 
hours). The l.5:2 PLA-PEG showed increased blood levels and lower uptake of the 
micelles by the liver compared with the 2:5 PLA-PEG micelles. This is thought to be due 
to differences in the packing density of the copolymer molecules on the micelle surface. 
The PLA-PEG particles were directed to the liver on intravenous injection into the rat 
model. Further studies are necessary to elucidate whether the particles have been 
captured by the reticuloendothelial system or if their small size has allowed them to 
penetrate through the fenestrations of the liver sinusoids and associate with the 
hepatocytes. A liver distribution experiment with the 4:2 PLA-PEG particles showed 
more than 20010 of activity associated with the hepatocyte fraction. Some RES uptake 
by the Kupffer cells may still be occurring, as has been shown previously with PEG-PE-
liposomes (Litzinger et ai, 1994). 
7.2 FUTURE WORK 
PLA-PEG copolymers have been successfully characterised in this thesis and show 
promise for the future. The requirements of having sterically stabilised systems with PEG 
at the surface and a hydrophobic core for drug incorporation have been fulfilled, and the 
micelles and particles are sub-2oo nm in size. Furthermore, substantial model drug has 
been incorporated, and released from PLA-PEG systems. This work therefore gives a 
promising basis for further study of these copolymers and the possibility of a 
biodegradable drug delivery system, which could be used for drug targeting purposes. 
However, the range of copolymers studied so far has been fairly limited. This has made 
it difficult in some cases to predict the trends of the data collected. Expanding the range 
of copolymers will therefore allow more information to be gained from results and 
increase the understanding of these systems. In some areas, such as the rheological 
experiments to calculate PEG chain layer thickness, expanding both the particle-forming 
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systems and the micelle-fonning systems would be useful. This would allow insight into 
the effect of having a micellar or particulate system on the PEG chain layer thickness. 
As the micelle-forming copolymers have also been used as coatings for polystyrene or 
PLGA particles, a comparison of the PEG chain layer thickness values of 1.5:2 PLA-
PEG and 2:5 PLA-PEG physically adsorbed onto these particles with the micelle values 
would give infonnation on the difference between the PEG chain layer thickness of self-
fonning systems as opposed to coated systems. The density ofPLA-PEG copolymers 
should also be measured to verify the assumption made in the rheology work that the 
density of PLA-PEG copolymers ~ ~ 1 gcm-3 . Small angle neutron scattering (SANS) 
could also be perfonned on the PLA-PEG copolymers to provide comparative values of 
the hydrophobic core radius, Rc and PEG chain layer thickness, Il. 
Drug loading of PLA-PEG copolymer systems has been fairly successful so far. 
However, more pharmaceutically relevant drugs should be explored in later work. The 
in vitro release studies also look promising, and studies performed at different 
concentrations of SBB are required to study the effect of drug loading on release. 
Detennination of the glass transition temperatures (T g) of PLA-PEG copolymers by 
differential scanning calorimetry (DSC) would give a comparison of the release rate 
between the different PLA-PEG copolymers. The lower the glass transition temperature, 
the faster the release. Similarly, an in depth degradation study should be performed to 
determine whether drug release follows degradation of the copolymer. This has 
implications for in vivo fate of the PLA-PEG systems, as the PEG chains could be 
cleaved by hydrolysis, thus removing the hydrophilic steric shell. An in vivo drug release 
would also be of value. 
Although the problems exposed in the serum stability experiment do not appear to have 
affected the in vivo results, finding a radiolabel that is more stable in the presence of 
serum would be instructive. A possible option is the complex, indium-l11-DTPA-SA, 
(the distearylamide of diethylenetriaminepentaacetic acid), which has successfully been 
used by other researchers in drug delivery (Klibanov et ai, 1991; Torchilin et ai, 1994; 
Gref et ai, 1994). The fate of PLA-PEG particles in the liver also needs investigating 
more closely, as discussed in chapter six, to discover if any of the PLA-PEG particles are 
associating with the hepatocytes or if the uptake is by the RES. If the RES is the source 
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of uptake, then changing the copolymer block lengths or the particle preparation method 
to produce larger particles (preferably more than 70 nm) may resolve the problem. 
In conclusion, there is much scope for future work on the PLA-PEG copolymer series. 
The promise of a biodegradable drug delivery system for drug targeting may not yet be 
reality, but these systems represent a further step forward. 
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APPENDIX ONE 
Nuclear Magnetic Resonance (NMR) Trace ofUnfractionated 1.5:2 LPLA-PEG 
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